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Mammalian cell entry (MCE) domains are so called due to the reported ability of an 
Escherichia coli strain harbouring the mce1 gene from Mycobacterium tuberculosis to 
invade mammalian cells. Bioinformatic analyses presented here demonstrated that proteins 
containing a single MCE domain are widespread in bacteria and that proteins containing 
multiple MCE domains are specific to and have evolved within Proteobacteria. Gene 
neighbourhood analyses revealed that MCE domain containing proteins are components of 
transporters and that multi MCE domain containing proteins constitute a novel type of 
transporter. E. coli was shown to harbour three MCE proteins: the single MCE domain 
protein MlaD and two multi-domain proteins PqiB and YebT. All three proteins were shown 
to locate to the inner membrane and bind phospholipids. Phenotypic studies revealed that 
their functions overlap but are distinct. Infection studies with Salmonella showed that the 
proteins are important for systemic infection but are not required for mammalian cell entry. 
Phospholipid growth experiments with Salmonella demonstrated that they are important 
for phospholipid uptake. These findings suggest that MCE domain containing proteins in 
Proteobacteria are not directly involved in mammalian cell entry and instead play a role in 
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1.1. Introduction  
Mammalian cell entry (MCE) domains are a type of protein domain that were first identified 
in Mycobacterium tuberculosis, where insertion of a gene from M. tuberculosis into non-
pathogenic Escherichia coli (E. coli) was shown to allow the bacterium to enter and survive 
in mammalian cells (Arruda et al., 1993). It is because of this acquired ability that this gene 
was named mce1A, for mammalian cell entry.  
 MCE domains are widespread in bacteria but their function has primarily been 
studied in Actinobacteria. Most literature suggests that MCE domain containing proteins 
are important for infection and are often implicated in lipid transportation and 
maintenance of the bacterial cell surface. The few studies that examine MCE domains in 
Gram-negative bacteria generally report a link to lipid trafficking, particularly of 
phospholipids, which are essential components of cell membranes. 
In this thesis, the evolution and distribution of MCE domains is investigated 
through a thorough bioinformatic analysis. The function of MCE domains is then studied in 
E. coli in order to understand more about their function in Proteobacteria, with particular 
focus on their role in phospholipid trafficking. Furthermore, Salmonella infection is used as 
a model to investigate whether MCE domain containing proteins are important for infection 
in Proteobacteria, given the known importance of MCE domains in Actinobacterial 
infection. 
 This introduction chapter summarises what is currently known about the field, and 
lays the foundations for an understanding of why the work presented in this thesis is 
important. The cell envelope of Gram-negative bacteria and the pathways involved in 
assembly and maintenance of the outer membrane are summarised, with particular focus 
on fatty acid and phospholipid metabolism. The Salmonella murine infection model is 





1.2. The cell envelope of Gram negative bacteria 
The Gram-negative bacterial cell envelope is a complex entity that is essential for the 
protection of bacterial cells against the external environment. The envelope consists of three 
major structures: the outer membrane, peptidoglycan and the inner membrane (Figure 1.1). 
The outer membrane is an asymmetrical lipid bilayer that consists of a lipopolysaccharide 
(LPS) outer leaflet and phospholipid inner leaflet. The outer membrane contains many 
integral outer membrane proteins (OMPs) and lipoproteins that are anchored to 
phospholipids and either face into the periplasm or are on the cell surface. In contrast to the 
outer membrane, the inner (cytoplasmic) membrane is a symmetrical phospholipid bilayer. 
The inner membrane contains integral inner membrane proteins (IMPs) and lipoproteins 
that anchor to the outer leaflet of the inner membrane. Between the inner and outer 
membranes lies the periplasm, which contains a polymer essential for maintaining cell 
structure and rigidity: the peptidoglycan cell wall.  
The major difference between Gram-negative and Gram-positive bacteria is that 
Gram-positive bacteria lack the outer membrane and have a much thicker layer of 
peptidoglycan, which is surface exposed. The additional membrane in Gram-negative 
bacteria acts as a selectively permeable barrier that allows influx of nutrients while 
preventing entry of harmful compounds such as antibiotics, detergents and antimicrobial 
peptides (Nikaido, 2003). 
1.2.1. Integral inner membrane proteins and the Sec translocon 
The inner membrane of Gram-negative bacteria contains many important inner membrane 
proteins involved in transport, energy production, lipid biosynthesis and protein secretion 
(Silhavy et al., 2010). One of the most important complexes of the inner membrane is 
SecYEG, which is responsible for the insertion or translocation of nearly all cell envelope 
and secreted proteins across the inner membrane. Most IMPs are targeted to the inner 
membrane by the first transmembrane (TM) region. Other cell envelope proteins 






Figure 1.1. The structure of cell envelope of Gram-negative bacteria. The inner membrane 
(IM) consists of a phospholipid bilayer and contains inner membrane proteins (IMPs). The 
outer membrane consists of an inner leaflet of phospholipids and an outer layer of 
lipopolysaccharide (LPS) and contains outer membrane proteins (OMPs). The membranes 
enclose the periplasm that contains the peptidoglycan cell wall. Lipoproteins (LP) interact 
with both the outer leaflet of the inner membrane and the inner leaflet of the outer 
membrane and face into the periplasm. Alternatively they can locate to the cell surface. 
nn
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of protein translocation and incorporation into the inner membrane are reviewed by 
Luirink et al. (2012). Protein translation occurs in the cytoplasm, at the ribosome. Beyond 
this, there are two possible routes to the Sec translocon: the co-translational signal 
recognition particle (SRP) – dependent pathway or the post-translational (SecB -
dependent) pathway (Figure 1.2). The SRP pathway usually targets the more hydrophobic 
TM regions of IMPs (Luirink and Sinning, 2004). In this co-translational pathway, the SRP 
binds to its target as it emerges from the ribosome exit tunnel (Figure 1.2A). Binding of SRP 
to the nascent peptide chain results in elongation arrest and the ribosome-SRP-peptide 
complex passes towards the inner membrane to bind the FtsY receptor. Upon binding to 
FtsY, SRP is released and elongation is continued (Luirink et al., 2012; Miller et al., 1994). 
At the inner membrane, the ribosome interacts with the SecYEG/YidC complex (Nissen et 
al., 2000). YidC is important for insertion, folding and assembly of IMPs, and can act both 
with and independently from the Sec translocon (Scotti et al., 2000). The Sec complex 
consists of the core SecYEG, through which the TM regions of IMPs are inserted into the 
inner membrane. The SecDF-YajC complex that transiently associates with SecYEG may 
also have a role in IMP insertion (Duong and Wickner, 1997).  
 In the post-translational pathway, the less hydrophobic signal sequences of non-
IMP proteins are targeted via the SecB chaperone pathway (Luirink et al., 2005). Although 
this pathway is known as “post-translational”, more recent evidence suggests the pathway 
targets proteins during translation (Huber et al., 2011; Huber et al., 2016). This pathway is 
the usual method of translocation of lipoproteins, periplasmic proteins, OMPs and secreted 
proteins across the inner membrane. SecB chaperones peptides to the SecYEG complex 
independently of the ribosome (Figure 1.2B) (Ullers et al., 2004). Translocation across the 
membrane requires the ATPase SecA that inserts itself into the SecYEG complex (Brundage 
et al., 1990). In particular, it is thought that SecA is required for the translocation of large 
periplasmic loops, which can also occasionally be found in IMPs (Andersson and von 
Heijne, 1993; Luirink et al., 2012). The accessory complex SecDF-YajC also aids in the post-




Figure 1.2. Pathways for the incorporation or translocation of proteins across the inner 
membrane. A. Pathways for the incorporation of inner membrane proteins (IMPs) into the 
inner membrane. Proteins targeted to the inner membrane via the SRP co-translational 
pathway are bound by SRP during translation. The ribosome-nascent chain-SRP complex 
interacts with the FtsY, releasing the ribosome and nascent chain from SRP and allowing 
further translation through SecYEG/YidC at the inner membrane. Some IMPs are 
translocated via YidC alone independently of the Sec translocon and sometimes completely 
independently of SRP. B. The SecB-dependent post-translational pathway for translocation 
of lipoproteins, periplasmic, outer membrane and secreted proteins. SecB chaperones 
polypeptides with a signal sequence to the SecYEG, where the protein is translocated with 
the aid of SecA. In the periplasm the signal sequence is removed. The SecDFYajC complex 
aids the Sec translocon in both the co- and post-translational pathways. C. The TAT 
pathway for the translocation of proteins that are folded in the cytoplasm, with major 





























the protein has been translocated through SecYEG, signal peptidase I (or II for lipoproteins) 
cleaves it from its signal sequence and other cell envelope proteins transport it to its final 
destination (Dev and Ray, 1984; Paetzel et al., 2002).  
SecYEG/YidC are not the only protein complexes involved in translocation across 
the inner membrane. The twin arginine translocation (TAT) system is important for 
translocation of proteins that are folded in the cytoplasm (Figure 1.2C) (Stanley et al., 
2001). In particular, proteins that fold with cytoplasmic cofactors are commonly 
translocated via this pathway (Berks et al., 2003). Proteins translocated via the TAT system 
have a specific N-terminal signal sequence that is defined by two consecutive arginine 
residues, giving rise to the pathway name (Sargent et al., 1998). Generally, it is the lower 
hydrophobicity of the N-terminal signal sequence that may prevent TAT proteins going via 
the Sec pathway (Cristobal et al., 1999). The core proteins in the TAT pathway are TatA, B 
and C. In their inactive state, TatB and C form a complex in the inner membrane, while 
TatA proteins are dispersed in the membrane (Palmer and Berks, 2012). Upon binding of a 
TAT signal sequence to the TatBC complex, TatA is recruited to form an active TatABC 
complex (Palmer and Berks, 2012). The targeted protein passes through the membrane via 
TatA whilst the N-terminal signal sequence remains bound to TatBC and is cleaved by a 
signal peptidase (Palmer and Berks, 2012). Other proteins involved in the TAT system 
include TatD and TatE. TatD is a quality control protein that is involved in the detection of 
misfolded proteins (Matos et al., 2009). TatE is homolgous to TatA and might be recruited 
to either the TatBC or TatABC complex for the translocation of particularly large proteins 
(Baglieri et al., 2012).  
 
1.2.2. Integral outer membrane proteins 
Integral outer membrane proteins are a subset of proteins in Gram-negative bacteria that 
form β-barrels in the outer membrane. One of the most abundant types of OMP are porins, 
which allow passive diffusion of small hydrophilic molecules across the outer membrane 
(Silhavy et al., 2010). Two of the most abundant porins, OmpC and OmpF, are used for 
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general diffusion of molecules across the outer membrane (including amino acids, sugars 
etc) and together they have around 250,000 copies per cell (Cowan et al., 1992). Other 
OMPs, such as TolC, are required for specific functions such as efflux or secretion. In terms 
of efflux, TolC forms the outer membrane component of the multiple efflux pumps, 
including the major AcrAB-TolC system (Fralick, 1996). TolC is also involved in type I 
secretion systems (T1SS), in which it forms the outer membrane factor of multiple secretion 
systems (Durand et al., 2009).  
 As with most proteins destined for the periplasm or outer membrane, OMPs are 
synthesised in the cytoplasm with an N-terminal signal peptide and translocated across the 
inner membrane via the SecYEG complex (Figure 1.3A) (de Keyzer et al., 2003). Periplasmic 
chaperones Skp and SurA are responsible for transporting proteins across the periplasm to 
the outer membrane (Bos and Tommassen, 2004). Although proteins remain largely 
unfolded at this stage, the periplasmic enzyme DsbA can form disulfide bonds between 
cysteine residues before the transported protein reaches the outer membrane (Eppens et al., 
1997). For insertion, OMPs are transported to the β-barrel assembly machinery (BAM) 
complex in the outer membrane. In E. coli, the BAM complex consists of the OMP BamA, 
which forms a complex with four lipoproteins (BamB-E), where both BamA and BamD are 
essential (Malinverni et al., 2006; Wu et al., 2005). In addition to a large β-barrel, there are 
five polypeptide transport-associated (POTRA) domains in BamA that might directly 
interact with OMPs in the periplasm (Sanchez-Pulido et al., 2003).  
 The entire process of OMP synthesis and transport is tightly regulated to prevent 
toxic accumulation of unfolded peptides in the cell. DegP is the major protease responsible 
for degrading misfolded proteins in the periplasm, but can also act as a chaperone under 
certain conditions (Spiess et al., 1999).  An accumulation of OMPs in the cytoplasm or 
periplasm can be toxic for the cell. OMP accumulation in the periplasm induces a σE stress 
response that in turn increases the production of periplasmic chaperones, proteases and the 
BAM complex (Ruiz et al., 2008).  
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Figure 1.3. The pathways for delivery of outer membrane proteins (OMP), lipoproteins 
(LP) and lipopolysaccharide (LPS) to the outer membrane. A. OMPs are translocated across 
the inner membrane and transported across the periplasm by periplasmic chaperones 
(Skp/SurA) to the Bam complex. OMPs are inserted through BamA to form a β-barrel in the 
outer membrane. B. Lipoproteins (LP) destined for the outer membrane are transported 
from the outer leaflet of the inner membrane to the inner leaflet of the outer membrane via 
the Lol pathway. C. The Lipid A-core is synthesised in the periplasm and flipped across the 
inner membrane by MsbA. The O-antigen component is made independently and ligated to 
the Lipid A core at the periplasmic leaflet of the inner membrane. The intact LPS molecule 














n n n n n
LolB 
LolA 























LptC A	 B	 C	
	 10	
1.2.3. Lipoproteins 
In Gram-negative bacteria, lipoproteins are found on the periplasmic side of the inner or 
outer membrane and on the cell surface. There are around 750,000 copies of the most 
abundant lipoprotein, Lpp, in E. coli. It creates a bridge between the OM and peptidoglycan, 
improving cell stability (Braun and Rehn, 1969; Braun, 1973; Inouye et al., 1972). There are 
around 100 different OM lipoproteins in E. coli, for most of which the function is unknown 
(Miyadai et al., 2004).  
As with other cell envelope proteins, lipoproteins are translated in the cytoplasm 
and targeted for translocation across the inner membrane by the Sec machinery (Figure 
1.3B). Whilst still attached to the Sec machinery, Lgt transfers a diacylglycerol group from 
phosphatidylglycerol to the N terminal cysteine residue of the lipoprotein (usually at the +1 
position after the signal sequence) (Sankaran and Wu, 1994). The lipoprotein is cleaved by 
signal peptidase II allowing further acylation of the cysteine by the enzyme Lnt (Dev and 
Ray, 1984; Gupta et al., 1993). At this stage the protein is attached to the membrane via the 
N-terminal acylated cysteine and is considered a mature lipoprotein (Bos and Tommassen, 
2004). The final location of lipoproteins is dependent on whether it harbours an IM 
retention (Lol avoidance) signal. A Lol avoidance signal is recognised as an aspartate 
residue at the +2 position of the mature protein, without which the lipoprotein is 
transported to the OM via the Lol pathway (Bos and Tommassen, 2004; Matsuyama et al., 
1995).  
The Lol pathway consists of an inner membrane ATP-binding cassette (ABC) 
transporter (LolCDE), a periplasmic chaperone (LolA) and an outer membrane lipoprotein 
receptor (LolB) (Figure 1.3C) (Bos and Tommassen, 2004; Matsuyama et al., 1997). 
Lipoproteins fated for the outer membrane are bound independently of ATP by the 
permeases LolC/LolE. This binding creates a conformational change and increases affinity 
of the LolD ATPase for ATP (Bos and Tommassen, 2004). The ATP binding causes a further 
conformational change in LolC/LolE that decreases its affinity for lipoproteins. ATP 
hydrolysis releases the lipoprotein from the LolC/LolE complex onto LolA (Bos and 
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Tommassen, 2004; Ito et al., 2006). The LolA-lipoprotein complex crosses the periplasm to 
interact with the OM lipoprotein, LolB (Matsuyama et al., 1997; Yokota et al., 1999). The 
method by which the lipoprotein is incorporated into the outer membrane remains 
unknown (Okuda and Tokuda, 2011). All five components of the Lol pathway (LolABCDE) 
are essential for cell viability in E. coli (Okuda and Tokuda, 2011).   
 
1.2.4. Lipopolysaccharide biogenesis and transport to the outer membrane 
LPS is the major component of the outer leaflet of the outer membrane in Gram-negative 
bacteria. The molecule forms a tight layer that is low in fluidity and has low permeability to 
hydrophobic solutes, particularly in the presence of divalent cations that form bridges 
between the molecules (Sperandeo et al., 2009). Loss of proteins involved in the 
biosynthesis or trafficking of LPS are lethal in many Gram-negative bacteria (Bos and 
Tommassen, 2004). LPS is made up of three main components: lipid A, core (inner and 
outer) and O-antigen (Figure 1.4) (Bos and Tommassen, 2004). Lipid A is the most 
conserved of these components and consists of two glucosamine units with 6 fatty acids and 
2 phosphate groups (Bos and Tommassen, 2004). It is also known as endotoxin and is 
detected by the TLR4 receptor of mammalian innate immunity (Sperandeo et al., 2009). 
The inner core is also well conserved and is anchored to lipid A, consisting of the unusual 
sugars KDO (3-deoxy-D-manno-oct-2-2-ulosonic acid) and heptose (Sperandeo et al., 
2009). Linked to the inner core is the outer core, which is slightly more variable and 
contains more common sugars such as hexoses and hexosamines (Erridge et al., 2002). 
Finally, the outer core is linked to O-antigen, a polysaccharide chain that is highly variable 
in bacteria. O-antigen is important in protecting bacteria during infection, particularly 
against phagocytosis and complement-mediated killing (Trent et al., 2006). As a surface-
exposed polysaccharide it is a prime antibody target and the different variations are used to 
serotype bacterial strains (Erridge et al., 2002). In the laboratory, O-antigen is non-




Figure 1.4. The structure of lipopolysaccharide (LPS). LPS is made up of three main 
components: lipid A, core (inner and outer) and O-antigen. Lipid A consists of two 
glucosamine units with 6 fatty acids and 2 phosphate groups. The inner core is anchored to 
lipid A and consists of KDO (3-deoxy-D-manno-oct-2-2-ulosonic acid) and heptose. Linked 
to the inner core is the outer core, which contains sugars such as hexoses and hexosamines. 










The lipid A and inner core components of LPS are synthesised separately and 
brought together at the inner leaflet of the inner membrane. The first few steps of lipid A 
biogenesis generate lipid IVA, the tetra-acylated precursor of lipid A. Lipid IVA consists of a 
disaccharide backbone with four fatty acid chains (Sperandeo et al., 2009). Lipid IVA is 
made from two uridine diphosphate N-acetylglucosamine (UDP-NAG) molecules by a series 
of Lpx proteins, C-D, H and K (Raetz et al., 2009). WaaA adds two cytidine 
monophosphate-KDO molecules to lipid IVA, which are synthesised by a separate pathway, 
to form (KDO)2-lipid IVA. LpxL and M catalyse two more acylation reactions, forming the 
hexa-acylated (KDO)2-Lipid A (Sperandeo et al., 2009). The core oligosaccharide (outer 
core) is synthesised from KDO2-Lipid A by a series of ten Waa enzymes to form the lipid A-
core structure (Karp et al., 2002). The lipid A-core is flipped across the inner membrane by 
the flippase MsbA (Figure 1.3) (Karow and Georgopoulos, 1993). When present, the O-
antigen component is made independently in the cytoplasm, flipped across the inner 
membrane and ligated to the lipid A-core at the periplasmic leaflet of the inner membrane 
by the ligase WaaL (Abeyrathne et al., 2005).  
 Once an intact LPS molecule has been assembled, it is transported to the outer 
membrane by the Lpt pathway (Figure 1.3). The inner membrane component of this 
pathway is a predicted ABC transporter, consisting of LptB, LptC, LptF and LptG (Narita 
and Tokuda, 2009). LptB is a cytoplasmic facing ATPase that interacts with inner 
membrane permeases LptG and LptF to form the core component of the ABC transporter 
(Ruiz et al., 2008). This complex associates with periplasmic facing LptC (Sperandeo 2006). 
The LptBCFG complex is thought to extract LPS from the inner membrane and pass it to the 
periplasmic chaperone LptA (Ma et al., 2008; Tran et al., 2008). LptA transfers LPS to the 
LptD–LptE outer membrane complex, which incorporates it into the outer leaflet (Wu et al., 
2006). It is thought that LptC, A and D may form a continuous transmembrane bridge 




1.2.5. Phospholipids  
Phospholipids are the main component of the inner membrane and the inner leaflet of the 
outer membrane. The major phospholipid species in E. coli, phosphatidylethanolamine 
(PE), phosphatidylglycerol (PG) and cardiolipin (CL), are synthesised from phosphatidic 
acid (PA) at the cytoplasmic side of the IM (see section 1.3.2 for details). The first evidence 
that phospholipids move between membranes was seen in the 1970s, when radiolabelled 
phospholipids were shown to rapidly move between the outer and inner membranes (Jones 
and Osborn, 1977). While some phospholipids remain at the inner leaflet of the inner 
membrane, others are flipped across the membrane, potentially by the flippase MsbA (Zhou 
et al., 1998). Some of these phospholipids are destined for the inner leaflet of the outer 
membrane, but the method of transport is currently unknown. Instead a pathway for 
retrograde phospholipid trafficking, the Mla pathway, has been identified.  
The Mla pathway consists of an inner membrane ABC transporter (MlaBDEF), a 
periplasmic chaperone MlaC, and an outer membrane lipoprotein (MlaA) (Figure 1.5B) 
(Malinverni and Silhavy, 2009). This pathway has been shown to be important for the 
prevention of phospholipid accumulation in the outer leaflet of the outer membrane 
(Malinverni and Silhavy, 2009). The outer membrane lipoprotein MlaA (VacJ) interacts 
with OmpC in the outer membrane and together they function to extract phospholipids 
from the outer leaflet (Chong et al., 2015; Malinverni and Silhavy, 2009). The phospholipid 
is passed from MlaA via the MlaC chaperone onto the inner membrane ABC transporter 
complex. This complex consists of MlaD, a predicted substrate binding protein that 
contains a sinlge MCE domain, MlaE, a transmembrane permease, MlaF, a cytoplasmic 
facing ATPase and MlaB, a predicted NTP binding protein (Malinverni and Silhavy, 2009). 
The fate of the phospholipids beyond this stage is unknown but there are two possible 
outcomes: 1) they are incorporated into the inner membrane or 2) they move into the 
cytoplasm for degradation (Malinverni and Silhavy, 2009).  
While the Mla pathway might have a role in phospholipid degradation, certain 
enzymes in the outer membrane are known to be involved in this process. PldA is an 
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Figure 1.5. Processes involved in phospholipid degradation in the outer membrane. A. 
PagP removes an acyl chain from phospholipids and donates it to lipid A in the outer leaflet. 
B. The Mla pathway and OmpC are involved in trafficking phospholipids from the outer 
leaflet of the outer membrane back into the cell. C. PldA is a phospholipase that degrades 



















enzyme that has lipolytic activity and degrades phospholipids at the outer membrane 
(Figure 1.5A) (Dekker, 2000). Also involved in the process is the enzyme PagP, which takes 
palmitate from phospholipids and donates it to lipid A (Bishop et al., 2000). This increases 
the acylation state of lipid A from hexa to hepta-acylated, which might prevent entry of 
cationic antimicrobial peptides (CAMPs) into the cell (Guo et al., 1998). Overexpression of 
PldA can compensate for the loss of the Mla pathway suggesting that they both play a part 
in removal of unwanted phospholipids from the outer membrane (Malinverni and Silhavy, 
2009). 
 
1.2.6. The periplasm and peptidoglycan  
The periplasmic space is a protein-dense environment that is considerably more viscous 
than the cytoplasm (Mullineaux et al., 2006). Compartmentalisation allows Gram-negative 
bacteria to harbour enzymes in the periplasm that would otherwise be harmful (MacAlister 
et al., 1972; Silhavy et al., 2010). Other proteins that occupy this space include chaperones 
and periplasmic binding proteins for sugar and amino acid transport (Erhmann, 2007; 
Silhavy et al., 2010). As ATP is absent from the periplasm, energy required for transport of 
several outer membrane components across the periplasm is obtained from ATP hydrolysis 
in the cytoplasm (Okuda et al., 2012). The important peptidoglycan cell wall is also located 
in the periplasm. It is a rigid entity that determines cell shape and prevents cell lysis 
(Silhavy et al., 2010). Peptidoglycan is a polysaccharide consisting of alternating N-acetyl 
glucosamine (NAG) and N-acetyl muramic acid (NAM) monosaccharides (Vollmer et al., 
2008), and its synthesis is reviewed by Lovering et al. (2012). Attached to NAM is a 
pentapeptide chain consisting of L-alanine, D-glutamic acid, mesodiaminopimelic (meso-
A2pm) acid and two D-alanine residues.  
 The bulk of peptidoglycan biosynthesis occurs in the cytoplasm, and starts with the 
conversion of uridine diphosphate (UDP)-NAG to UDP-NAM in a two-step process 
catalysed by MurA and B (Figure 1.6) (Benson et al., 1996; Benson et al., 1997; Brown et al., 
1995). The five amino acids are added to UDP-NAM in a stepwise fashion by four different 
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Figure 1.6. The biosynthesis of the peptidoglycan cell wall. Synthesis starts in the 
cytoplasm with the conversion of uridine diphosphate (UDP)-NAG to UDP-NAM, catalysed 
by MurA and B. MurC-F add the five amino acids to form NAM-pentapeptide. At the 
membrane, the NAM-pentapeptide is converted to lipid I by its transfer onto the 
undecaprenyl phosphate (UP) carrier by MraY. This is coupled to the transfer of UDP-
activated N-acetyl D-glucosamine to lipid I (to form lipid II), by MurG. Lipid II is flipped 
across the membrane by MurJ. In the periplasm lipid II is elongated with the repeating unit 
of the NAG-NAM disaccharide by a glycosyltransferase (GT). A transpeptidase (TP) creates 
crosslinks between the pentapeptides.  
MurJ IM 
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ligases: MurC-F. At the membrane, the NAM-pentapeptide is converted to lipid I by its 
transfer onto the undecaprenyl phosphate (UP) carrier, which is catalysed by the inner 
membrane protein MraY (MurX) (Ikeda et al., 1991). This step is coupled to the MurG 
catalysed transfer of UDP-activated N-acetyl D-glucosamine to lipid I, to form lipid II 
(Lovering et al., 2012; Mengin-Lecreulx et al., 1991). Lipid II is flipped to the periplasmic 
leaflet by an inner membrane flippase, which was recently identified as MurJ (Sham et al., 
2014). In the periplasm lipid II is elongated with the repeating unit of the NAG-NAM 
disaccharide by glycosyltransferase, forming a nascent peptidoglycan strand. A 
transpeptidase creates crosslinks between the pentapeptides of different nascent chains to 
form the complex mesh that is the bacterial cell wall (Lovering et al., 2012). Both 
glycosyltransferase and transpeptidase are types of penicillin binding protein, which are one 
of the most common targets for treatment of Gram-positive infections. In particular, 
vancomycin affects transpeptidase activity by binding the double D-alanine amino acids of 
the peptide chain, preventing cross-linkage of nascent peptidoglycan strands. Gram-
positive bacteria can become resistant to vancomycin by alteration of the double D-alanine 
moiety to D-alanine D-lactate (Xie et al., 2011).  
 
1.3 Fatty acid metabolism 
Fatty acids are an important source of energy and an essential component of cell 
membranes. E. coli primarily synthesises unbranched fatty acid chains with an even 
number of carbons, whereas several Gram-positive bacteria favour the production of 
branched fatty acid chains with an odd number of carbons (Choi et al., 2000; Khandekar et 
al., 2001). The biosynthesis and degradation of fatty acids are two separate pathways that 
are switched on and off depending on fatty acid availability in the cell (Fujita et al., 2007). 
The regulator FadR oversees fatty acid metabolism by repressing degradation and activating 
some genes involved in biosynthesis (DiRusso et al., 1992). FadR is repressed by the 
binding of long acyl-CoA thioesters, a substrate for fatty acid degradation (DiRusso et al., 
1992). 
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1.3.1. Fatty acid biosynthesis 
There are two types of fatty acid biosynthesis pathways: Fatty acid synthase (FAS) I and II. 
Animals and fungi primarily use a FAS I system, which involves multifunctional enzymes 
catalysing multiple steps in biosynthesis (Jenke-Kodama et al., 2005). FAS II is found in 
bacteria and plants and includes several monofunctional enzymes (Jenke-Kodama et al., 
2005).  
The stages involved in bacterial fatty acids biosynthesis are reviewed by Parsons and 
Rock (2013). The FAS II pathway is divided into two main stages: the initiation module and 
the elongation module. The initiation module begins with the carboxylation of acetyl-CoA to 
malonyl-CoA by the acetyl-CoA carboxylase AccABCD (Figure 1.7) (Cronan and Waldrop, 
2002). Next, FabD transfers the malonyl group to the acyl carrier protein (ACP), which is 
necessary for subsequent recognition by FAS II enzymes (Zhang and Rock, 2008). Malonyl-
ACP is used for one of two things: initiation of the elongation cycle (via β-ketoacyl-ACP) or 
extension of the fatty acid chain during the elongation cycle (Tsay et al., 1992). For 
initiation of the elongation module, malonyl-ACP is first condensed with a short chain acyl-
CoA to form β-ketoacyl-ACP, a reaction catalysed by FabH (Tsay et al., 1992). FabH 
substrate specificity differs between different bacteria and is in part responsible for the 
major fatty acid type found within a species (Choi et al., 2000; Qiu et al., 2005).  
To begin the elongation cycle, β-ketoacyl-ACP is reduced by FabG to form β-
hydroxyl-ACP (Figure 1.8). Either FabA or FabZ dehydrates β-hydroxyl-ACP to form trans-
2-enoyl-ACP (Heath and Rock, 1996). The specificities of FabA and FabZ largely overlap, 
but FabA can convert trans-2-enoyl-ACP to cis-2-enoyl-ACP, a precursor required for the 
generation of unsaturated fatty acids (Heath and Rock, 1996). Following dehydration, 
trans-2-enoyl-ACP is reduced by FabI to form acyl-ACP (Heath and Rock, 1995). Acyl-ACP 
can either be used in the acyl transfer module (see 1.3.2) or it can be condensed by 




Figure 1.7. The initiation module of fatty acid biosynthesis. Acetyl-CoA is carboxylated to 
malonyl-CoA by AccABCD. FabD transfers the malonyl group to acyl carrier protein (ACP). 
Malonyl-ACP is either used for the initiation of the elongation cycle (via conversion to β-



























Figure 1.8. The elongation module of fatty acid biosynthesis. β-ketoacyl-ACP is reduced to 
β-hydroxyl-ACP by FabG. FabA/FabZ dehydrates β-hydroxyl-ACP to trans-2-enoyl-ACP. 
Trans-2-enoyl-ACP is reduced to acyl-ACP by FabI. Acyl-ACP can either be used in the acyl 


































The elongation module is primarily used for the formation of saturated fatty acids, 
but unsaturated fatty acids can also utilise parts of the cycle. The isomerisation catalysed by 
FabA specifically occurs at the 10-carbon stage of the elongation module, forming cis-2-
decenoyl-ACP (Heath and Rock, 1996). The molecule is then elongated by FabB/FabF to 
form an unsaturated fatty acid (Heath and Rock, 1996). Fatty acid biosynthesis is partly 
regulated by internal feedback loops. For example, AccABCD that catalyses the first step of 
the initiation module is inhibited by acyl-ACP, the final product of the elongation module 
(Davis and Cronan, 2001). Several intermediates of fatty acid biosynthesis are used for 
other important cellular processes. Enzymes of lipid A biosynthesis are specific for ACP 
thioesters and therefore the elongation cycle provides the only source of hydroxyl fatty acids 
for lipid A biosynthesis (Raetz et al., 2007).  
 
1.3.2. The acyltransferase module and phospholipid biosynthesis 
The acyltransferase module involves the transfer of acyl chains from acyl-ACP onto glycerol-
3-phosphate to begin the synthesis of phopsholipids (Figure 1.9). The enzymes involved in 
this process in E. coli are the phospholipid acyltransferases PlsB and PlsC (Bell, 1975). PlsB 
ligates a fatty acid at the sn-1 carbon position of glycerol-2-phosphate to form 1-acyl-
glycerol-3-phosphate or lysophosphatidic acid. PlsC subsequently ligates a fatty acid at the 
sn-2 position producing 1,2-diacyl-sn-glycerol-3-phosphate or phosphatidic acid (PA), the 
phospholipid precursor for all other phospholipids (Bell, 1975). Like all naturally occurring 
phospholipids, a saturated fatty acid is found at position 1 of PA and an unsaturated at 
position 2 (Cronan and Vagelos, 1972).  
 In E. coli the membrane phospholipid content is primarily made up of 
phosphatidylethanolamine (PE), followed by phosphatidylglycerol (PG) and cardiolipin 
(CL). To start phospholipid synthesis, CdsA converts PA to the intermediate molecule, 
cytidine diphosphate diacylglycerol (CDP-DAG) (Parsons and Rock, 2013). At this stage, 
phospholipid head group synthesis can be split into two pathways: zwitterionic 




Figure 1.9. Phospholipid biosynthesis pathway. Phosphatidic acid (PA) is the precursor for 
all other phospholipids. PA is converted to CDP-diacylglycerol by CdsA. PssA starts the 
zwitterionic phospholipids synthesis pathway by conversion of CDP-diacylglycerol to 
phoshatidylserine (PS), which is subsequently converted to phosphatidylethanolamine (PE) 
by Psd. Alternatively, CDP-DAG can be converted to phosphadtidylglycerol-phosphate by 
PgsA to begin anionic phospholipids synthesis. Phosphadtidylglycerol-phosphate is 
converted to phosphatidylglycerol by the three enzymes PgpA, B and C. Cardiolipin is 
synthesised by ClsA, B and C, either from two PG molecules or one PE and one PG 

















The first step of the PE pathway is the condensation of CDP-DAG with serine to 
produce phosphatidylserine (PS), a reaction that is catalysed by PssA. PS is then 
decarboxylated by Psd to form PE (Parsons and Rock, 2013). As the most abundant 
phospholipid in the cell, mutants defective in PE synthesis can only grow under certain 
conditions. The temperature-sensitive phenotype of a psd mutant is a consequence of PS 
accumulation in the membrane (Hawrot and Kennedy, 1978). A pssA deletion strain cannot 
produce PS or PE and compensates with increased amounts of PG and CL. A pssA mutant is 
only viable when grown in media supplemented with Ca2+, Mg2+ or Sr2+ (DeChavigny et al., 
1991).  
The first step of the PG pathway involves the replacement of cytidine 
monophosphate on CDP-DAG by glycerol-phosphate, a reaction catalyzed by the enzyme 
PgsA (Miyazaki et al., 1985). The product phosphadtidylglycerol-phosphate is 
desphosphorylated by the three enzymes PgpA, B and C to form PG (Lu et al., 2011). A pgsA 
deletion is only viable in the presence of a secondary mutation in lpp. This is because PG 
donates an acyl group to the N-terminal cysteine of lipoproteins, allowing correct 
localization (Suzuki 2002). Lpp is a highly expressed lipoprotein that locates to the OM and 
forms interactions with peptidoglycan (Braun and Rehn, 1969). In the case of a pgsA 
knockout, Lpp cannot localise correctly and builds up in the inner membrane, interacting 
with peptidoglycan and resulting in cell lysis (Suzuki et al., 2002). The viability of a pgsA 
lpp double mutant suggests that the E. coli does not need anionic phospholipids under 
laboratory conditions.  
CL is synthesised by three different enzymes: ClsA, B and C. ClsA is the main CL 
synthase during exponential growth, while all three are active during stationary phase (Tan 
et al., 2012). ClsA and B both form CL by the condensation of two PG molecules. ClsC uses 
PE as a phosphatidyl donor to PG to form CL, providing some crossover between the 
zwitterionic and anionic phospholipid pathways (Tan et al., 2012). A triple clsABC mutant 
completely lacks CL synthesis but is viable, suggesting that CL is not essential in E. coli (Tan 
et al., 2012).  
	 25	
 A phospholipid breakdown pathway has been defined, which mainly targets PG as a 
substrate. The sn-glycerol-1-phosphate headgroup is removed from PG by the enzyme 
MdoB, producing DAG (Jackson et al., 1984). This headgroup is donated to the formation of 
membrane-derived oligosaccharides (MDOs). MDOs are known to be important in the 
regulation of osmolality in the periplasm, as an mdoB mutant is sensitive in environments 
that cause osmotic stress (Jackson et al., 1984; Rajagopal et al., 2003). Following removal of 
the headgroup, DAG is transformed back into PA by the enzyme DgkA (Raetz and Newman, 
1978). Mutants in dgkA show accumulation of DAG, which is lethal in osmotically 
challenging environments (Jackson et al., 1984).  
 As with fatty acid biosynthesis, a feedback loop for phospholipid biosynthesis helps 
regulate the inhibition and activation of different pathways. For example, an increase in the 
number of anionic phospholipids in the membrane activates Pss to increase PE synthesis 
(Louie et al., 1986). The phospholipid content of the membrane also changes in response to 
external stimuli, such as temperature. As temperature decreases, the membrane becomes 
more rigid, which is compensated by the increased incorporation of unsaturated fatty acids 
into phospholipids (Jackowski et al., 2002). When the temperature increases, the 
membrane fluidity increases and the proportion of unsaturated fatty acids in the membrane 
is decreased (Jackowski et al., 2002).  
  
1.3.3. Fatty acid degradation 
E. coli can import fatty acids from outside the cell for use as either a carbon source, or as 
precursors for phospholipid biosynthesis (Fujita et al., 2007). The pathway for fatty acid 
degradation is known as the β-oxidation pathway. To enter the cell, short-chain fatty acids 
can diffuse across the membrane and do not require a specific uptake mechanism. Longer 
chain fatty acids are too large for this diffusion and are transported across the membrane 
via the FadL/FadD system (Figure 1.10). FadL is responsible for transport of long-chain 
(C12-18) fatty acids across the OM (Black, 1991). At the inner membrane, fatty acids are 
transported and activated by FadD to form acyl-CoA in the cytoplasm (Black et al., 1992). 
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Figure 1.10. Fatty acid degradation in Escherichia coli. Short chain fatty acids can diffuse 
across the outer and inner membranes without aid. FadL is required for transport of long 
chain fatty acids across the outer membrane. FadD helps transport of long chain fatty acids 
across the inner membrane and activates all fatty acids for degradation, forming acyl-CoA. 
The β-oxidation cycle begins with the conversion of acyl-CoA to enoyl-CoA by FadE. FadB 
converts enoyl-CoA to β-ketoacyl-CoA, which is then shortened by FadA shortens, 
producing a shortened acyl-CoA plus acetyl-CoA. The acyl-CoA then enters another round 
of the β-oxidation cycle. FadH is responsible for the introduction of unsaturated fatty acids 






















































The method by which fatty acids cross the periplasm is currently unknown (Parsons and 
Rock, 2013). In the cytoplasm, the β-oxidation cycle begins with the conversion of acyl-CoA 
to enoyl-CoA by FadE, the only acyl-CoA dehydrogenase found in E. coli (Campbell and 
Cronan, 2002; Fujita et al., 2007). FadB hydrates and oxidises enoyl-CoA to β-ketoacyl-CoA 
via the intermediate β-hydroxyacyl-CoA (Pramanik et al., 1979). FadA shortens β-ketoacyl-
CoA by two carbons per cycle, producing a shortened acyl-CoA plus acetyl-CoA (Pramanik 
et al., 1979). The β-oxidation cycle can also degrade unsaturated fatty acids via their 
derivative, 2,4-dienolyl-CoA. FadH transforms 2,4-dienolyl-CoA into enoyl-CoA, allowing 
subsequent hydration and oxidation by FadB and cleavage by FadA (Fujita et al., 2007). 
During anaerobic β-oxidation, FadI, FadJ and FadK replace FadA, FadB and FadD 
respectively, but carry out equivalent functions (Campbell et al., 2003).  
 
1.4. The Salmonella infection model  
Salmonella is a clinically important Gram-negative pathogen belonging to the family 
Enterobacteriaceae. Together, Salmonella and Campylobacter are the most commonly 
diagnosed foodborne pathogens (Silva et al., 2011). The species S. enterica contributes to 
the majority of Salmonella infection in mammals with over one billion cases reported 
annually (Coburn et al., 2007). There are multiple subspecies of S. enterica, including S. 
enteria subsp. enterica. The enterica subspecies is further derived into serovars based on 
their flagella, carbohydrate and LPS properties (Fierer and Guiney, 2001). In humans most 
enterica serovars cause enteritis, with the exception of Typhi, Paratyphi and Sendai, which 
can cause enteric (typhoid) fever (Coburn et al., 2007). S. enteria subsp. enterica serovar 
Typhimurium (S. Typhimurium) is a serovar that causes enteritis in humans but can cause 
typhoid fever in susceptible mouse strains.  
S. Typhimurium infection in mice is used as a model of S. Typhi infection in humans 
and is the source of much of the understanding of systemic Salmonella infection (Coburn et 
al., 2007). In short, Salmonella are ingested and infect epithelial cells in Peyer’s patches in 
the small intestine. The bacteria enter phagocytes and disseminate through the 
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reticuloendothelial system, gaining access to reticuloendothelial system organs, where the 
infection can persist long term (Figure 1.11) (Monack et al., 2004).  
The innate immune response is the first line of defence against invading pathogens. 
It includes physical barriers such as skin, mucus and stomach acid and induced response 
such as inflammation and phagocytosis-mediated killing (Medzhitov, 2010). Pattern-
recognition receptors are a group of receptors of the host immune system that detect 
pathogen-associated molecular patterns (PAMPs) (Vance et al., 2009). They include the 
well studies Toll-like receptors (TLRs) that play an important role in the innate 
inflammatory response (Broz et al., 2012). Factors of the innate immune response work to 
clear Salmonella infection and prevent systemic spread and persistence. If this fails, the 
adaptive immune response is required for clearance of more persistent infections.  
During infection, Salmonella has to overcome these barriers of the immune system, 
which change as infection proceeds and the bacteria move to different locations. The stages 
of infection can be split as follows: 1) passage through the stomach, 2) invasion of the small 
intestine, 3) establishment of systemic infection and 4) persistence and the adaptive 
immune response.  
 
1.4.1. Passage through the stomach  
Salmonella infections begin with ingestion. The first barrier to overcome is the low pH of 
stomach acid, an environment to which Salmonella is exposed only for a short time (Ohl 
and Miller, 2001). Salmonella is usually ingested with food, when the pH of the stomach is 
increased along with the chances of survival (Waterman and Small, 1998). Salmonella have 
evolved an acid tolerance response (Garcia-del Portillo et al., 1993). To maintain 
intracellular pH, proton pumps continuously export H+ ions out of the cytoplasm (Foster, 
2000). Similarly, low pH induces amino acid decarboxylase systems that incorporate 
protons into certain amino acids and export them out of the cell (Alvarez-Ordonez et al., 




Figure 1.11. The Salmonella Typhimurium murine model for systemic infection. After 
ingestion, the bacteria infect epithelial cells in the Peyer’s patches of the small intestine. The 
bacteria cross the epithelial barrier to reach immune cells including dendritic cells and 
submucosal macrophages. The bacteria enter phagocytes and disseminate through the 
mesenteric lymph nodes (MLNs) and onto the liver, gall bladder, spleen and bone marrow. 
During persistent infection, which involves long-term colonisation of the gall bladder, the 













unsaturated fatty acids) and induction of acid shock proteins that repair damage caused by 
low pH (Alvarez-Ordonez et al., 2011; Audia et al., 2001).  
   
1.4.2. Invasion of the small intestine  
Having survived passage through the stomach, bacteria are exposed to new challenges in 
the small intestine. The intestinal lumen is high in salt, and Salmonella respond to this by 
increasing intracellular levels of solutes (including K+, betaine, carnitine and proline) either 
by uptake or synthesis (Alvarez-Ordonez et al., 2011). Salmonella also have to respond to 
the reduced oxygen levels in the gut by inducing expression of genes involved in anaerobic 
metabolism (Alvarez-Ordonez et al., 2011). In the small intestine, Salmonella adhere to 
epithelial cells, with a particular preference for microfold (M) cells (Ohl and Miller, 2001). 
M cells are found in Peyer’s patches and monitor intestinal antigens via pinocytosis, a 
specialised type of endocytosis for fluids (Brandtzaeg, 1989). Salmonella adhere to 
epithelial cells via their fimbriae and other surface structures. At this stage, genes located on 
the chromosomal Salmonella pathogenicity island 1 (SPI-1) are activated. SPI-1 includes 
components of a type 3 secretion system (T3SS), which transports effectors via an 
injectisome from the cytoplasm of the bacterium into the cytoplasm of the host cell (Ramos-
Morales, 2012). The effector protein SopE is translocated via this SPI-1 T3SS and interacts 
with members of the Rho-family proteins in the host that regulate the actin cytoskeleton 
(Hall, 1998). SipA, SipC, SopB, SopD and SopE2 are also involved in actin rearrangement of 
the host cell (McGhie et al., 2001; McGhie et al., 2009; Raffatellu et al., 2005). This actin 
rearrangement results in Salmonella engulfment into the host cell to form Salmonella 
containing vesicles (Francis et al., 1992). Once the Salmonella is internalised, another SPI-1 
effector, SptP, returns the host cell back to its resting state (Patel and Galan, 2005).  
At this stage, serovars associated with enteritis trigger a large secretory response in 
the epithelia via the host pattern-recognition receptors such as TLRs (Broz et al., 2012). 
Following detection by TLRs, host cells express proinflammatory cytokines that induce the 
production of mucins, antimicrobial peptides and chemokines (Galyov et al., 1997). Certain 
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chemokines, such as IL-8, recruit neutrophils that subsequently accumulate in the 
intestinal lumen (Galyov et al., 1997). In Salmonella, SopB (a SPI-1 effector) is required for 
neutrophil accumulation and increased secretion of chloride ions in the lumen, both of 
which promote diarrhoea (Norris et al., 1998).  
 
1.4.3. Systemic infection 
After uptake into epithelial cells, Salmonella migrates through the epithelia to reach sub-
mucosal macrophages at the sub-mucosal membrane (Ohl and Miller, 2001). Within the 
macrophage phagosome, Salmonella has to withstand factors designed to kill pathogens, 
including reactive oxygen species, cationic antimicrobial peptides (CAMPs) and hydrolytic 
enzymes (Ohl and Miller, 2001). At this stage, bacteria that cause enteritis proceed no 
further, while enteric fever serovars can use the macrophage for replication and hide from 
the immune system.  One of the major regulators of survival in these conditions is the PhoP-
PhoQ two-component system, which is activated inside the macrophage phagosome by 
antimicrobial peptides and low Mg2+ levels (Hancock and McPhee, 2005; Miller et al., 1989; 
Ohl and Miller, 2001). Amongst other things, this system activates modifications in LPS, 
such as acylation by the enzyme PagP, which prevent membrane disruption and cell death 
by CAMPs (Ganz and Weiss, 1997; Guo et al., 1998). Furthermore, these modifications 
reduce the immunogenicity of LPS by up to 100-fold (Kawasaki et al., 2004). In total, the 
PhoPQ system regulates over 200 different genes including those involved in drug 
resistance, motility and defence against oxidative stress (Minagawa et al., 2003).  
In the phagosome, genes found on another pathogenicity island, SPI-2, are induced 
via the OmpR-EnvZ system. OmpR-EnvZ is activated in conditions of low osmolality and 
nutrients, and by acidification of the Salmonella containing vesicle in the macrophage 
(Kaur and Jain, 2012). These genes encode another T3SS that injects effector proteins into 
the host cell. The SPI-2 T3SS injects an array of proteins (including SifA, SifB, SseF, SseG, 
SseJ, PipB and SopD2) involved in formation of Salmonella-induced filaments (Waterman 
and Holden, 2003). These filaments extend from the vesicle and might have a role in the 
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intracellular replication of Salmonella (Knodler and Steele-Mortimer, 2003). Other SPI-2 
effector proteins are involved in avoidance of NADPH-oxidase dependent killing, delay of 
host cell apoptosis-like death, and maintenance of the Salmonella containing vesicle 
membrane (Waterman and Holden, 2003).  
 In the sub-mucosal environment, it is possible that Salmonella specifically targets 
host cells that disseminate through the lymphatic system. As well as the sub-mucosal 
macrophages, Salmonella can also enter dendritic cells where they cannot replicate but 
remain viable (Kaur and Jain, 2012). Dendritic cells migrate widely within the body and are 
important for antigen presentation. Salmonella harbouring dendritic cells and 
macrophages disseminate through the lymphatic system to the mesenteric lymph nodes 
(MLNs) and onto the liver, gall bladder, spleen and bone marrow (Kaur and Jain, 2012).  
 
1.4.4. Persistence and the adaptive immune response 
Once systemic, Salmonella infection can persist for months with periodical shedding of 
bacteria in the stool (Monack et al., 2004). In mice, early prevention of persistence is partly 
due to nramp1 found in monocytes/macrophages. It prevents the intracellular replication of 
Salmonella by depriving the bacteria of divalent cations, controlling bacterial growth in 
RES organs during the first week of infection (Gruenheid et al., 1997; Vidal et al., 1995). 
Later clearance of Salmonella (3-4 weeks of infection) involves input from the adaptive 
immune response. In particular, CD4+ and CD8+ T lymphocytes and the humoral 
(antibody) response are all important for late stage infection (Monack et al., 2004). Antigen 
presentation via the major histocompatibility complex (MHC) II on the surface of antigen 
presenting cells, such as macrophages and dendritic cells, activates CD4+ T cells that 
provide positive feedback to the innate immune system (Monack et al., 2004). CD4+ T 
helper cells are important for the humoral response, by aiding in the stimulation of B-cells 
and subsequent antibody production. CD8+ T cells function by inducing apoptosis of 
infected cells following the detection of foreign antigens on the cell surface (via MHC I 
molecules) (Monack et al., 2004).  
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 Most systemic Salmonella infections will be successfully cleared by the immune 
system. Persistent Salmonella infection is in part due to effectors of the SPI-2 T3SS that can 
suppress antigen presentation, and limit the chance of an adaptive immune response 
(Waterman and Holden, 2003).  Furthermore, Salmonella can modulate the immune 
response for example by inducing the production of cytokines that play a role in 
immunosuppression (Pie et al., 1996). However, its most successful survival tactic is simply 
to hide from the immune system long term. Aside from intracellular protection, S. Typhi is 
adapted to long-term colonisation of the gall bladder by forming a biofilm that protects it 
from the antimicrobial effects of bile and the immune system (Gunn et al., 2014). During 
persistent infection, bacteria continually shed via faeces. In some cases S. Typhi can cause 
chronic life-long infection that is often asymptomatic. These carriers shed Salmonella in 
their stool and act as a reservoir for the pathogen that is easily spread to new, susceptible 
hosts (Monack et al., 2004).   
 
1.5. Mammalian cell entry domains 
The PFAM database defines an MCE domain through a hidden Markov model (HMM) 
describing an 81 amino acid sequence. The hidden Markov model contains particularly well-
conserved hydrophobic residues including valines, leucines, isoleucines and glycines (Finn 
et al., 2016). The glycine residue at position 29 is by far the most conserved amino acid in 
the model (Figure 1.12).  
MCE domain-containing proteins have been reported to resemble components of 
ABC transporters (Casali and Riley, 2007). A typical ABC transporter consists of four core 
protein domains. Two of these domains are permeases, which span the membrane 6 times 
forming a pore through which solutes pass. The other two domains are ATP binding 
domains, which face the cytoplasm and are responsible for the hydrolysis of ATP (Higgins, 
2001). It is these conserved ATPase domains that are used to classify proteins as part of the 




Figure 1.12. The PFAM HMM for an MCE domain. The numbers represent amino acid 





MCE domain containing proteins resemble substrate-binding proteins (SBPs) 
(Kumar et al., 2005), which are usually specific to ABC importer systems (Casali and Riley, 
2007; Higgins, 2001). SBPs are thought to bind substrates in the periplasm (or externally in 
Gram-positive bacteria) and deliver them to the membrane component of the transporter. 
The presence of SBPs tends to increase the specificity of an ABC transporter (Higgins, 
2001). MCE domains are widespread across bacteria and are found in both Gram- positive 
and Gram-negative phyla. In particular, they are prominent in Proteobacteria, 
Bacteroidetes, and Actinobacteria (Finn et al., 2016). While some studies have looked at the 
role of MCE domains in Proteobacteria, most information on MCE domains has been 
acquired from studies in Actinobacteria. 
 
1.5.1. Mammalian cell entry domains in Actinobacteria 
Actinobacteria is a phylum that includes clinically important Mycobacterium and 
Streptomyces species. As a whole the phylum is classed as Gram-positive, but 
Mycobacterium species do not Gram stain due to their unusual mycolic acid-rich outer 
membrane.  
The first MCE domain was identified in the gene mce1A from M. tuberculosis in 
1993 (Arruda et al., 1993). This was later identified as being part of an operon containing six 
mce genes and two yrbE genes, the latter of which encode permeases and are orthologues of 
mlaE (Figure 1.13) (Casali and Riley, 2007). The Mce proteins each contain one MCE 
domain and are sometimes associated with a domain of unknown function, DUF3407, 
within the same protein. The sequencing of the M. tuberculosis genome in 1999 revealed 
that there are four variants of this operon in the genome, presumably following duplication 
events (Casali and Riley, 2007; Cole et al., 1998). These operons all contain the two yrbE 
genes and six mce genes, and MCE-associated genes are found downstream in three of the 
four operons (Figure 1.13) (Casali and Riley, 2007). Operons one to three contain genes that 
regulate the operon: mce1R, mce2R and mce3R. The mce1 operon also contains fadD5, 




Figure 1.13. The four mce operons found in Mycobacterium tuberculosis. Each operons 
contains two yrbE genes followed by six mce genes. Operons 1, 3 and 4 contain mce-
associated (mas) genes at the end of the operon. Operons 1, 2 and 3 contain mce regulator 
genes (e.g. mce3R) at the start of the operon. The mce1 operon also contains fadD5, a gene 
involved in fatty acids degradation. 
yrbE1B mce1A yrbE1A mce1B mce1C mce1D mce1E mce1F mas1A mas1B mas1C mas1D fadD5 mce1R 
yrbE2B mce2A yrbE2A mce2B mce2C mce2D mce2E mce2F mce2R 
yrbE3B mce3A yrbE3A mce3B mce3C mce3D mce3E mce3F mas3A mas3B mce3R 
yrbE4B mce4A yrbE4A mce4B mce4C mce4D mce4E mce4F mas1A mas1B 
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Several studies have shown that the different mce operons in M. tuberculosis are 
expressed at different times during growth and infection, with the mce4 operon having 
particular importance in late persistent infection (Haile et al., 2002; Kumar et al., 2003). In 
general, the Mce proteins are prominent during growth of M. tuberculosis in stationary 
phase (Singh et al., 2016). This M. tuberculosis operon structure is fairly conserved in 
Actinobacteria, but the number of operons per species can vary between 1 and 12 (Casali 
and Riley, 2007).  
As the name suggests, several studies indicate that Mce proteins have a direct 
function in mammalian cell entry. Beads coated with M. tuberculosis proteins Mce1A or 
Mce3A have the ability to enter HeLa cells, and both Mce1A and Mce4A proteins allow the 
entry of non-pathogenic E. coli (Arruda et al., 1993; Chitale et al., 2001; El-Shazly et al., 
2007; Saini et al., 2008). The Mce2A protein cannot aid entry as it lacks the “cell entry 
epitope” found in Mce1A, Mce3A and Mce4A, suggesting its function might differ from the 
other proteins (Chitale et al., 2001; Mitra et al., 2005). Despite their apparent role in 
mammalian cell entry, mutants disrupted in the mce1 genes in M. tuberculosis show no 
decreased ability to enter and survive in mammalian cells (Marjanovic et al., 2010; Shimono 
et al., 2003). This suggests that the links to mammalian cell entry could be an artifact of 
inserting M. tuberculosis proteins into E. coli and the artificial coupling of the proteins to 
beads.  
 Several studies have suggested that Mce proteins in Actinobacteria are important 
during infection. The presence of antibodies against Mce proteins in patients with 
tuberculosis indicates that they are expressed during infection and that they are 
immunogenic (Ahmad et al., 1999; Ahmad et al., 2004). Some Mce proteins have been 
shown to directly induce an inflammatory response and mce mutants in M. tuberculosis 
induce less of an inflammatory response than the WT in mice (Marjanovic et al., 2010; 
Shimono et al., 2003; Xu et al., 2007; Xu et al., 2008; Xue et al., 2007). In M. tuberculosis, 
mutants in either the mce2, 3 or 4 operons are attenuated in mice (Marjanovic et al., 2010; 
Senaratne et al., 2008). In contrast, an mce1 mutant in M. tuberculosis is hypervirulent 
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(Lima et al., 2007; Shimono et al., 2003; Uchida et al., 2007). Similarly, a Streptomyces 
mce operon mutant is hypervirulent in the amoebae vacuole (Clark et al., 2013). However, 
the spores of the Streptomyces strain lacking the mce operon are more wrinkled and weak, 
and the mutant cannot colonise plants as well as the parent stain (Clark et al., 2013).  
 Whilst all of these results indicate that Mce proteins are important for infection 
and/or colonisation, there is no indication of the specific function of these proteins in 
Actinobacteria. Some studies of M. tuberculosis propose a more specific role of Mce 
proteins as lipid transporters. An mce1 mutant in M. tuberculosis accumulates mycolic acid 
in its cell wall and is less efficient at the uptake of palmitic acid than the parent (Cantrell et 
al., 2013; Forrellad et al., 2014). Strains disrupted in the mce2 operon accumulate 
sulpholipids and are therefore likely to be involved in sulpholipid degradation (Marjanovic 
et al., 2011). The 3rd MCE operon is regulated by Mce3R, which also regulates expression of 
genes involved in lipid metabolism, including fatty acid degradation (de la Paz Santangelo 
et al., 2009). The mce4 operons of M. tuberculosis, M. smegmatis and Rhodococcus have 
all been linked to cholesterol uptake (Klepp et al., 2012; Mohn et al., 2008; Pandey and 
Sassetti, 2008). Cholesterol utilisation is an important step in the survival of M. 
tuberculosis in macrophages, explaining why the mce4 operon in particular is important for 
persistent infection in mice (Pandey and Sassetti, 2008).  
 
1.5.2. Mammalian cell entry domains in Proteobacteria 
The most recognised MCE domain containing protein in Proteobacteria is MlaD, which 
contains a single MCE domain and is the substrate-binding component of the Mla 
retrograde phospholipid trafficking pathway in E. coli (Malinverni and Silhavy, 2009). 
Predicted MlaD-like ABC transporters are found across Proteobacteria. In Sphingobium 
japonicum the transporter is required for the uptake of gamma-hexachlorohexane, which it 
uses as its sole carbon source (Endo et al., 2007). In Shigella flexneri, it is required for 
multiplication and spreading within epithelial cells (Hong et al., 1998). In Pseudomonas 
putida the operon is hypothesised to function by altering phospholipid composition of the 
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outer membrane, which makes it essential for resistance to toluene (Kim et al., 1998). In 
Neisseria meningitidis, the transporter is required for uptake of L-glutamate, which is 
essential for survival in low sodium conditions (Monaco et al., 2006).  
Proteobacteria is the only phylum in which proteins containing multiple MCE 
domains have been studied. The best-studied multi MCE domain containing protein is 
multivalent adhesion molecule- 7 (MAM-7) in Vibrio parahaemolyticus, in which there are 
seven MCE domains (Krachler et al., 2011). MAM-7 is reported to be an adhesin involved in 
early infection that binds to mammalian cells via phosphatidic acid and fibronectin 
(Krachler et al., 2011; Krachler and Orth, 2011). Mutants in MAM-7 are less able to adhere 
to mammalian cells and are less cytotoxic than the parent strain (Krachler et al., 2011). 
More recent research has identified that once MAM-7 establishes attachment with the host 
cell it can induce signalling processes including the activation of RhoA, which is involved in 
cytoskeleton rearrangement (Lim et al., 2014). This rearrangement increases the 
permeability of the intestinal epithelial barrier allowing the bacteria to establish deeper 
infection. Studies have also focused on the use of MAM-7 as an anti-adhesion therapy. The 
attachment and cytotoxic effects of clinically isolated pathogens on mammalian cells can be 
decreased by the addition of bacteria overproducing MAM-7 or by beads coupled to the 
protein (Hawley et al., 2013; Krachler et al., 2012a; Krachler et al., 2012b).  
Despite their similarity to MAM-7, research into other multi-MCE domain 
containing proteins is sparse and the functions of those found in E. coli are currently 
unknown. The two multi-domain proteins in E. coli are PqiB and YebT, the latter of which is 
a MAM-7 orthologue. Given the literature on MCE domain containing proteins, PqiB and 
YebT could be involved in a range of cellular functions from inducing mammalian cell entry 
and playing a key role in infection to lipid transportation and maintenance of the cell 






In E. coli, there are three genes predicted to encode MCE domain-containing proteins: 
mlaD; pqiB; and yebT (UniProt Consortium, 2015). There are predicted to be one, three 
and seven MCE domains in MlaD, PqiB and YebT, respectively. While the function of MlaD 
has been studied to some extent, the functions of PqiB and YebT in E. coli are currently 
unknown. The main focus of this study is to investigate MCE domain containing proteins in 
Proteobacteria, with particular focus on the E. coli multi-domain proteins PqiB and YebT. 
The aims were as follows: 
1) Conduct a large-scale bioinformatic study on all MCE domain containing proteins to 
determine their prevalence, co-occurring protein domains, neighbouring genes, and 
evolution with particular focus on Proteobacteria 
2) Identify a phenotype for pqiB and yebT mutants in E. coli and determine the cellular 
locations of PqiB and YebT to provide an insight into their functions 
3) Investigate the role of MlaD, PqiB and YebT as components of lipid transporters by 
testing their affinity to lipids and whether they have a role in maintaining the lipid 
composition of the cell membranes 
4) Solve the structure of PqiB, as no structure for an MCE domain containing protein 
currently exists 
5) Use Salmonella Typhimurium, in which MlaD, PqiB and YebT are also found, to 


















2.1. Culture media, growth conditions and strains 
Strains were inoculated into lysogeny broth (LB) consisting of 10 g/l tryptone, 10 g/l NaCl 
and 5 g/l yeast extract. Overnight cultures were always 5 ml in volume grown in a 20 ml 
universal bottle. All other liquid cultures were grown in Erlenmeyer flasks with 1:10 culture 
to flask volume ratio. Liquid cultures were incubated in a shaking incubator at 180 rpm. For 
LB agar (LA), 1.5% (w/v) nutrient agar was added to LB. For growth on a sole carbon 
source, M9 minimal medium was used (5 x M9 salts from Sigma Aldrich) and supplemented 
with 200 mM MgSO4, 1 mM CaCl2 and the desired carbon source (e.g. 10 mg/ml glucose). 
Unless otherwise stated, cultures were incubated at 37oC, or 30oC for cultures retaining a 
temperature sensitive plasmid. If required, medium was supplemented with 50 µg/ml 
kanamycin sulfate, 100 µg/ml carbenicillin disodium salt or 100 µg/ml chloramphenicol.  
 
2.1.1. Dilution plates 
Square petri dishes (120 mm x 120 mm, Greiner Bio One) were filled with 50 ml of LA and 
the desired chemical. Overnight cultures were adjusted to an OD600 of 1, and serially diluted 
(1 in 10) to 10-7 in a 96-well plate (Greiner Bio One). Per strain, 2 µl of each dilution was 
pipetted on the square plate using a multichannel pipette.  
 
2.1.2. Bacterial strains and plasmids 
Table 2.1 shows a list of strain used in this study, and table 2.2 shows a list of plasmids. 
 
2.2. Molecular genetic techniques 






Table 2.1. Strains used in this study. 
Strain Genotype Source 
E. coli K-12 BW25113 F
- λ- rrnB3 ΔlacZ4787 hsdR514 Δ(araBAD)567 
Δ(rhaBAD)568 rph-1 Baba et al., 2006 
BW25113 pqiAB::aph E. coli K-12 BW25113 with pqiAB disrupted by a kanamycin cassette This study 
BW25113 ΔpqiAB E. coli K-12 BW25113 with a pqiAB deletion This study 
BW25113 yebST::aph E. coli K-12 BW25113 with yebST disrupted by a kanamycin cassette This study 
BW25113 ΔyebST E. coli K-12 BW25113 with a yebST deletion This study 
BW25113 ΔpqiAB, 
yebST::aph 
E. coli K-12 BW25113 with a pqiAB deletion and 
yebST disrupted by a kanamycin cassette This study 
BW25113 ΔpqiAB 
ΔyebST 
E. coli K-12 BW25113 with a pqiAB and yebST 
deletions This study 
BW25113 mlaD::aph E. coli K-12 BW25113 with mlaD disrupted by a kanamycin cassette This study 
BW25113 ΔpqiAB 
mlaD::aph 
E. coli K-12 BW25113 with a pqiAB deletion and 
mlaD disrupted by a kanamycin cassette This study 
BW25113 ΔyebST 
mlaD::aph 
E. coli K-12 BW25113 with a yebST deletion and 
mlaD disrupted by a kanamycin cassette This study 
BW25113 ΔpqiAB 
ΔyebST mlaD::aph 
E. coli K-12 BW25113 with a pqiAB and yebST 
deletion and mlaD disrupted by a kanamycin 
cassette 
This study 
BW25113 ΔmlaD E. coli K-12 BW25113 with an mlaD deletion This study 
BW25113 ΔmlaD 
ΔpqiAB 
E. coli K-12 BW25113 with an mlaD and pqiAB 
deletion This study 
BW25113 ΔmlaD 
ΔyebST 
E. coli K-12 BW25113 with an mlaD and yebST 
deletion This study 
BW25113 ΔmlaD 
ΔpqiAB ΔyebST 
E. coli K-12 BW25113 with an mlaD, pqiAB and 
yebST deletions This study 
BW25113 pqiA::aph E. coli K-12 BW25113 with pqiA disrupted by a kanamycin cassette This study 
BW25113 pqiB::aph E. coli K-12 BW25113 with pqiB disrupted by a kanamycin cassette This study 
BW25113 ymbA::aph E. coli K-12 BW25113 with ymbA disrupted by a kanamycin cassette This study 
BW25113 mlaC::aph E. coli K-12 BW25113 with mlaC disrupted by a kanamycin cassette This study 
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Strain Genotype Source 
BW25113 ΔpqiAB, 
mlaC::aph 
E. coli K-12 BW25113 with a pqiAB deletion 
and mlaC disrupted by a kanamycin cassette This study 
BW25113 ΔpqiAB 
ΔyebST, mlaC::aph 
E. coli K-12 BW25113 with a pqiAB and yebST 
deletion and mlaC disrupted by a kanamycin 
cassette 
This study 
E. coli BL21 DE3 DE3 phage T7 protein expression strain  Invitrogen 
Salmonella 
Typhimurium SL1344 
Salmonella enterica subsp. enterica serovar 
Typhimurium  Wray et al.,1978 
SL1344 pqiAB::aph Salmonella Typhimurium SL1344 with pqiAB disrupted by a kanamycin cassette This study 
SL1344 yebST::aph Salmonella Typhimurium SL1344 with yebST disrupted by a kanamycin cassette This study 
SL1344 ΔpqiAB Salmonella Typhimurium SL1344 with a deletion in pqiAB This study 
SL1344 ΔyebST Salmonella Typhimurium SL1344 with a deletion in yebST This study 
SL1344 ΔpqiAB, 
yebST::aph 
Salmonella Typhimurium SL1344 with a 





Salmonella Typhimurium SL1344 with a 
deletion in pqiAB and yebST This study 




Salmonella Typhimurium SL1344 with a 
deletion in pqiAB and yebST and mlaD 
disrupted by a kanamycin cassette 
This study 
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Table 2.2. Plasmids used in this study. 
 
 
Plasmid Properties Source 




Temperature sensitive plasmid with arabinose 




pCP20 Temperature sensitive plasmid with FLP recombinase. AmpR 
Datsenko and 
Wanner, 2000 
pET17b Constitutively active T7 expression vector, IPTG inducible, AmpR Novagen 
pET22b (+) T7 protein expression vector, N terminal his tag, IPTG inducible, AmpR Novagen 
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2.2.1. Preparation of DNA 
Plasmid DNA was isolated from an overnight culture using the Qiagen QIAprep Spin 
Miniprep kit. For isolation of genomic DNA, the STRATEC RTP Bacteria DNA Mini kit was 
used following the protocol for extraction of DNA from a Gram-negative bacterial cell pellet.  
 
2.2.2. Polymerase chain reaction 
Primers used in this study are found in table 2.3. Fragments required for cloning and 
mutagenesis were amplified using Phusion High-Fidelity DNA Polymerase (New England 
Biolabs) and included the optional use of 5x GC buffer and 3% (v/v) DMSO. Unless 
otherwise specified the thermocycling conditions for Phusion PCR were as in table 2.4. PCR 
products amplified by Phusion were purified using the Qiagen QIAquick PCR purification 
kit. 
 For colony PCR, MyTaq Red Mix (Bioline) was used. A small amount of bacterial 
colony was added straight into the reaction mix.  The thermocycling conditions included a 
10-minute initial denaturation step (at 95oC) to lyse the cells, and an annealing temperature 
of 55oC (unless otherwise specified).  
 
2.2.3. Agarose Gel Electrophoresis 
DNA fragments were separated using 1% (w/v) agarose (Bioline) gels in 1 x TAE buffer (50x 
TAE buffer = 2 M Tris, 1 M acetic acid, 0.05 M EDTA in water) with Midori Green (Nippon 
Genetics) as the DNA dye. DNA samples were loaded using 5 x DNA loading buffer Blue 
(Bioline) at a 1:4 buffer:sample ratio, with the exception of PCR products from MyTaq Red 
Mix, which includes a dye. In all cases Hyperladder 1 kb (Bioline) was used as a marker. 
Gels were run in 1 x TAE buffer at 100 – 120 V until the loading dye had run sufficiently. 
Analytical gels were viewed under UV light (300 nm UV light) in a Gel Doc (Bio-Rad), and 




Table 2.3. Primers used in this study. 
Primer Sequence (5′ to 3′) Description 
pqiA_DW_F AGTCATCTGTAAAATAGCGCATCATTAAGGAGTACCAATGGTGTAGGCTGGAGCTGCTTC 
Forward primer for amplification of kanamycin 
resistance cassette pqiAB gene deletion 
pqiB_DW_R ATCGTCACTAGCCACTTTTTCATTGTTTCGCCCTCTTCGGCATATGAATATCCTCCTTAG 
Reverse primer for amplification of kanamycin 
resistance cassette for pqiAB gene deletion 
pqiA_check_F AACAGAGACAGCTGACAACG Forward flanking primer to check pqiAB gene deletion in E. coli BW25113 
pqiB_check_R TGTTGCGCAACTGTTGATCC  Reverse flanking primer to check pqiAB gene deletion in E. coli BW25113 
yebS_DW_F TAAGATTAATGTTAATTCTTATTACATTTGGCACGTCATGGTGTAGGCTGGAGCTGCTTC 
Forward primer for amplification of kanamycin 
resistance cassette for yebST gene deletion in 
E. coli BW25113 
yebT_DW_R CACGCCGGAGCAGTGGGCATTATTTGGGAAGCGCAGTTCCCATATGAATATCCTCCTTAG 
Reverse primer for amplification of kanamycin 
resistance cassette for yebST gene deletion in 
E. coli BW25113 
yebS_check_F TAACAACGCACTGGTGTTCG  Forward flanking primer to check yebST gene deletion in E. coli BW25113 
yebT_check_R CAGCGTATTAACGCGAATGC  Forward flanking primer to check yebST gene deletion E. coli BW25113 
mlaD_check_F TGGAAAGGCATTGATAGCGG Forward flanking primer to check mlaD gene deletion in E. coli BW25113 
mlaD_check_R TCTTGTAATACTGGCCCAGC Reverse flanking primer to check mlaD gene deletion in E. coli BW25113 
pqiA_NdeI_F GGCGGCCATATGTGCGAACATCATCATGCCGC Forward primer for generation of a pqiA/pqiAB fragment for cloning into pET17b/pET22b(+) 
pqiB_XhoI_R CGAAGCCTCGAGTTGTTTCGCCCTCTTCGGCT Reverse primer for generation of a pqiB fragment for cloning into pET22b(+) 
pqiB_comp_R TCACGAAGCCTCGAGTTGTTTCGCCCTCTTCG Reverse primer for generation of a pqiAB fragment for cloning into pET17b 
yebS_NdeI_F GGCGGCCATATGGCTCTTAACACACCACAAAT  
Forward primer for generation of a yebS/ 
yebST fragment for cloning into pET17b/
pET22b(+) 
yebT_XhoI_R CGAAGCCTCGAGTTTGGGAAGCGCAGTTCCCC Reverse primer for generation of a yebT fragment for cloning into pET22b(+) 
yebT_comp_R  TCACGAAGCCTCGAGTTTGGGAAGCGCAGTTC 
Reverse primer for generation of a yebST 
fragment for cloning into pET17b 
mlaD_NdeI_F CATATGATGCAAACGAAAAAAAATGAA Forward primer for generation of a mlaD fragment for cloning into pET17b/pET22b(+) 
mlaD_XhoI_R CTCGAGTTATTTCGTTGTACCCACAGG Reverse primer for generation of a mlaD fragment for cloning into pET17b/pET22b(+) 
T7_F TAATACGACTCACTATAGGG  Forward primer used for colony PCR/sequencing of pET17b/pET22b(+) constructs 
T7_R GCTAGTTATTGCTCAGCGG  Reverse primer used for colony PCR/sequencing of pET17b/pET22b(+) constructs 
ymbA_check_F AGCCTACAACAAGATGGTGG Forward flanking primer to check ymbA gene deletion in E. coli BW25113 
ymbA_check_R CACAGTTAAGCAATACCGCG Reverse flanking primer to check ymbA gene deletion in E. coli BW25113 
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Primer Sequence (5′ to 3′) Description 
mlaC_check_F ACTGCTATCCTGAAGGATGG Forward flanking primer to check mlaC gene deletion in E. coli BW25113 
mlaC_check_R CCAGGGTATACACTTTGTCG Reverse flanking primer to check mlaC gene deletion in E. coli BW25113 
pqiA_XhoI_R CGAAGCCTCGAGGGACTCCTCATGCTCTGATT Reverse primer for generation of a pqiA fragment for cloning into pET22b(+) 
pqiB_NdeI_F GGCGGCCATATGGAATCTAATAATGGGGAAGC Forward primer for generation of a pqiB fragment for cloning into pET22b(+) 
pqiB_TM_NdeI_F GGCGGCCATATGCAGGGACCGGAAGTGACCCT 
Forward primer for generation of a pqiB 
fragment without the first 120 bps for cloning 
into pET22b(+) 
yebS_XhoI_R CGAAGCCTCGAGGTCGTCGAAGCGGGCGTTTC Reverse primer for generation of a yebS fragment for cloning into pET22b(+) 
yebT_NdeI_F GGCGGCCATATGAGTCAGGAAACGCCCGCTTC Forward primer for generation of a yebT fragment for cloning into pET22b(+) 
yebT_TM_NdeI_F GGCGGCCATATGAGTTATCAGGACCGGGGTAA 
Forward primer for generation of a yebT 






Forward primer for amplification of 
kanamycin resistance cassette for pqiAB 
deletion in S. Typhimurium SL1344 
pqiB_GD_R CATATGGCTAGCTCACGACTAGCCATTTTTTCATTGTTTCGCCCTCTTAGG  
Reverse primer for amplification of 
kanamycin resistance cassette for pqiAB 
deletion in S. Typhimurium SL1344 
pqiA_STm_check_F AATCGGACGTTATATCGGCG Forward flanking primer to check pqiAB gene deletion in S. Typhimurium SL1344 





Forward primer for amplification of 
kanamycin resistance cassette for yebST 





Reverse primer for amplification of 
kanamycin resistance cassette for yebST 
deletion in S. Typhimurium SL1344 
yebS_STm_check_F CGTTGAACCTTATTCTGCGC Forward flanking primer to check yebST gene deletion in S. Typhimurium SL1344 
yebT_STm_check_R TAAATGCTCAGCGGTACTGC Reverse flanking primer to check yebST gene deletion in S. Typhimurium SL1344 
mlaD_STm_DW_F TTTCATTGCCGCTACTGA 
Forward primer for generation of kanamycin 
cassette for construction of mlaD gene 
deletion is S. Typhimurium SL1344 
mlaD_STm_DW_R CGCTATCTGGTAAGTCTGACC 
Reverse primer for generation of kanamycin 
cassette for construction of mlaD gene 
deletion is S. Typhimurium SL1344 
mlaD_STm_check_F CTCCAGTATGGAGATGATGG Forward flanking primer to check mlaD gene deletion in S. Typhimurium SL1344 
mlaD_STm_check_R TACACGGATAGGCACAATG Reverse flanking primer to check mlaD gene deletion in S. Typhimurium SL1344 
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Table 2.4. Thermocycling conditions used for Phusion PCR. 
 
 
Cycles Step Temperature Time  
1 Initial denaturation 98oC  5 minutes 
30 Denaturation 98oC  10 seconds 
Annealing 55oC  30 seconds 
Extension 72oC  30 seconds/kb 
1 Final extension 72oC 5 minutes 
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2.2.4. Cloning 
Purified PCR fragments and plasmids were digested with two restriction enzymes (most 
commonly NdeI and XhoI) using FastDigest enzymes (Thermo Scientific). Digested 
products were separated by agarose gel electrophoresis and extracted using Qiagen 
QIAquick Gel Extraction kit. The vector was treated with Antarctic Phosphatase (New 
England Biolabs) to prevent vector re-ligation. DNA was quantified using Nanodrop and the 
insert was ligated into the vector at a 3:1 ratio with 50 ng of vector DNA, using T4 ligase 
(NEB). After incubation at 16oC overnight, 5 µl of the ligation mixtures were transformed 
into NEB 5-alpha Competent E. coli (High Efficiency) and plated onto LA with appropriate 
antibiotics.  
 
2.3. Bacterial transformation 
2.3.1. Chemical competence  
The desired strain was inoculated into 5 ml LB and grown overnight at 37oC. The cells were 
diluted 1:100 into 100 ml of fresh LB and grown to OD600 of 0.5. The cells were stored on ice 
for 30 min and centrifuged for 10 min at 6000 g and 4oC. The pellet was re-suspended in 
12.5 ml of ice cold 0.1 M CaCl2 and stored on ice for 30 min. The cells were centrifuged 
again and re-suspended in 1 ml of 0.1 M calcium chloride and stored on ice for 1 hour.  
For transformation, 50 ng of vector DNA was mixed with 50 µl of competent cells in 
a 1.5 ml microcentrifuge tube. The mixture was heat shocked for 90 s in a 42oC water bath 
and placed on ice for 5 min. 1 ml of LB was added and the cultures were aerated at the 
appropriate temperature for 1 hour (usually 37oC, but 30oC for temperature sensitive 
vectors). The cells were pelleted at 6000 g for 5 min and re-suspended in 100 µl of LB. The 
transformation was plated onto LA with the appropriate antibiotic and incubated overnight. 
 
2.3.2. Electroporation 
An overnight culture was diluted 1: 100 into 100 ml of fresh LB and grown to an OD600 of 
0.6. The cultures were placed on ice for 30 min and centrifuged at 6000 g for 10 min at 4oC. 
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The pellet was wash three times by resuspension and centrifugation with decreasing 
volumes of ice cold H2O (100 ml, 50 ml and 10 ml), and were finally re-suspended in 1 ml of 
H2O. 
For transformation, 50 µl of cells were mixed with 50 ng of plasmid DNA or 300 ng 
of linear DNA. The mixture was transferred to a 2 mm electroporation cuvette (Cell 
Projects) and pulsed at 2200V, after which 1 ml SOC medium (New England Biolabs) was 
added immediately. The mixture was transferred to a test tube for recovery for 1 hour in a 
shaking incubator at either 37oC or 30oC. The transformation was then plated onto LA with 
the appropriate antibiotic and incubated overnight at 37oC or 30oC.  
 
2.4. Chromosomal genetic engineering 
2.4.1. Datsenko and Wanner method for gene inactivation 
The gene of interest was replaced with a linear fragment containing an antibiotic resistance 
cassette, using λ Red recombination as described by Datsenko and Wanner (2000). The 
steps in this protocol are summarised in figure 2.1. In the first step, a linear fragment 
containing a kanamycin resistance (aph) cassette with flanking homology to the region up 
and downstream of the gene of interest was generated by PCR with the plasmid pKD4 as a 
template.  The 5o bp at the 5ʹ end of the forward primer were homologous to the region 
upstream of the gene of interest (H1). The next 20 bp were homologous to 5ʹ end of the aph 
cassette on pKD4 (P1). The 50 bp at 5ʹ end of the reverse primer were homologous to the 
last seven codons of the gene of interest and the region downstream (H2). The next 20 bp of 
the reverse primer were homologous to the end of aph cassette on pKD4 (P2). Retaining the 
last seven codons prevented disruption of any overlapping downstream gene or DNA 
binding sites. 
 The strain of interest was made chemically competent and transformed with 
temperature sensitive plasmid pKD46, which contains an arabinose inducible λ Red 
recombinase, and incubated at 30oC on LA supplemented with carbenicillin. The strain 




Figure 2.1. The main steps for gene inactivation using lambda red recombination. In the 
first step, a linear fragment containing a kanamycin resistance (aph) cassette with flanking 
homology to the region up (H1) and downstream (H2) of the gene of interest is generated. 
The target strain is transformed with the linear DNA fragment to recombine with the gene 
of interest on the chromosome.   
gene of interest 5’ gene 3’ gene 
H1 H2 
5’ gene 3’ gene Kan resistance gene 
FRT FRT 
5’ gene 3’ gene 
FRT 
Kan resistance gene 





Kan resistance gene 
FRT FRT 
Regions used in primer design 
PCR 
Lambda Red recombination 
Removal of cassette 
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L-arabinose for induction of recombination machinery expression) and transformed with 
the linear DNA fragment and recovered at 37oC. Half of the transformation was plated on 
LA supplemented with kanamycin and incubated overnight at 37oC. The other half was left 
overnight at room temperature for subsequent plating if there were no colonies on the first 
plate. Resultant colonies were re-streaked LA supplemented with kanamycin to purify the 
potential knockouts from dead WT cells. The colonies were checked by colony PCR using 
check primers homologous to between 100 and 500 bp either side of the gene of interest. A 
change in band size from WT to kanamycin cassette confirmed successful gene replacement.  
 
2.4.2. P1 transduction 
P1 transduction was used to transfer mutations made by λ Red recombination into E. coli 
strain BW25113, or into a strain constructed during this project. The method used is based 
on the protocol described by Thomason et al. (2007). An overnight 5 ml culture of the donor 
strain was diluted 1: 100 into 5 ml LB containing 0.2% glucose and 5 mM CaCl2 and 
incubated with shaking for 45 min at 37oC. The culture was infected with 100 µl of recently 
prepared virulent P1 stock and incubation was continued until lysis occurred (~3 h). To kill 
any un-lysed bacteria, 2oo µl of chloroform was added and incubated for a further 5 min. 
The liquid was centrifuged at 10 000 g for 10 min at 4oC and the supernatant (p1 lysate) was 
stored at 4oC until required.  
 Two 1.5 ml samples of an overnight culture of the recipient strain were pelleted by 
centrifugation in a micro centrifuge tube at maximum speed for 2 min at room temperature. 
The pellet was re-suspended in 750 µl of P1 salts (1o mM CaCl2, 5 mM MgSO4) and 100 µl of 
cells were mixed with 0, 1, 1o and 1oo µl of P1 lysate in glass tubes and left at room 
temperature for 30 min. LB (1 ml) and 0.2 mM sodium citrate was added to each 
transduction and recovered at 37oC for 1 hour. The cells were then pelleted in micro 
centrifuge tubes at maximum speed for 2 min at room temperature. The pellet was re-
suspended in 100 µl of LB and plated onto LA containing kanamycin and 5 mM sodium 
citrate and incubated overnight at 37oC. The plate that showed colonies from the least 
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amount of phage was selected and colonies were screened by colony PCR using check 
primers between 100 and 500 bp up either side of the gene of interest. 
 
2.4.3. Removal of kanamycin cassette 
To remove the kanamycin resistance gene, confirmed mutant strains were made chemically 
competent and transformed with the temperature sensitive plasmid pCP20, and incubated 
at 30oC with carbenicillin. The plasmid pCP20 contains the yeast FLP recombinase gene 
that recombines the two FLP sites flanking the kanamycin resistance gene, removing the 
gene and leaving a small scar on the chromosome. Colonies containing pCP20 were 
inoculated into 5 ml of LB for 6 h at 42oC to cure the bacteria of the temperature sensitive 
plasmid. A small volume of this culture was spread onto plain LA to give single colonies 
after growth overnight at 42oC. The colonies were patch plated onto LA, LA supplemented 
with carbenicillin and LA supplemented with kanamycin to check for loss of pCP20 and the 
kanamycin cassette. Colonies that grew only on plain LA were checked by colony PCR to 
confirm removal of the kanamycin resistance cassette.  
 
2.5. Sequencing 
2.5.1. Genome sequencing 
Strains for sequencing were sent to MicrobesNG sequencing service, University of 
Birmingham, which uses an Illumina MiSeq or HiSeq platform. The service included SNP 
and short indel calling compared to the chosen reference strain and aligned reads were 
browsed manually using Artemis Comparison Tool to confirm SNPs, indels and gene 
deletions.  
 
2.5.2. Plasmid sequencing 
Plasmids were sequenced using the Functional Genomic Unit, University of Birmingham. In 
a 10 µl sequencing reaction there was 200-500 ng of vector DNA and 3.2 pmol of 
sequencing primer. The service uses the capillary sequencer ABI 3730. 
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2.6. Protein analysis 
2.6.1. SDS-PAGE analysis 
In this study all protein samples were analysed on 10% resolving and 6% acrylamide 
stacking gels made in 1 mm gel casts (BioRad). Per 10 ml of resolving gel there were 3.3 ml 
of 30% (w/v) acrylamide (Protogel), 2.5 ml of resolving buffer (Protogel), 4.2 ml of H2O, 
180 µl of 1o% (w/v) ammonium persulphate (APS) and 24 µl of TEMED. Per 10 ml of 
stacking buffer there were 1.7 ml of 30% (w/v) acrylamide (Protogel), 2.5 ml of stacking 
buffer buffer (0.5 M Tris, pH 6.8), 5.8 ml of H2O, 100 µl of 10% (w/v) ammonium 
persulphate (APS) and 14 µl of TEMED.  
 Protein samples were loaded in 2x Laemmli sample buffer (Sigma Aldrich). For 
whole cell lysates an equivalent of 1 ml of culture with an OD600 of 1 were pelleted in a 
microcentrifuge tube at maximum speed for 2 min. The pellet was re-suspended in 100 µl of 
Laemmli buffer and boiled for 15 min to lyse the cells. All other sample types were loaded in 
a 1: 1 ratio with the sample buffer without boiling. For 10 and 15 well gels a maximum of 20 
µl and 10 µl were loaded, respectively.  Gels were run at 120 V until the loading dye reached 
the bottom of the gel. Gels were stained with R-250 Coomassie Brilliant Blue (Thermo 
Fisher Scientific) for 30 min and destained with destain solution (10% (v/v) glacial acetic 
acid, 40% (v/v) methanol, 50% (v/v) H2O).  
 
2.6.2. Protein expression 
For expression of a particular protein, the desired gene was cloned into the pET22b, which 
harbours a C-terminal polyhistine tag, and was transformed into chemically competent E. 
coli BL21 DE3. Transformants were incubated overnight in LB supplemented with 
carbenicillin and were subsequently diluted 1: 100 for further growth. The cells were grown 
to an OD600 of 0.6 and induced with IPTG (usually at a final concentration of 1 mM). 
Cultures were left for a further 3 h at 37oC (to produce protein for antibodies) or overnight 
at 18oC (to produce protein for crystallography). 
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2.6.3. Protein purification 
Conditions for protein purification varied depending on whether the protein was soluble or 
insoluble (membrane located). For soluble protein, the induced cells were pelleted at 16000 
g for 10 min at 4oC. The pellet cells were re-suspended (3 ml/g pellet) in binding buffer 
(50mM NaP pH 7, 500 mM NaCl and 50mM imidazole) and broken in a C3 cell disrupter 
until visible lysis had occurred. To pellet unbroken cells the suspension was centrifuged at 
17400 g for 20 min at 4oC. The supernatant was bound to either a 1 ml (for antibodies) or 5 
ml (for crystallography) HisTrap column (GE healthcare) overnight, using a peristaltic 
pump. After binding, the column was washed twice using binding buffer (5x column 
volume). The protein was eluted in 5 x 1 ml fractions (for 1 ml column) or 10 x 1 ml fractions 
(for 5 ml column) in elution buffer (50 mM NaP pH 7, 500 mM NaCl and 500 mM 
imidazole). At all stages, Complete EDTA-free Protease Inhibitor Cocktail Tablets (Roche) 
were used to prevent protein degradation. The flow-through, washes and elutions were 
analysed by SDS-PAGE to determine the success of the purification. 
 For membrane-localised proteins, the purification protocol was altered. Following 
the pelleting of unbroken cells after lysis, the supernatant was spun again at 48400 g for 1 
hour at 4oC, to pellet cell membranes. The membrane was solubilised overnight shaking at 
4oC in binding buffer and 0.5% n-Dodecyl β-D-maltoside (DDM) with 1 ml of buffer per 40 
mg of membrane. The remaining steps were as for the soluble protein, except the wash and 
elution buffers contained 0.1% DDM.  
 
2.6.4. Generation of polyclonal antibodies 
For generation of antibodies, soluble protein was purified as described in the previous 
section. The protein was sent to Eurogentec for the Anti-protein 28-day Speedy polyclonal 
package, where antibodies are raised in rabbits. This protocol involved injection of 200 µg 
of protein into two rabbits on days 0, 7, 10 and 18, with final serum collect on day 28. The 
final serum was used to detect the desired protein by western blot. 
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2.6.5. Western blotting 
Samples for western blotting were separated using SDS-PAGE. The protein was transferred 
to a nitrocellulose membrane using the iBlot 2 Dry Blotting System (Thermo fisher). 
Membranes were blocked in 5% (w/v) milk buffer (per l: 50 g skimmed milk, 2.42 g Tris 
base, 8 g NaCl, pH 8.4) for 1 hour at room temperature. The membrane was incubated 
overnight at 4oC in primary antibody (diluted in 5% (w/v) milk buffer at the required ratio). 
The membranes were washed three times for 5 min in TBS-T (per l: 1 ml Tween-20, 2.42 g 
Tris base, 8 g NaCl, pH 8.4). For secondary incubation, the HRP secondary antibody (Sigma 
Aldrich) was added at a ratio of 1: 15000 into 5% (w/v) milk buffer and incubated with the 
membrane for 1 hour. The membrane was washed a further 3 times in TBS-T. The western 
blot was developed using ECL Prime Western Blotting Detection Reagent (Amersham), and 
exposed to Hyperfilm ECL (Amersham) for between 5 s and 5 min.  
 
2.7. Preparation of cellular fractions  
2.7.1. Separation of soluble and insoluble cellular compartments  
Two litres of cells were grown to an OD600 of 0.6-0.8. The cells were pelleted at 16000 g for 
10 min at 4oC and re-suspended in 3 ml/g of phosphate buffered saline (PBS, per l: 8 g 
NaCl, 0.2 g KCl, 1.42 g Na2HPO4, 0.24g KH2PO4). The cells were broken in a C3 cell 
disrupter (at 15000 Psi) and unbroken cells were pelleted at 17400 g for 20 min at 4oC. The 
supernatant was spun again at 48400 g for 1 hour at 4oC to pellet cell membranes and leave 
the soluble cell components in the supernatant.  
For determination of protein location by western blot, the pellet was re-suspended 
in 5 ml of PBS and the supernatant was concentrated down to 5 ml using a Vivaspin 500 
concentrator (GE Healthcare, MWCO 5000). The protein concentration of each sample was 
determined by a Bradford Protein Assay. For the western blot, 10 µg and 50 µg of protein 
were analysed for the insoluble and soluble fractions, respectively, based on the estimated 
amount of protein found in the insoluble and soluble compartments of the cell (Ames, 
1974). 
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2.7.2. Sarkosyl extraction for separation of inner and outer membranes 
This protocol was adapted from Hobb et al., (2009). Membranes from 2 l of culture were 
isolated as described in the previous section and re-suspended in 80 ml of HEPES buffer 
(10 mM HEPES, pH 7.4) to wash the membranes. The membranes were re-pelleted at 
10000 g for 1 hour at 4oC. The pellet was re-suspended in 40 ml HEPES buffer and 1% 
(w/v) sarkosyl (Sigma Aldrich) and incubated shaking at 37oC for 30 min. The sarkosyl-
treated membranes were pelleted again at 10000 g for 1 hour at 4oC. The outer membrane 
pellet was re-suspended in 5 ml of HEPES buffer, and the inner membrane supernatant was 
concentrated down to 5 ml using a Vivaspin 500 concentrator (GE Healthcare, MWCO 
5000). The success of the separation was determined by western blot, using known inner 
and outer membrane protein markers against 10 µg of protein per sample.  
 
2.7.3. Short protocol for separation of inner and outer membrane using a 
sucrose gradient 
The method was adapted from online protocol for isolation of the outer membrane (cmdr 
website, 2000). Isolation of membranes was done as described previously, with an 
additional step before cell disruption. This was an osmotic shock step to remove periplasmic 
contents using a protocol described by Magnusdottir et al., (2009). Whole cells were re-
suspended in 5 ml/g of sucrose buffer (50 mM HEPES, 20% (w/v) sucrose, 1 mM EDTA pH 
7.9) and re-pelleted at 7000 g for 30 min at 4oC. The pellet was re-suspended again in 5 
ml/g of 5 mM MgSO4 and stored on ice for 10 min. The cells were pelleted again at 4500 g 
for 20 min at 4oC. This pellet was re-suspended in 3 ml/g of PBS and lysed in a C3 cell 
disrupter. The cell membranes were isolated as described previously and re-suspended in 5 
ml of 20% (w/v) sucrose.  
 The sucrose gradient was set up with 4 ml 70% (w/v) sucrose (bottom), 4 ml 
60%(w/v) sucrose (middle) and 4 ml 20% (w/v) sucrose containing the isolated membranes 
(top) made in 14 ml Ultra-Clear Thinwall tubes (Beckman Coulter). A total of 1 mg of 
protein was loaded per gradient. The gradients were ultracentrifuged at 285000 g for 16 h 
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at 4oC in a SW 40 Ti rotor. After centrifugation, the tube was pierced at the bottom and 
fractions of ~500 µl were obtained. The fractions were analysed by SDS-PAGE and western 
blot with known membrane markers to determine the success of inner and outer membrane 
separation.  
 
2.7.4. Long protocol for separation of inner and outer membrane using a 
sucrose gradient 
This protocol was adapted from Osborn and Munson, (1974) and Dalebroux et al., (2015). 
Before cell disruption and isolation of membranes spheroplasts were prepared. The cell 
pellet (from 2 l of cells at an OD600 of 0.6-0.8) was re-suspended in 10 ml of sucrose-Tris 
buffer (0.75 M sucrose, 10 mM Tris, pH 7.8). The mixture was transferred to an Erlenmeyer 
flask where 500 µl of 2 mg/ml lysozyme was added. After a 2 minute incubation on ice, 20 
ml of ice cold 1.5 mM EDTA was slowly added over 10 min using a peristaltic pump, with 
gentle stirring. The spheroplasts were broken using a C3 cell disrupter, and the membranes 
were isolated as described previously. To wash the membranes, the pellet was re-suspended 
in 20 ml of sucrose-Tris-EDTA buffer 1 (0.25 M sucrose, 3.3 mM Tris, pH 7.8, 1 mM EDTA) 
and re-pelleted at 165 ooo g for 1 hour at 4oC. The membranes were re-suspended again in 
10 ml of sucrose-Tris-EDTA buffer 2 (20% (w/v) sucrose, 0.5 mM EDTA, 10 mM Tris, pH 
7.8) and were ready for separation by sucrose gradient.  
 For the gradient, all sucrose was made up in EDTA-Tris buffer (0.5 mM EDTA, 10 
mM Tris, pH 7.8). The gradient was made up in 38.5 ml Ultra-Clear Thinwall tubes 
(Beckman Coulter) with 10 ml of 73% (w/v) sucrose (bottom), 18 ml of 53% (w/v) sucrose 
(middle) and 10 ml of 20% (w/v) sucrose including the membrane sample (top). The 
gradient was centrifuged 141 000 g for 40 h in a SW 28 Ti rotor at 4oC. To obtain the inner 
membrane a pipette was used to withdraw the membrane through the top of the gradient 
from the 20%-53% boundary. To obtain the outer membrane the tube was pierced at the 
bottom and collected by gravity flow from the 53%-73% boundary. To assess the success of 
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separation, the isolated fractions were analysed by western blot using known membrane 
markers.  
 
2.8. X-ray Crystallography of PqiB 
2.8.1. Size exclusion to obtain cleaner purified protein 
Purifed PqiB was separated from any contaminants by size exclusion using a Superdex 200 
10/300 GL column on an AKTA Pure system. This gel filtration system elutes proteins 
based on sized. The buffer used throughout was 200 mM NaCl and 20 mM HEPES, pH 8 
(plus 0.5% DDM for insoluble protein). The system was set up to elute in 2 ml fractions and 
measure the protein concentration of each fraction by absorbance at 280 nm. The fractions 
that contained high amounts of protein were analysed by SDS-PAGE and clean fractions of 
the correct molecular weight were pooled and concentrated for crystallography.  
 
2.8.2. Crystal tray set up 
After gel filtration, protein was concentrated using a Vivaspin 500 concentrator (GE 
Healthcare, MWCO 30000), to ~20 mg/ml. The following 96 condition screens were used 
to test for crystal formation: JCSGand, ProPlex, Morpheus HT-96, Midas HT-96, PACT 
premier (Molecular Dimensions) and PEGRx (Hampton Research). Sitting drops were set 
up at a 300: 300 nl protein: condition ratio using the mosquito Crystal automated liquid 
handler (TTP Labtech), with a 30 µl reservoir of each condition. The crystal trays were 
checked at regular intervals for crystal formation. Any condition that formed a crystal was 
scaled up manually in a 24 well plate with hanging drops of 2 : 2 µl protein: condition ratio, 
over a 1  ml reservoir. These scale-up trays were designed to cover a small range of pH’s and 
precipitant concentration around the original condition in an attempt to repeat and 
improve crystal formation. Poor quality crystals and microcrystals were used for seeding 
crystal growth. The crystals were broken up by harsh vortexing in ~20 µl of the solution it 
formed in. This stock was used to seed back into the same condition manually (24 well) or 
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into a new screen using the mosquito. The drops were set up at a 3: 2: 1 ratio of protein: 
condition: seed stock in a 4 µl drop for manual trays and a 600 nl drop for mosquito trays.  
 
2.8.3. Testing the diffraction of crystals 
Crystals were picked with appropriate sized loops under a 10x microscope, frozen in liquid 
nitrogen and transported to Diamond Light Source by members of the Lovering research 
group, University of Birmingham. Crystals were picked with and without soaking in 
bromine to help overcome the phasing problem (see 5.1). 
 
2.9. Lipidomics techniques 
2.9.1. Extraction of lipids from purified protein 
To extract lipid, 2 ml of chloroform and 1 ml of methanol was added to 2 ml of 1 mg/ml 
protein in a glass tube. The mixture was vortexed for 2 min and incubated at 50oC for 30 
min. The mixture was vortexed for another 2 min and centrifuged at 1000 RPM for 10 min 
in an IEC tabletop centrifuge forming a two-phase system (top=aqueous, bottom=organic). 
The lower phase was collected using a glass Pasteur pipette and transferred to a fresh glass 
tube. The tubes were placed in a heat block at 100oC without lids until all liquid had 
evaporated. The lipids were re-dissolved in 200 µl of chloroform ready for thin layer 
chromatography.  
 
2.9.2. One-directional thin layer chromatography 
TLC plates (Silica gel 60 – Merck Millipore) were cut to 10 cm in length and a width that 
allowed 1 cm between each sample and the edge of the plate. A total of 10 µl of each sample 
was loaded with 5 µl glass microcapillary tubes (Sigma Aldrich) 1 cm from the bottom of the 
TLC plate. The plate was placed in a solvent system designed for separation of 
phospholipids by head group polarity: 65:25:4 chloroform: methanol: water. The silica plate 
remained in the solvent until the solvent front was ~1 cm from the top of the plate. The 
plate was left to dry thoroughly for 30 min and stained with phosphomolybdic acid. The 
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stained plated was heated with a hair-dryer to activate phosphomolybdic acid until lipid 
species became visible.  
For identification of lipid species, two plates were run side by side. One was stained 
to identify the location of the lipids and one remained unstained for mass spectrometry. The 
unstained TLC was sent to the Centre for Chemical and Materials Analysis, School of 
Chemistry, University of Birmingham for identification of the lipids species by mass 
spectrometry. The masses were analysed directly from the TLC plates using the combined 
Plate ExpressTM and expression® compact mass spectrometer system from Advion. PE, PG 
and CL standards were also analysed alongside to aid with identification of the masses. 
 
2.9.3. Extraction of membrane lipids 
For analysis of lipid composition of the inner and outer membranes, lipids were extracted 
from samples obtained from sucrose gradient protocol 2 (see 2.7.4). For 1.5 ml of isolated 
membrane sample, 5.7 ml of 1:2 chlorform: methanol was added and vortexed. An 
additional 1.875 ml of chloroform was added and vortexed again followed by a further 1.875 
ml of water and a further vortex. The mixture was centrifuged at 1000 RPM in an IEC table-
top centrifuge for 5 min, forming a two-phase system. The bottom phase was collected using 
a glass Pasteur pipette and transferred to a new tube.  
 To clean the bottom layer “authentic upper phase” was prepared. This involved 
repeating the same steps for lipid extraction but with water in place of sample. After the 
centrifugation the upper phase was collected. This authentic upper phase was mixed back 
with the lipid extract at a 2.25: 1 ratio and vortexed and centrifuged as before. The bottom 
phase was collected and transferred into a clean glass tube. The liquid was evaporated off at 
100 oC and the lipids were re-dissolved in 200 µl of chloroform ready for TLC.  
 
2.9.4. Phospholipid quantification using ammonium ferrothiocyanate 
An ammonium ferrothiocyanate assay was used to normalise loading of phospholipid 
samples onto 2D TLC plates. This assay was used as described by Stewart (1980). 
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2.9.5. Two-directional thin-layer chromatography 
For visualisation of membrane lipid content, lipid extracts were analysed using 2D-TLC on 
7 x 7 cm silica plates.  At total of 10 µl of each sample was loaded with 5 µl glass 
microcapillary tubes in the bottom left corner of the plate, 1 cm the edges. For direction one, 
the plate was placed in the same solvent system used previously: 65:25:4 chloroform: 
methanol: water, until the solvent front was 1 cm from the top of the plate. The plate was 
allowed to dry thoroughly before being rotated 90o anticlockwise and placed in the second 
solvent system: 80:12:15:4 chloroform: methanol: acetic acid: water. This solvent system is 
mainly designed to separate phosphotidylglycerol and cardiolipin, which co-migrate in the 
first system. After thorough drying the plate was sprayed with phosphomolybdic acid and 
heated until lipids were clearly visualised.  
 
2.10. Salmonella techniques 
2.10.1. Gene doctoring 
Gene doctoring was used to construct gene deletions in S. Typhimurium. The principle for 
creating the deletion is similar, except the recombination fragment is transformed on a 
vector rather than a linear fragment (Lee et al., 2009). In the first step, a linear fragment 
containing a kanamycin resistance (aph) cassette with flanking homology to the regions up 
and downstream of the gene of interest was generated by PCR with the plasmid pDoc-K as a 
template. The plasmid pDoc-K carries a kanamycin resistance cassette that is flanked by 
FLP sites. The primers were designed so the fragment could be ligated into pDoc-C using 
the HindIII and BamHI restriction sites.  After the HindIII restriction site, the 39 bp at the 
5ʹ end of the forward primer were homologous to the region upstream of the gene of 
interest. The next 20 bp were homologous to 5ʹ end of the aph cassette on pDoc-K. After the 
BamHI restriction site, the 50 bp at 5ʹ end of the reverse primer were homologous to the 
last seven codons of the gene of interest and the region downstream. The next 20 bp of the 
reverse primer were homologous to the end of aph cassette on pDoc-K. The generated 
fragment was ligated into pDoc-C using HindIII and BamHI restriction sites, and 
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transformed and checked as described previously. Features of the pDoc-C plasmid include a 
multiple cloning site that is flanked by two I-SceI sites, the sacB gene (for sucrose sensitive) 
and an ampicillin resistance gene. The sacB gene is important for the determination of 
genuine recombinants later in the protocol.  
 For construction of the gene deletion, Salmonella Typhimurium SL1344 was 
electroporated with pDoc-C containing the PCR fragment and pACBSCE and plated onto LA 
supplemented kanamycin, ampicillin and chloramphenicol (LACAK). The plasmid pACBSCE 
carries the λ-Red recombination machinery and I-SceI. The transformants were plated onto 
LACAK with and without 5% (w/v) sucrose to ensure the sacB gene on pDoc-C was still 
intact. A sucrose sensitive colony was inoculated into 1 ml LBCAK with 0.5% glucose (to 
prevent expression of  I-SceI and λ-Red genes on pACBSCE) and grown for 2 h at 37oC. The 
cells were pelleted by centrifugation at 6000 g for 5 min and re-suspended in LB with 0.5% 
arabinose to induce expression of the I-SceI and λ-Red genes on pACBSCE. The I-SceI 
endonuclease cleaves the I-SceI sites either side of the cloning site in pDoc-C, linearising 
the kanamycin resistance cassette for recombination on the chromosome. It also cleaves the 
I-SceI sites in pACBSCE to encourage plasmid loss. The culture was grown at 37oC for 4-5 h 
and pelleted again at 6000 g for 5 min. The cells were re-suspended in 100 µl of LB and 
plated on LA with kanamycin and 5% (w/v) sucrose. The sacB gene on p-Doc-C allows the 
distinction of kanamycin resistant colonies that have had successful chromosomal 
recombination (i.e. are sucrose resistant and lack pDoc-C) from those that have not had 
successful recombination (i.e. are sucrose sensitive and kanamycin resistant due to the 
presence of pDoc-C). Kanamycin and sucrose resistant colonies were screened for loss of 
pDoc-C and pACBSCE by patch plating onto LA, LA with ampicillin and LA with 
chloramphenicol. Ampicillin and chloramphenicol sensitive colonies were checked for gene 





2.10.2. P22 transduction 
In this study P22 phage was used to transfer kanamycin cassette insertion mutations to a 
clean background of S. Typhimurium. For generation of the donor phage stock, the donor 
strain was grown overnight in 5 ml LB with kanamycin. The next day the overnight was 
diluted 1:100 in 5 ml of LB containing 10 mM magnesium sulphate and 5 mM calcium 
chloride and was incubated at 37oC for 30 min. Five microlitres of P22 phage stock 
(previously generated from the parent strain) was added to the culture, which was then 
incubated overnight at 37oC. Following overnight incubation, 1ml of chloroform was added 
to the culture and vortexed for 15 s, to kill the donor bacteria. This was centrifuged at 6000 
g for 10 min at 4oC. The clear supernatant was transferred to a glass universal containing 
200 µl chloroform for storage.  
For transduction, the recipient strain was grown overnight in 5 ml LB. To pellet the 
cells, the culture was centrifuged at 6000 g for 5 min at room temperature. The pellet was 
re-suspended in 1 ml of LB containing 10 mM magnesium sulphate and 5 mM calcium 
chloride. Separate transductions were prepared with 200 µl of recipient bacteria and 5, 10, 
50 or 100 µl of the donor phage stock. The mixtures were incubated for 15 min at 37oC 
before the addition of 100 µl sodium citrate and 1 ml LB. After a further 45 min of 
incubation the cells were pelleted at 6000 g for 5 min at room temperature. The pellet was 
washed 3 times in PBS before a final resuspension in 100 µl LB. The cells were and plated 
onto LA with kanamycin and incubated at 37oC for 48 h. Any colonies were checked for gene 
insertion mutations by colony PCR using check primers. 
 
2.10.3. Preparation of Lipopolysaccharide 
In order to establish an infection in mice, Salmonella Typhimurium requires intact 
lipopolysaccharide (LPS). To check for the presence of LPS, the strain of interest was grown 
overnight in 5 ml LB. After overnight incubation, 250 µl of culture with an OD600 of 4 (or the 
equivalent volume for the correct number of cells) was centrifuged at 14000 g for 10 min. 
The pellet was re-suspended in 2x laemmli sample buffer (Sigma) and incubated for 4 min 
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at 100oC. The suspension was incubated at -80oC for 5 min, then defrosted and incubated 
again at 100oC for a further 4 min. The samples were centrifuged at 14000 g for 2 min and 
80ul of the supernatant was removed and combined with 5 µl of 5 mg/ml proteinase K and 
incubated at 60 oC for 1 hour. To deactivate proteinase K, the samples were incubated at 95 
oC for 5 min. The LPS extract was separated by SDS-PAGE and visualised using the Silver 
Quest Staining Kit (Invitrogen).  
 
2.10.4. Serum bactericidal assay 
Serum bactericidal assay (SBA) was used to check if different S. Typhimurium strains were 
sensitive to serum from healthy humans. After overnight incubation, 1.5 ml of culture with 
an OD600 of 0.6 (or equivalent) was centrifuged at 6000 g for 5 min at room temperature. 
The pellet was washed twice and re-suspended in 1 ml PBS to make the strain stock 
inoculum. The stock inoculum was diluted 1:10 by transfer of 100 µl into 900 µl of PBS. In 
four fresh tubes, 10 µl of the 1: 10 dilution was added to of 90 µl serum and incubated for 45, 
90 and 180 min at 37oC. At each time point a tube was collected and the contents were 
diluted down to 10-3 by mixing 10 µl of the tube contents with 90 µl of PBS. Ten microliters 
of each dilution was pipetted as drops in triplicate on LA plates. The original stock was also 
diluted down 10-8 and plated. After all the time points were collected, the plates were 
incubated overnight at 37oC. The number of colonies was counted and the values were 
adjusted to CFUs/ml for 100. The data were plotted as a log decrease in colonies relative to 
the strain stock inoculum.  
 
2.10.5. Adhesion and invasion of HeLa cells 
HeLa cells were taken from liquid nitrogen stocks and placed into a 37oC water bath to 
thaw. The cells were removed and placed in a 75 ml tissue culture flask with 10 ml of 
complete DMEM media (DMEM supplemented with 2 mM L-glutamine, 10% (v/v) fetal 
bovine serum (FBS) and 1% (w/v) penicillin-streptomycin). At all stages, tissue culture 
media were pre-warmed to 37oC and mammalian cells were incubated in 5% CO2 The next 
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day the medium was removed and the cells were washed once with 10ml PBS and replace 
with 10 ml fresh complete DMEM medium. The cells were left for approximately 3 days 
until the cells were 80% confluent. 
 To prepare for infection assays, medium was removed from the confluent cells and 
the cells were washed once with 10 ml PBS.  To detach the cells 1 ml of trypsin was added 
and incubated for 5 mins at 37oC. After incubation, 10 ml of complete DMEM was added to 
the cells and pipetted up and down to remove clumps of cells. A small volume of cells was 
counted using a haemocytometer and the number of cells/ml was calculated. The cells were 
adjusted to a concentration of 1 x 105 cells/ml and 1 ml of cells were added to each well of a 
24 well plate. The cells were incubated overnight before infection studies.  
The following day, bacterial cells were adjusted from an overnight culture to a 
concentration of 5 x 106 cells/ml in plain DMEM medium. The number of bacterial cells was 
calculated based on the estimation that 1 ml of culture with an OD600 of 1 contains 1 x 109 
bacterial cells. For infection, the complete DMEM was removed from the HeLa cells and 
each well was washed twice with 1 ml of PBS. For each bacterial strain, 1 ml of bacterial cells 
(in plain DMEM) was added in triplicate to the wells containing macrophages. To initiate 
infection, the plates were centrifuged at 600 g for 5 min at 37oC. The plates were incubated 
for 30 min at 37oC in 5% CO2 to allow infection. After 30 min the media was changed to 
complete DMEM with 100 µg/ml gentamycin to kill external bacteria. This was considered 
time 0 for invasion experiments. To prevent damage of the HeLa cells from long-term 
exposure to a high concentration of gentamycin, the media was changed again to plain 
DMEM with 10µg/ml gentamicin after 1 hour of invasion. To end the experiment after 0, 2 
or 5 h of invasion, the cells were washed twice with 1 ml of PBS. To lyse the HeLa cells, 1 ml 
of PBS and 0.5% Triton-X 100 was added to each well and pipetted up and down. The lysed 
cells were diluted down 10-3 in a 96 well plated. LA plates were split into quarters and 10 µl 
of each dilution (100 to 10-3) was plated and incubated overnight at 37oC. The following day 
the plates were counted and the CFUs/ml of the 100 stocks were calculated.  
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2.10.6. Preparation of L-cell media for differentiation of bone marrow cells to 
bone marrow derived macrophages 
L-cell media is used to differentiate murine bone marrow cells to bone marrow derived 
macrophages.. To prepare L-cell media, a 1 ml aliquot of L-cells was thawed in a water bath 
at 37oC. Once thawed, the cells were re-suspended in 1 ml of complete RPMI media (RPMI 
and 10% (v/v) FBS and 1% (w/v) penicillin-streptomycin) and transferred to a 15 ml 
centrifuge tube with 9 ml of complete RPMI media (cRPMI). The cells were centrifuged at 
1000 g for 10 min at 4oC. The media was gently removed and the cells were re-suspended in 
10 ml of cRPMI and transferred to a 25 ml tissue culture flask. A further 15 ml of cRPMI 
was added to the culture flask to make a final volume of 25 ml and the flask was incubated 
overnight at 37oC. The following day, the media was removed and dead cells were washed 
off with 10 ml of cRPMI. 25 ml of fresh cRPMI was added and the cells were incubated at 
37oC until confluent (approx. 2 days).  
 Once confluent, the medium was removed and the cells were washed with 10 ml of 
PBS. The cells were detached from the flask by the addition of 2 ml of trypsin and incubated 
for 5 min at 37oC with gentle agitation. The cells were mixed in 10 ml of cRPMI by pipetting 
and transferred to a 50 ml centrifuge tube. A small volume of cells was counted using a 
haemocytometer, and the number of cells/ml was calculated. A total of 2.5 x 105 cells were 
seeded into a 175 ml tissue culture flask with 50 ml of cRPMI. The cells were incubated until 
confluent (approx. 5 days). Once confluent, the media was removed and filtered through a 
0.22 µM filter into a 50 ml tube. The media was stored at -80oC until required.  
 
2.10.7. Preparation of bone marrow derived macrophages 
To obtain bone marrow derived macrophages, the bone marrow was isolated from mice 
aged 6-8 weeks. The bones of the hind legs were removed and placed into a petri dish with 5 
ml of cRPMI. All excess muscle and skin was removed and each leg was cut in two at the 
joint using a scalpel. To remove bone marrow, the ends of each bone were cut and the bone 
marrow was rinsed through using cRPMI and a needle and syringe. The bones were rinsed 
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until they were translucent to remove all of the bone marrow. The isolated bone marrow 
was transferred to a 50 ml centrifuge tube and centrifuged at 600 g for 10 min at room 
temperature. The pellet was re-suspended in 1 ml of red blood cell lysis buffer (Sigma) and 
incubated at room temperature for 5 min. 10 ml of cRPMI was added and the white blood 
cells were pelleted at 600 g for 10 min at room temperature. The cells were re-suspended in 
10 ml of cRPMI and passed through a cell strainer into a fresh 50 ml tube. The cells were 
counted using a haemocytometer and 5 x 106 cells were seeded into a petri dish with 10 ml 
of cRPMI and 10% (v/v) L-cell medium. One petri dish provided enough cells for 5 invasion 
experiments. The cells were incubated overnight at 37oC in 5% CO2. The following day an 
additional 1o ml of cRPMI and 10% (v/v) L-cell medium was added to each petri dish. After 
3 days, 10 ml of media was removed and replaced with 10 ml of fresh cRPMI and 10% (v/v) 
L-cell medium. After a further 3 days the cells were ready the invasion experiments.  
 
2.10.8. Invasion of bone marrow derived macrophages 
For invasion experiments, 15 ml of medium was removed from each petri dish of recently 
prepared bone marrow derived macrophages. In the remaining 5 ml of medium, the cells 
were removed from the bottom of the petri dish using a cell scraper and transferred to a 50 
ml centrifuge tube. The cells from all of the petri dishes were centrifuged at 600 g for 10 
min at 37oC and re-suspended in 5 ml of cRPMI. The cells were counted and diluted to a 
concentration of 5 x 105/ml using cRPMI. For each invasion experiment 200 µl were placed 
in triplicate into a 96-well tissue culture plate and left overnight at 37oC in 5% CO2.  
 The following day, bacterial cells were adjusted from an overnight culture to a 
concentration of 5 x 106 cells/ml in plain RPMI medium. The number of bacterial cells was 
calculated based on the estimation that 1 ml of culture with an OD600 of 1 contains 1 x 109 
bacterial cells. For infection, the cRPMI was removed from the macrophages and each well 
was washed twice with 200 µl of PBS. For each bacterial strain, 200 µl of bacterial cells (in 
plain RPMI) was added in triplicate to the wells containing macrophages. To initiate 
infection, the 96 well plates were centrifuged at 600 g for 5 min at 37oC. The plates were 
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incubated for 30 min at 37oC in 5% CO2 to allow infection. After 30 min the media was 
changed to plain RPMI with 100 µg/ml gentamycin to kill external bacteria. This was 
considered time 0 for invasion experiments. After 1 hour the media was changed to plain 
RPMI with 10µg/ml gentamicin. To end the experiment after 2, 5 or 24 h of invasion, the 
cells were washed twice with 200 µl of PBS. To lyse the mammalian cells, 40 µl of PBS and 
1% (w/v) Triton-X 100 was added to each well and incubated at 37oC for 10 min. After 
incubation, an additional 160 µl of PBS was added to each well and the suspensions were 
diluted down to 10-3. LA plates were split into quarters and 10 µl of each dilution (100 to 10-
3) was plated and incubated overnight at 37oC. The following day the plates were counted 
and the CFUs/ml of the 100 stocks were calculated.  
 
2.10.9. Intraperitoneal infection of mice with Salmonella 
To study the pathogenesis of different Salmonella strains, C57/Bl6 mice were infection via 
intraperitoneal (IP) infection. Overnight cultures of each strain were inoculated 1:20 into 10 
ml of fresh LB and grown to and OD600 of 1. The cells were centrifuged at 6000 g for 5 min 
and the pellets were washed twice with PBS. After a final re-suspension the concentration of 
cells was adjusted to a concentration of 5000 cells/ml by a series of dilutions. For injection, 
each mouse was injected with 200 µl of bacteria (1000 bacterial cells). For pilot 
experiments 2 mice were infected per Salmonella strain, and this was scaled up to 4 mice 
for full experiments.  
 After 3 days of infection, the mice were culled and the livers and spleens were 
isolated. The organs were mashed through a cell strainer using a sterile syringe and rinsed 
through with 5 ml of PBS into a 50 ml tube. The mixture was diluted down to 10-3 and 10 µl 
of each dilution were plated and spread onto a quarter of an LA plate. Each organ was 
plated out in duplicate. After overnight incubation at 37oC, Salmonella colonies were 





The bioinformatics analyses were carried out in collaboration with Nathaniel J. Davies, 
University of Leicester. Nathaniel’s input included advice on software use, making custom 
Perl scripts where software was unavailable, and construction of heat maps.  
 
2.11.1. MCE sequence retrieval and architecture definition 
All MCE domain-containing sequences were retrieved by scanning the UniProtKB database 
(version 2015_03) for matches to the PFAM MCE HMM (accession PF02470.15) using 
HMMER (hmmsearch 3.1b2) (Finn et al., 2015; UniProt Consortium, 2015). Originally, the 
PFAM gathering bit threshold was used which resulted in some known MCE domain 
containing proteins having too few MCE domains. Therefore HMMER default significance 
values were used and the thresholds were judged appropriate through manual inspection of 
known MCE domain-containing E. coli proteins. All MCE domain containing protein 
sequences were compiled and put again into HMMER to scan for all PFAM domains (Pfam 
database 27.0), using the PFAM gathering bit score thresholds. As per the ‘no overlap’ rule 
in PFAM (Finn et al., 2016), in the case of overlapping predictions with members of the 
same clan only the most significant hit was retained. These resulting predicted domains 
were sorted by start position and were used to define the architectures. 
 
2.11.2. Phylogenetic distribution  
To provide a percentage measure of prevalence for each MCE architecture in each 
taxonomic rank, all of the species with complete proteomes were examined for the absence 
or presence of each MCE architecture. To avoid bias, one proteome sequence per species 
was selected randomly. These results were then summed for each 
species/genera/class/phylum to calculate the percentages. Heat maps were made using a 





As the full set of MCE-domain containing proteins was too large for cluster analysis, 
proteins were reduced to a representative set using the CD-HIT suite at a cut-off of 50% 
protein identity (Huang, 2010). This resulted in a computationally tractable set of 1,734 
proteins. These proteins were used in all-against-all searches in BLASTP with various e-
value thresholds. Information about each protein (phylum, architecture, etc) was 
incorporated into the BLAST results based on the previous architecture designations and 
the information from Uniprot. Cluster diagrams were constructed using Cytoscape (v.3.3.0), 
where each node represents a single protein sequence and each line (or edge) represents a 
match below the e value threshold. The nodes were coloured by either architecture, phylum 
or class.  
 
2.11.4. Gene neighbourhoods 
For each MCE-domain containing protein in Bacteria, the Ensembl gene IDs provided by 
Uniprot were cross-referenced in conjunction with the NCBI taxonomic identifier to 
retrieve the sequence database for each organism in Ensembl (using the Ensembl Perl 
API)(Cunningham et al., 2015; Sayers et al., 2009). A section of the genome 10 kbp either 
side of each MCE gene was extracted and gene information was retrieved for all genes in 
this region. Domain architectures were predicted for the proteins encoded by these genes by 
scanning for PFAM domains (PFAM database 27.0) using HMMER (hmmsearch 3.1b2). 
Where several genomes for a particular species were found, a single representative genome 
was chosen randomly so that each species was only represented once in the neighbourhood 
maps. Sets of adjacent MCE domain-containing genes were grouped together, sorted in 
ascending order by start position, oriented by the strand of the first gene in the group, and 
analysed as a single neighbourhood based on the 5’-most gene.  
In order for groups of conserved neighbourhoods to be displayed together, gene 
neighbourhoods were first clustered using a nearest neighbour joining approach. The 
similarity measure used in the clustering method gives greater weight to genes closer to the 
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centre of the neighbourhood, based on the assumption that gene positions further away 
from the centre of the neighbourhood are less likely to be conserved. The analysis was done 
with a maximum of 10 genes up and downstream. This clustering method was used to 
constructs neighbourhood diagrams for each protein architecture and/or phylum, where 
similar neighbourhoods were clustered together. The most common neighbourhoods were 
manually selected from these diagrams. To calculate a percentage for a particular gene 
neighbourhood architecture, the number of genes with that architecture was divided by the 
total number of genes in that category (phylum and/or protein architecture).  
 
2.11.5. Secondary structure prediction 
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3.1. Introduction 
An MCE domain is defined by an 81 amino acid PFAM hidden Markov model (see figure 
1.12). This model can be used to identify MCE domains in a given protein and with the aid 
of other bioinformatic resources all MCE domain-containing proteins can be analysed. A 
limited bioinformatics analysis of MCE domains already exists, focusing on Actinobacteria 
(Casali and Riley, 2007). This study from 2007 looked closely at the distribution and operon 
types across Actinomycetales, with a brief insight into the genomic neighourhoods of genes 
that encode MCE domain containing proteins in Gram-negative bacteria. This study did not 
look at their evolution outside Actinobacteria nor did it distinguish between the different 
architectures of the proteins. In the 9 years since the publication of this paper, the 
decreased cost of sequencing has resulted in a far greater phylogenetic depth and breadth of 
the genomic data upon which such studies can be conducted.    
The aim of this chapter was therefore to conduct a bioinformatic study of MCE 
domain containing proteins, utilising new genomic data and expanding the focus to the 
bacterial kingdom as a whole. Such a study could answer several unanswered questions. 
First, what are the main protein architectures (types of MCE domain containing protein) 
and in which bacteria are they found? Secondly, are these different types of protein 
associated with different sets of neighbouring genes, and does this give an insight into the 
different functions of these proteins? Thirdly, how conserved are MCE domains across 
bacteria and how have they evolved?  
 
3.2. Results 
3.2.1. The top MCE domain containing protein architectures 
To identify the top protein architectures, the PFAM HMM was scanned against all 
UniProtKB proteins using HMMscan. A total of 17,282 MCE domain containing proteins 
were identified. These proteins were scanned further for other PFAM domains in order to 
construct protein architectures. A total of 38 architectures were detected, with the top four 
architectures found in over 97% of the proteins (Figure 3.1). For a full list of protein 
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Figure 3.1. The top four MCE domain containing protein architectures, ordered by the 
number of proteins they are found in. “Other” is the sum of 32 other protein architectures 
and the full list can be found in appendix i. 
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architectures see appendix i. There was an N-terminal TM region in nearly all of the MCE 
domain containing proteins analysed. The most common architecture, found in over 11,000 
proteins, was a single MCE domain (type I). Type II proteins contained a single MCE 
domain followed by a domain of unknown function (DUF) 3407 and were the second most 
common protein architecture. DUF3407, also known as Mce4_CUP1 (Cholesterol Uptake 
Porter) domain, is Actinobacteria-specific and is associated with a single MCE domain in 
99% of its occurrences (Finn et al., 2016). The 3rd and 4th most common architectures, type 
III and IV proteins, contained multiple MCE domains with three and seven MCE domains 
in tandem, respectively. These top protein architectures were used as a foundation for the 
rest of the bioinformatic study. 
 
3.2.2. Phylogenetic distribution of MCE domain containing proteins 
All species with fully sequenced genomes were analysed to determine the distribution and 
prevalence of the top protein architectures. To remove bias, the analysis was limited to one 
proteome per species. The results were presented as heat maps that reveal the distribution 
of the top four MCE architectures in the Metazoa, Viridiplantae and Bacteria kingdoms (as 
defined by NCBI) (Figures 3.2 and 3.3).  
For bacteria, proteins containing MCE domains were found in 24 of the 31 phyla 
(Figure 3.2). Type I proteins were by far the most common, and were usually more 
abundant than any other architecture within a phylum. The only exception was in 
Actinobacteria, where type I and II proteins were equally as prevalent. Type III and IV 
proteins were specific to Proteobacteria, along with all proteins with greater than 2 MCE 
domains (see appendix ii).  
A number of MCE domains were identified in eukaryotic proteomes (Figure 3.3). 
Type I proteins were abundant in Viridiplantae and a small number of MCE domain-
containing protein of other architectures were identified in animal proteomes. While the 
Viridiplantae type I proteins appeared to be genuine, all but one of the animal proteins 




Figure 3.2. A heat map showing the distribution of MCE domain containing proteins 
across bacterial phyla. The heat map is separated by architecture type and phylum, with the 
number of species in brackets. A white tick indicates that a given architecture is found in 























Figure 3.3. A heat map showing the distribution of MCE domain containing proteins 
across Metazoa and Viridiplantae phyla. The heat map is separated by architecture type and 
phylum, with the number of species in brackets.  
	


















Trichoplax adhaerens, a simple animal with an unusually large mitochondrial 
genome found in the Placozoa phylum (Dellaporta et al., 2006; Signorovitch et al., 2007). 
This protein is similar to a mitochondrial NADH dehydrogenase subunit (NDUFA12) in 
other animal species and is encoded by a gene that contains introns, making a bacterial 
contamination origin unlikely. In this protein, the MCE domain is found between the 
domains NDUFA12 and DUF155, a conserved bacterial domain of unknown function.  
Overall, this analysis revealed the widespread distribution of the different protein 
architectures in bacterial phyla as well as a genuine unstudied MCE domain-containing 
protein in an animal species. 
 
3.2.3. Distribution of MCE architectures in Proteobacteria, Gamma-
proteobacteria and Enterobacteriaceae 
As the aim of this project was to understand the function of MCE domains in E. coli, the 
distribution of MCE architectures in Proteobacteria, Gammaproteobacteria and 
Enterobacteriaceae were studied more closely. Type I and III proteins were found in all five 
classes of Proteobacteria and type I proteins were the most abundant (Figure 3.4). Type IV 
proteins were only found in Delta, Epsilon and Gammaproteobacteria and were completely 
absent from Alpha and Betaproteobacteria.  
Closer analysis of Gammaproteobacteria revealed that MCE domain containing 
proteins were found in all of the families (Figure 3.5). Type III proteins were much more 
widespread than type IV, the latter of which were only found in 7 of the 31 families, 
including Enterobacteriaceae. In Enterobacteriaceae, type III and IV proteins were almost 
as prevalent type I proteins. In over 50% of the Enterobacteriaceae genera, including 
Escherichia and Salmonella, type I, III and IV proteins were found in all species analysed, 







Figure 3.4. A heat map showing the distribution of MCE domain containing proteins 
across Proteobacteria. The heat map is separated by architecture type and class, with the 
number of species in brackets.  





















Figure 3.5. A heat map showing the distribution of MCE domain containing proteins 
across Gammaproteobacteria. The heat map is separated by architecture type and family, 
with the number of species in brackets.  




















Figure 3.6. A heat map showing the distribution of MCE domain containing proteins 
across Enterobacteriaceae. The heat map is separated by architecture type and genus, with 
the number of species in brackets.  



















3.2.4. Clustering of MCE domain containing proteins 
To help understand the relationships between MCE domain containing proteins, protein-
protein similarity clusters were constructed. The cluster database CD-HIT was used to 
select a computationally tractable set of 1,734 proteins that were used in all-against-all 
BLASTP searches, with an e-value cut-off of 1e-15.  The results were visualised using 
Cytoscape and the networks were coloured by protein architecture or phylum (Figure 3.7). 
The cluster diagrams revealed that MCE domain containing proteins generally clustered 
within phyla. Nearly all Actinobacteria proteins formed a single cluster, containing type I 
and II proteins.  Type I proteins from most other phyla clustered loosely together, including 
proteins from Cyanobacteria, Bacteroidetes, and Proteobacteria. All of the plant proteins 
clustered closely with Cyanobacteria, and the single Trichoplax protein clustered with 
Proteobacteria. All multi-domain proteins clustered together within a large cluster 
dominated by Proteobacteria. The positions of type III and IV proteins in this cluster 
suggest that they are a functionally divergent population that arose from a type I 
Proteobacterial protein in a single event.   
As MCE domain containing proteins in Proteobacteria were found in two distinct 
clusters, the diagram was re-coloured to determine whether the distinction was class-
dependent (Figure 3.8). All five major classes were found in both clusters, suggesting that 
the divergence of these protein types into distinct clusters occurred before the divergence of 
the classes. Overall, this analysis provides an insight into the evolution of the different 
protein types in Proteobacteria. 
 
3.2.5. The genomic neighbourhoods of genes that encode MCE domains 
In this study, a genomic neighbourhood is defined as the region surrounding the gene of 
interest on the genome. The neighbourhoods of genes that encode type I – IV proteins were 
analysed to identify proteins that might be functionally linked to MCE domains. The 10 kb 
regions up and downstream of genes that encode MCE domains were translated and 




Figure 3.7. A cluster diagram of MCE domain containing proteins. Each node represents a 













































Figure 3.8. A cluster diagram of MCE domain containing proteins. Each node represents a 














in Actinobacteria were remarkably similar, and therefore their analyses were combined. In 
Proteobacteria, the neighbourhoods for the genes that encoded type I, III and IV proteins 
were analysed separately. The neighbourhoods of all other phyla were analysed together. 
For each architecture and/or phylum the top MCE neighbourhoods were selected and their 
prevalence was calculated as a percentage (Figure 3.9).  
Sixty-three percent of the mce operons in Actinobacteria consisted of 6 mce genes 
with 2 ABC transporter permease genes upstream, supporting a role as an ABC transporter 
(Figure 3.9i) (Casali and Riley, 2007). In around 20% of cases, this operon was associated 
with an ATP-binding gene, a component essential for a functional ABC transporter (Higgins 
et al., 1986). A similar ABC transporter operon structure was present in other bacterial 
phyla, including Cyanobacteria, Spirochaetes and Firmicutes, but with only one MCE repeat 
per operon (Figure 3.9v).   
In Proteobacteria, type I genes were found with the same permease and ATP-
binding domains upstream as Actinobacteria, 59% of the time (Figure 3.9ii). The most 
common domain encoded downstream in Proteobacteria was DUF330, found in 29% of the 
Proteobacteria type I neighbourhoods. In Beta- and Gammaproteobacteria, this DUF330 
gene was replaced by genes that encode the periplasmic Tol domain, related to toluene 
resistance (Kim et al., 1998) and the cytoplasmic NTP binding STAS domain (Aravind and 
Koonin, 2000). This operon encodes the Mla pathway in E. coli, with the ATPase, permease, 
MCE, Tol and STAS domains found in MlaF, MlaE, MlaD, MlaC and MlaB, respectively. In 
Betaproteobacteria, such as Neisseria meningitidis, the gene that encodes outer membrane 
protein MlaA (VacJ) was found in the same operon (Caspi et al., 2016). 
In Proteobacteria, genes that encode multi domain proteins were nearly always 
associated with upstream genes that encode two PqiA domains (Figure 3.9iii and iv). A PqiA 
domain has similarity to Proton_antipo_M, an antiporter domain involved in bidirectional 
membrane transport that requires energy from ATP hydrolysis but does not directly bind it 





Figure 3.9. The most common MCE gene neighbourhoods separated by phylum and/or 
protein type.  The percentages represent the prevalence of that given neighbourhood type 
within a category. All Actinobacteria neighbourhoods were analysed together. 
Proteobacteria were split into separate analyses based on protein architecture. All other 






I/II I/II I/II I/II I/II 

























% (per architecture) 











However type IV encoding genes were not associated with a DUF330 gene, highlighting a 
distinction between these two multi-domain proteins. 
In the neighbourhoods that encode type I proteins in Alphaproteobacteria, it was 
common to find upstream genes that encode proteins with an NADH dehydrogenase 
subunit domain (NDUFA12), which is involved in ATP generation in mitochondria (UniProt 
Consortium, 2007). It is not clear if these genes are functionally related in bacteria. The 
same two domains were found together in the T. adhaerens protein suggesting a gene 
fusion event might have occurred following the formation of mitochondria from 
Alphaproteobacteria (Andersson et al., 1998). In Bacteroidetes, a gene that encodes a 
protein with an amidase 3 domain was found upstream of a type I MCE gene. The amidase 3 
domain is involved in peptidoglycan synthesis, but there is no evidence that this protein is 
functionally linked to the MCE domain containing protein or encoded in the same operon 
(Caspi et al., 2016). Overall, this analysis revealed that neighbourhoods of the genes are well 
conserved within phyla and protein architecture types. The neighbourhoods of genes that 
encode MCE domain containing proteins usually resemble transportation machinery.  
 
3.2.6. Three operon architectures in E. coli  
As the MCE operons in E. coli were the focus of this study, the predicted operon 
architectures in these organisms were determined. InterPro defines 3 proteins in E. coli 
named MlaD, PqiB and YebT, which are type I, III and IV proteins, respectively (Hunter et 
al., 2009). The mlaD gene is part of the mlaFEDCB operon, which has been reported here 
as the second most common gene neighbourhood for type I proteins in Proteobacteria. To 
obtain the same information for pqiB and yebT, their operons were predicted using 
ProOpDB and EcoCyc, using the E. coli K-12 MG1655 genome (Karp et al., 2002; Taboada 
et al., 2012). The most likely operon structures were as follows: pqiAB-ymbA and yebST 
(Figure 3.10). The domain architecture for each protein encoded in these operons was 
predicted using HMMER. The pqiAB-ymbA operon encodes proteins with two PqiA 




Figure 3.10. The three MCE operons in E. coli. Each gene is coloured by the domains that 
they encode. 
	 	













The yebST operon in E. coli encoded YebS (which contains two PqiA domains), and YebT 
(which contains seven MCE domains). Therefore, the pqiAB-ymbA and yebST operons 
resembled the most common type III and type IV MCE neighbourhoods, respectively. 	
 
3.2.7. Conserved secondary structure of MCE domains 
To determine whether the secondary structures of MCE domains are conserved across all 
life, proteins from M. tuberculosis, E. coli, A. thaliana and T. adhaerens were analysed 
using PSIPRED (Figure 3.11). Six beta strands were found in conserved locations in all of 
the MCE domains analysed. In multi-domain proteins there were some additional beta or 
alpha sheets in some of the MCE domains. Overall, these predictions showed a great 
conservation of the secondary structure of MCE domains across life.   
 
3.3. Discussion 
Many studies have shown that MCE domain containing proteins function in lipid trafficking 
(Cantrell et al., 2013; Klepp et al., 2012; Mohn et al., 2008; Pandey and Sassetti, 2008). The 
PFAM HMM defines highly conserved hydrophobic residues, which could be important for 
the binding of hydrophobic substrates such as lipids. The results presented in this chapter 
show that the most common type of MCE domain containing protein consists of a single 
MCE domain and no other predicted PFAM domains (type I). This type of protein is 
widespread in bacteria and includes MlaD, the MCE component of the retrograde 
phospholipid transport pathway identified in E. coli, and multiple predicted lipid transport 
proteins in Actinobacteria (e.g. Mce4B from predicted cholesterol uptake pathway in M. 
tuberculosis) (Malinverni and Silhavy, 2009; Pandey and Sassetti, 2008). In Actinobacteria, 
an MCE domain is commonly found in the same protein as DUF3407 (type II), an 
architecture that is specific to this phylum. This type of protein is often encoded by the same 
operons as type I proteins, indicating that the two protein types have similar functions in 
Actinobacteria. The next most abundant types of protein are the multi domain proteins, 




Figure 3.11. The predicted secondary structures of various MCE domain containing 
proteins, as predicted by Psipred.  
Type I: Ttg2, Arabidopsis  
Type II: Mce4A, M. tuberculosis 
Type III: PqiB, E. coli 
Type IV: YebT, E. coli 





These types of protein are specific to Proteobacteria, being particularly prominent in 
Enterobacteriaceae, indicating that they may be important for survival in the gut.  
MCE domain containing proteins were also present in some Eukaryotes, where type 
I proteins were particularly prominent in Viridiplantae. In Arabidopsis thaliana this 
protein is found in the inner membrane of the chloroplast and is involved in the trafficking 
of phosphatidic acid from the outer membrane (Awai et al., 2006). A genuine MCE domain 
containing protein was found in the mitochondria of the animal T. adhaerens, which has a 
particularly large mitochondrial genome (Dellaporta et al., 2006; Signorovitch et al., 2007). 
It is feasible that this protein is only present due to a lack of evolutionary pressure on T. 
adhaerens to reduce its mitochondrial genome. Alternatively, the protein might be 
important for the existence of T. adhaerens in its marine habitat (Pearse and Voigt, 2007).  
Type I – IV proteins make up over 97% of all identified MCE domain containing 
proteins, all of which contain an odd number of MCE domains. Given that multi-MCE-
domain proteins with an even number of MCE domains are exceedingly rare, it may be that 
having an odd number of domains reflects an evolutionary constraint related to the function 
of these proteins. The clustering analysis indicated that MCE domains evolved with no 
major horizontal gene transfer events. Their existence in early branching lineages of 
bacteria (such as Cyanobacteria and Actinobacteria) suggests that these proteins were likely 
to have been present in early bacterial species (Hug et al., 2016). All examples of eukaryotic 
MCE domains are ultimately bacterial in origin, including those present in chloroplasts and 
the mitochondria of T. adhaerens. The chloroplast proteins clustered closely with 
Cyanobacteria and the T. adhaerens protein with Proteobacteria, as would be expected 
given the bacterial origins of chloroplasts and mitochondria, respectively (Andersson et al., 
1998; Bonen and Doolittle, 1975). Overall, the single MCE domain type I architecture has 
remained remarkably conserved throughout bacterial evolution. The two major exceptions 
include the evolution of type II proteins in Actinobacteria, and multi-domain proteins in 
Proteobacteria. The close clustering of type III and IV proteins in Proteobacteria indicate 
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that multi-MCE domain containing proteins evolved from a single type I protein to fulfil a 
function specific to this lineage.  
Previous bioinformatic research indicates that MCE domain containing proteins 
resemble the substrate-binding constituents of ABC transporters (Casali and Riley, 2007). 
The neighbourhood analysis lends support to this view, with the most common 
neighbourhood type across all bacteria resembling an ABC transporter. A typical ABC 
transporter core consists of two ATPase domains and two permease domains (Higgins et al., 
1986). In Actinobacteria, it is common to find six MCE genes and two permease genes in an 
operon, but only occasionally does the operon encode an ATPase. It has however been 
shown in Mycobacterim species that MCE-related ATPases are often found elsewhere in the 
genome (Casali and Riley, 2007) rather than being strictly tied to the ABC operon. Two 
MCE-associated (mas) genes are found downstream in most of the studied MCE operons in 
Actinobacteria, but these were not identified in this analysis as they encode proteins 
without a conserved domain. This operon structure is specific to Actinobacteria and could 
be linked to the types of lipids these organisms require and/or the complex cell wall 
structures of some species. In Mycobacterium tuberculosis there are four MCE operons that 
have been reported to traffick lipids including palmitic acid and cholesterol (Forrellad et al., 
2014; Mohn et al., 2008; Pandey and Sassetti, 2008).  
The type I neighbourhoods of Cyanobacteria, Firmicutes and Spirochaetes typically 
encoded a single ATPase, permease and MCE domain. This type of operon also encodes the 
phosphatidic acid trafficking pathway in Arabidopsis thaliana (Awai et al., 2006). When 
considering the origin of chloroplasts, it is likely that these transporters have similar 
functions in both plants and Cyanobacteria. In Proteobacteria, type I neighbourhoods 
encode the same 3 protein domains but with conserved genes downstream of the MCE-
encoding gene. The most conserved downstream gene encodes a protein that contains the 
ABC auxiliary domain DUF330. In Spingobium japonicum, this ABC transporter is 
essential for the uptake and utilisation of γ-hexachlorocyclohexane in S. japonicum, an 
insecticide used as its sole carbon source (Endo et al., 2007). In other Proteobacteria type I 
	 95	
neighbourhoods, the downstream genes encode proteins that contain STAS and Tol 
domains. In E. coli, these proteins make up the phospholipid trafficking Mla pathway 
(MlaBCDEF) (Malinverni and Silhavy, 2009). This operon has been studied in other 
Proteobacteria, including Pseudomonas putida, where it is required for toluene resistance 
and Shigella flexneri, where it is needed for intracellular spreading (Kim et al., 1998; Hong 
et al., 1998).  
In Proteobacteria, the neighbourhoods of genes that encode multi-domain proteins 
do not clearly resemble an ABC transporter. Although genes that encode DUF330 are often 
found downstream of type III protein-encoding genes, genes that encode two PqiA domains 
replace the upstream ATPase and permease genes in both type III and IV neighbourhoods. 
As the PqiA domain resembles an NADH antiporter domain it is possible that these operons 
encode a different type of transporter that lacks direct binding of ATP (i.e. not strictly ABC) 
(Finn et al., 2016; Hunter et al., 2009). This suggests that the mechanism of action of type 
III and IV transport might differ from type I/II proteins. 
The operons that encode the two multi-domain proteins in E. coli (pqiAB-ymbA and 
yebST) were found to resemble the most common type III and IV gene neighbourhoods, 
respectively. The tight clustering and conservation of type III and IV proteins in 
Proteobacteria indicates that they fulfil an important and possibly unique function in this 
phylum. In the next chapter, phenotypes of pqiAB and yebST deletion strains and 
properties of PqiB and YebT are investigated in order to shed light on the function of these 














IDENTIFICATION OF NOVEL PHENOTYPES, 
PROTEIN LOCALISATION AND LIPIDOMICS 
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Bioinformatic analysis has confirmed the presence of 3 MCE domain-containing proteins in 
E. coli: MlaD, PqiB and YebT. There are 1, 3 and 7 MCE domains in MlaD, PqiB and YebT, 
respectively. MlaD is reported to be part of a phospholipid trafficking pathway, but the 
functions of PqiB and YebT remain unknown. The genes pqiB and yebT are found directly 
downstream of pqiA and yebS, respectively. The gene ymbA is downstream of pqiAB and is 
predicted to be in the same operon (Petersen et al., 2011; Taboada et al., 2012). In the 
previous chapter, bioinformatic analysis revealed that both multi-MCE domain operons 
resemble a type of transporter.  
The genes pqiA and pqiB were named following the observation that they were 
“paraquat induced” and therefore might be involved in protection against reactive oxygen 
species (ROS) (Koh and Roe, 1996). The pqiAB genes are regulated by SoxRS in E. coli, a 
regulon that directly governs the response to superoxide radicals (Koh and Roe, 1995; Koh 
and Roe, 1996). ROS play a key part in the immune response to invading microorganisms, 
particularly in phagocytes. The pqiAB operon is also induced by membrane stress from 
overproduction of fatty acids and by cyclic-di-GMP, a compound that regulates virulence, 
adherence and motility in prokaryotes (Mendez-Ortiz et al., 2006). Furthermore, both 
pqiAB and yebS are regulated by σs, the sigma factor that regulates starvation and 
stationary phase responses (Weber et al., 2005). The best-studied multi MCE-domain 
containing protein is Multivalent Adhesion Molecule- 7 (MAM-7) from Vibrio 
parahaemolyticus, which is a homologue of YebT. MAM-7 is reported as an outer 
membrane adhesin that binds to mammalian cells via phosphatidic acid and fibronectin 
(Krachler et al., 2011; Krachler and Orth, 2011). As a whole, the literature on PqiB and YebT 
signifies a role in virulence and protection again stress. However, no specific function has 
yet been identified for these operons in E. coli. 
Of all the MCE domain containing proteins in E. coli, only the location of MlaD has 
been determined experimentally. MlaD has been characterised as an inner membrane 
periplasmic-facing protein with an N-terminal transmembrane (TM) domain (Malinverni 
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and Silhavy, 2009). This type I protein is part of the Mla pathway in E. coli, which is 
required for phospholipid trafficking from the outer membrane back into the cell. Strains in 
which individual components of the mlaFEDBC operon have been deleted accumulate 
phospholipids on the cell surface suggesting that the pathway is involved in removing 
unwanted phospholipids from the outer leaflet of the outer membrane (Malinverni and 
Silhavy, 2009). However, no research has thus far shown whether disruption of the Mla 
pathway results in altered lipid composition of the inner and outer membranes, or whether 
the Mla proteins directly interact with phospholipids.    
To address what is unknown about MCE domain containing proteins, the aims of 
this chapter were as follows: 1) phenotypically characterise mutants of pqiAB and yebST in 
E. coli to determine the function of the two operons; 2) determine the locations of PqiB and 
YebT; 3) investigate the lipid-binding properties of MlaD, PqiB and YebT and 4) determine 
whether MCE mutants in E. coli have altered membrane phospholipid compositions.  
 
4.2. Results 
4.2.1. Construction of a pqiAB deletion in E. coli K-12 BW25113 
In this study all gene deletions were constructed in E. coli K-12 BW25113, the parent 
strain for the Keio collection of single gene deletions that is closely related to the genome-
sequenced strain W3110 (Baba et al., 2006). The pqiAB genes span positions 1012423 to 
1015321 on the E. coli K-12 W3110 genome, the parental strain of BW25113. The genes are 
located between uup and ymbA. To investigate the function of pqiAB, deletions were 
constructed in E. coli K-12 BW25113 using λ Red recombination. First, a linear fragment for 
recombination was generated by PCR using the plasmid pKD4 as a template and 
pqiA_DW_F and pqiB_DW_R primers. The primers were designed from the E. coli K-12 
W3110 genome to generate a kanamycin resistance cassette flanked by 50 bp of the 
sequence found directly upstream and downstream of pqiAB.  
 E. coli strain BW25113 was transformed with pKD46, a temperature sensitive vector 
harbouring the λ Red recombination machinery. The transformant was electroporated with 
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the pqiAB linear fragment to allow recombination. Kanamycin resistant colonies were 
checked by colony PCR for deletion of the pqiAB genes using pqiA_check_F and 
pqiB_check_R primers, which annealed to the flanking regions of pqiAB (Figure 4.1A). The 
PCR included BW251113 WT as a control, and a successful deletion was shown by a decrease 
in PCR product from ~3000 bp to ~2000 bp (Figure 4.1B, lanes 2 and 3). The confirmed 
pqiAB::aph deletion was transduced into a clean background of BW25113 using P1 
bacteriophage to leave behind any second site mutations caused by λ Red recombination. 
Successful transduction was confirmed by colony PCR using the same check primers.  
To remove the kanamycin resistance cassette, the pqiAB::aph mutant was 
transformed with the temperature sensitive plasmid pCP20, which encodes FLP 
recombinase. Successful removal of the kanamycin resistance gene resulted in a decrease in 
PCR product size from ~2000 bp to ~500 bp (Figure 4.1B, lanes 3, 4 and 5).  
 
4.2.2. Construction of a yebST deletion in E. coli K-12 BW25113 
The yebST genes span positions 1917972 to 1921857 on the W3110 chromosome, located 
between msrC and rsmF. To investigate the function of yebST, deletions were made in 
BW25113 using the same protocol described for construction of the pqiAB mutants. A linear 
yebST fragment generated by PCR using the primer pair yebS_DW_F and yebT_DW_R 
was electroporated into E. coli strain BW25113, which had been previously transformed 
with pKD46. Kanamycin resistant colonies were checked by colony PCR using the primer 
pair yebS_check_F and yebT_check_R (Figure 4.1A). A decrease from ~4500 bp to ~2000 
bp showed successful deletion of yebST (Figure 4.1B, lanes 6 and 7). The deletion was 
transferred into a clean BW25113 parent background using P1 transduction. For 
construction of a kanamycin sensitive yebST deletion, the yebST::aph mutant was 
transformed with pCP20. Colony PCR confirmed the removal of the cassette by a decrease 






Figure 4.1. Gel electrophoresis of PCR products confirming the disruption of pqiAB and 
yebST in E. coli K-12 BW25113. A. Positions of pqiAB and yebST check primers. B. Results 
from PCR using check primers: lanes 2 to 5 show PCR products obtained using pqiAB check 
primers, lane 2: WT, lane 3: pqiAB::aph, lanes 4 and 5: ΔpqiAB deletion strain. Lanes 6 to 9 
show PCR products generated using yebST check primers, lane 6: WT, lane 7: yebST::aph, 
lanes 8 and 9: ΔyebST deletion strain.  
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4.2.3. Construction of a pqiAB yebST double deletion in E. coli K-12 BW25113 
To construct a pqiAB yebST double deletion, the ΔyebST mutant was transduced with the 
same P1 phage lysate that had been used to construct the pqiAB::aph strain. Kanamycin 
resistant colonies were checked with both sets of check primers by colony PCR. To remove 
the kanamycin resistance cassette, the ΔpqiAB yebST::aph mutant was transformed with 
pCP20 and a kanamycin sensitive double deletion was constructed. The strain was further 
checked by colony PCR. All of the kanamycin sensitive strains were further checked by 
whole genome sequencing and confirmed the gene deletions and the absence of secondary 
mutations.  
 
4.2.4. Biolog screen of deletion mutants 
The parent strain BW25113, the pqiAB deletion mutant, the ΔyebST mutant and the double 
mutant were sent to Biolog Inc., USA, for phenotypic microarray analysis. This service 
provides growth kinetics of the desired strain in approximately 2000 different conditions, 
measured relative to the parent strain. In the results provided by Biolog, the ΔpqiAB 
mutant was reported to be more sensitive to the lipophilic chelator clioquinol and to the 
zwitterionic detergent lauryl sulfobetaine (LSB) than the parent strain (Figure 4.2A). The 
ΔyebST mutant was also more sensitive to clioquinol and to the antibiotics tetracycline and 
penimepicycline (Figure 4.2B). The double deletion strain was sensitive to LSB but more 
resistant to the antibiotic azlocillin (Figure 4.2C). The full results from the Biolog analyses 
can be found in appendix iii.  
 
4.2.5. Preliminary attempts to confirm the Biolog data 
The Biolog analysis included results for a concentration range for each of these five 
chemicals as follows: clioquinol (1-100 µg/ml), LSB (0.02-2% (w/v)), tetracycline (0.2-50 





Figure 4.2. Results of the Biolog screen for the ΔpqiAB, ΔyebST and ΔpqiAB ΔyebST 
mutants vs the parent. Red represents growth of the parent and green represents growth of 
the mutants. Each row shows growth in a particular chemical at four different 
concentrations. A. Growth of the ΔpqiAB mutant relative to the parent strain on lauryl 
sulfobetaine (0.02-2% (w/v)) and clioquinol (1-100 µg/ml). B. Growth of the ΔyebST 
mutant relative to the parent strain on clioquinol, tetracycline (0.2-50 µg/ml) and 
penimepicycline (1.5-50 µg/ml). C. Growth of the ΔpqiAB ΔyebST mutant relative to the 
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to confirm the Biolog results, overnight cultures of all four strains were inoculated into a 
96-well microtitre plate containing 200 µl of LB supplemented with the same range of 
concentrations of these chemicals. The strains were grown from a starting OD600 of 0.05 for 
16 hours at 37°C in a FLUOstar Optima plate reader. No growth curve was obtained for 
clioquinol due to insolubility of the compound. There were no substantial growth 
differences between the 4 strains when cultured in the presence of tetracycline, 
penimepicycline, or azlocillin. Therefore, it was concluded that the Biolog data were not 
reproducible (Figure 4.3 A to C). In contrast to the other chemicals tested, LSB inhibited 
growth of both the ΔpqiAB mutant and the double mutant (Figure 4.4). Although the 
ΔyebST mutant also initially appeared to have a minor growth defect, after 7 hours the 
OD600 of these cultures was the same as the parent.  Subsequent experiments focused on the 
effect of LSB on these strains on a larger scale.   
 
4.2.6. Confirmation of the effect of lauryl sulfobetaine on growth of the four 
strains 
The LSB phenotype was explored further through growth of the strains in 25 ml of LB 
supplemented with 1% (w/v) LSB, in shake flasks. All four strains grew the same in LB 
(Figure 4.5A). In LB supplemented with 1% (w/v) LSB, the phenotype initially matched the 
phenotype shown by Biolog, with decreased growth for the ΔpqiAB mutant and the double 
mutant, but no growth inhibition for the ΔyebST single mutant (Figure 4.5B). However 
after 3 to 4 hours all of the strains lysed rapidly, a phenomenon often observed during 
bacterial growth in liquids containing detergents (Kramer, 1980). These preliminary 
experiments confirmed the LSB phenotype, but indicated that liquid broth might not be the 
best method to assay the effect of this detergent on bacterial growth.   
 
4.2.7. Construction of mlaD gene deletions  
The mlaD gene encodes a protein with a single MCE domain. Having established a 




Figure 4.3. Growth of E. coli strain BW25113, the ΔpqiAB mutant, the ΔyebST mutant and 
the double mutant in the presence of tetracycline, penimepycycline and azlocillin. Each 
strain was challenged with the range of concentrations used in the Biolog assay. The graphs 
represent one concentration from each of these ranges A. Growth in 10 µg/ml tetracycline, 
B. Growth in 10 µg/ml penimepycline, C. Growth in 100 µg/ml azlocillin. Strains were 
























































Figure 4.4. Growth curves of BW25113 and the three mutants in 1% (w/v) lauryl 
sulfobetaine in a microtitre plate. Strains were grown in the FLUOstar Optima and readings 























Figure 4.5. Growth curves of BW25113 and the ΔpqiAB, ΔyebST and ΔpqiAB ΔyebST 









































phenotype of a strain defective in mlaD. The mlaD gene spans positions 3338316 to 
3337765 on the W3110 genome as part of the mlaFEDCB operon. Two copies of an 
mlaD::aph insertion mutant were already available in the Keio library (Baba et al. 2006). 
This library was made in E. coli strain BW25113 using lambda red recombination (Datsenko 
and Wanner, 2000). The two mlaD mutants were checked by colony PCR using 
mlaD_check_F and mlaD_check_R primers (Figure 4.6A). An increase in the size of the 
PCR product from ~1000 bp to ~2000 bp indicated that the mlaD gene had been replaced 
with a kanamycin resistance cassette. These data indicate that both strains in the Keio 
library harbour deletions in mlaD (Figure 4.6B, lanes 2, 3 and 4).  
The mlaD::aph mutation from one of these strains was transduced from the Keio 
library strain into the BW25113 parent strain and the ΔpqiAB, ΔyebST and ΔpqiAB ΔyebST 
mutants and was checked again by colony PCR. This produced 4 new kanamycin resistant 
strains: mlaD::aph, ΔpqiAB mlaD::aph, ΔyebST mlaD::aph and ΔpqiAB ΔyebST 
mlaD::aph. To construct kanamycin sensitive derivatives, all 4 strains were transformed 
with pCP20 to remove the kanamycin resistance cassette and several colonies were checked 
by colony PCR. This resulted in the construction of 4 new kanamycin sensitive strains: 
ΔmlaD, ΔmlaD ΔpqiAB, ΔmlaD ΔyebST and ΔmlaD ΔpqiAB ΔyebST. 
 
4.2.8. Screening of all seven deletions on lauryl sulfobetaine 
Due to the cell lysis observed during growth in LB with 1% (w/v) LSB, the phenotypes were 
tested on agar plates. The parent strain and all seven mutants were diluted from overnight 
cultures to an OD600 of 1 and diluted serially down to 10-5. The dilutions were plated onto 
square plates with LA, LA supplemented with 1% (w/v) LSB, and LA supplemented with 4% 
(w/v) LSB. All strains grew equally well on LA (Figure 4.7A). On LA supplemented with 1% 
(w/v) LSB, growth of the ΔmlaD and ΔpqiAB mutants was observed down to a dilution of 
10-3, whilst BW25113 grew down to a dilution of 10-5 (Figure 4.7B).  Growth of the ΔyebST 
mutant was not inhibited. The growth of the ΔmlaD ΔpqiAB mutant was further reduced to 




Figure 4.6. Gel electrophoresis of PCR products confirming the disruption of mlaD in E. 
coli K-12 BW25113 from the Keio library. A. Position of mlaD check primers. B. Results 
from PCR using check primers: Lane1: ladder, lane 2: BW25113, lanes 3 and 4: mlaD::aph.  
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 ~2000 bp 
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Figure 4.7. Growth of the parent and all mlaD, pqiAB and yebST mutant combination on 
lauryl sulfobetaine (LSB). The strains were plated onto A. LA, B. LA supplemented with 1% 
















































































Growth of the ΔpqiAB ΔyebST mutant was only observed down to 10-1 dilution, showing a 
greater growth defect than the ΔpqiAB mutant. The ΔmlaD ΔyebST mutant only grew 
marginally worse than the ΔmlaD mutant. No growth was observed for the triple mutant on 
agar supplemented with 1% (w/v) LSB. On agar supplemented with 4% (w/v) LSB, the same 
pattern of phenotypes were observed but the sensitive mutants appeared to have an even 
greater growth defect when compared to the parent strain (Figure 4.7C).  
Overall, the phenotypes of the pqiAB mutants were clearer on agar plates than in 
broth. The plates revealed similar sensitivity phenotypes for the ΔmlaD and ΔpqiAB 
mutants, and a clear additive phenotype for the ΔmlaD ΔpqiAB mutant. In agreement with 
the Biolog results, the ΔyebST mutant was not sensitive to LSB, but increased the sensitivity 
of a ΔpqiAB mutant. The largest growth defect was seen for the triple deletion strain, which 
suggested that increased sensitivity on LSB occurs with increased loss of MCE domain 
encoding genes.  
 
4.2.9. Complementation of the lauryl sulfobetaine phenotypes 
In order to confirm the phenotypes observed in the previous section, complementation 
plasmids were constructed in the plasmid pET17b. The pqiAB, yebST, and mlaD genes were 
amplified using the following primer pairs: 1) pqiA_NdeI_F and pqiB_comp_R, 2) 
yebS_NdeI_F and yebT_comp_R, and 3) mlaD_comp_F and mlaD_comp_R. The pqiAB, 
yebST and mlaD fragments were purified and digested with NdeI and XhoI restriction 
enzymes. The fragments were ligated into pET17b digested with the same enzymes and 
transformed into 5-alpha E. coli competent cells. Several colonies were screened by PCR 
using T7_F and T7_R primers. Plasmids that contained an insert of the correct size were 
sequenced using the same primers. The 3 plasmid constructs were designated pET17b-
mlaD, pET17b-pqiAB and pET17b-yebST.  
For complementation, pET17b-mlaD, pET17b-pqiAB and pET17b-yebST were 
transformed into the ΔmlaD, ΔpqiAB and ΔpqiAB ΔyebST mutants, respectively. To allow 
growth on carbenicillin, the pET17b plasmid was transformed into the same strains and 
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BW25113. The strains were prepared as described previously and plated onto agar plates 
supplemented with carbenicillin and 1% (w/v) LSB (Figure 4.8). The plasmids pET17b-
mlaD and pET17b-pqiAB fully complemented the phenotypes of the ΔmlaD and ΔpqiAB 
mutants, respectively, on LSB. The plasmid pET17b-yebST partially complemented the 
phenotype of the ΔpqiAB ΔyebST mutant, back to the level of the ΔpqiAB mutant, 
confirming that the additive ΔpqiAB ΔyebST phenotype was due to the deletion in yebST. 
Overall, these results confirm that the LSB phenotypes observed can be complemented by 
reintroduction of the deleted gene(s) into the deletion strains.  
 
4.2.10. Screen of mutants on other sulfobetaines 
To investigate whether detergents similar to LSB also inhibited growth of the mutants, 
other sulfobetaine detergents were tested. LSB is also known as sulfobetaine (SB) 3-12 as it 
has a 3 and a 12-carbon chain that meet at an ammonium ion. Sulfobetaine 3-10 (SB 3-10) 
and sulfobetaine 3-14 (SB 3-14) differ from LSB (or SB 3-12) by their hydrocarbon chain 
length only. Where LSB has a 12-long hydrocarbon chain, SB 3-10 and SB 3-14 have 10 and 
14 carbons, respectively (Figure 4.9). The parent and all 7 deletions strains were plated as 
described previously onto square agar plates with 1% (w/v) SB3-10 and SB3-14. On SB 3-10, 
an LSB-like phenotype was observed for the pqiAB mutants, including the ΔpqiAB ΔyebST 
additive phenotype. However the additive phenotype was less extreme than the phenotype 
observed on LSB (Figure 4.10A and B). Deletions in mlaD had no effect on the ability of the 
strains to grow. For SB 3-14, there were no observed growth defects for any of the deletion 
strains (Figure 4.10C). Increasing the concentration to 4% (w/v) SB3-10 resulted in very 
faint growth that was difficult to interpret, and no growth inhibition of any strains was 
observed on LA supplemented with 4% (w/v) SB 3-14 (see appendix iv). In conclusion, the 
pqiAB mutants were sensitive to both SB-10 and LSB. However, further introduction of a 
yebST deletion had more of an additive effect on LSB than it did on SB-10.  
	 112	
 
Figure 4.8. Complementation of the ΔpqiAB, ΔpqiAB ΔyebST and ΔmlaD mutant 
phenotypes on lauryl sulfobetaine. The strains were plated onto A. plain LA, B. LA 







































































































Figure 4.9. The structures of the three sulfobetaines used in this study: A. sulfobetaine 3-






















Figure 4.10. Growth of the parent and all mlaD, pqiAB and yebST mutant combination 
strains on sulfobetaines with different chain lengths. The strains were plated onto A. LA 
supplemented with 1% (w/v) LSB (taken from figure 4.6 for comparison), B. LA 















































































4.2.11. Screening of MCE mutants for sensitivity to SDS or vancomycin 
Increased sensitivity to detergents can indicate a loss of outer membrane integrity. Two 
chemicals commonly used to screen bacteria for outer membrane defects are sodium 
dodecyl sulphate (SDS) and vancomycin. Previously, decreased growth was observed for an 
mlaD deletion strain on agar plates supplemented with both SDS and EDTA (Malinverni 
and Silhavy, 2009). To confirm this phenotype and screen for new phenotypes, the 
BW25113 parent and mutants were plated onto LA supplemented with 1% (w/v) SDS, 0.5% 
SDS and 1.1mM EDTA, or 300 µg/ml vancomycin. SDS alone did not inhibit growth of any 
of the 8 strains (Figure 4.11A). On SDS and EDTA combined, no growth was observed for 
any strain with a deletion in mlaD, but growth of all of the other strains was similar to that 
of the parent strain (Figure 4.11B). No inhibition was observed for any strain on 1.1 mM 
EDTA, indicating that the phenotypes observed for the mlaD mutants were due to SDS and 
EDTA combined and not EDTA alone (Figure 4.11C). 
On vancomycin, growth of the parent strain was limited to a dilution of 10-1, while 
growth of all of the mlaD mutants was increased to a dilution of 10-4 or 10-5 (Figure 4.12). 
Similarly the ΔpqiAB ΔyebST mutant grew to a dilution of 10-5, whilst there was no growth 
of the ΔpqiAB and ΔyebST mutants at dilutions greater than 10-1 and 10-2, respectively. This 
reveals yet another additive phenotype for the ΔpqiAB ΔyebST mutant. Overall these 
results reveal a novel vancomycin resistance phenotype for the ΔpqiAB ΔyebST mutant and 
all of the mlaD mutants, whilst confirming the SDS+EDTA sensitivity phenotype of the 
ΔmlaD mutant. 
 
4.2.12. Screening of single pqiA, pqiB and ymbA mutants for sensitivity to 
lauryl sulfobetaine 
The pqiAB genes are predicted to be in an operon with the downstream gene ymbA. So far 
in this study, the phenotypes of pqiAB mutants have been investigated, rather than the 
phenotypes of strains lacking pqiA, pqiB or ymbA. To address this, individual pqiA::aph, 




Figure 4.11. Growth of the parent and all mlaD, pqiAB and yebST mutants on SDS and/or 
EDTA. The strains were plated onto A. LA supplemented with 1 % (w/v) SDS, B. LA 



















































































Figure 4.12. The growth the parent and all mlaD, pqiAB and yebST mutants on 






























































BW25113 background. The same primers used to check the pqiAB mutants were used to 
screen potential pqiA::aph and pqiB::aph mutants, and the ymbA::aph mutant was 
checked with ymbA_check_F and ymbA_check_R primers. The pqiA::aph, pqiB::aph and 
ymbA::aph mutants were screened for their ability to grow on agar plates in the presence of 
1 and 4% (w/v) LSB. The growth of all three deletions strains was observed down to a 
dilution of 10-3 on 1% (w/v) LSB, while the parent strain grew to a dilution of 10-5 (Figure 
4.13B). On 4% (w/v) LSB, the pqiA::aph mutant was less sensitive than the pqiB::aph and 
ymbA::aph mutants, but more sensitive than the parent strain (Figure 4.13C). These results 
indicate that both PqiA and PqiB are required for resistance to LSB. Furthermore, observing 
the same phenotype for the ymbA::aph mutant strain suggests that the three genes are 
functionally related and supports the prediction that ymbA is in the same operon as pqiAB.  
 
4.2.13. Screening of mlaC deletion strains for sensitivity to lauryl 
sulfobetaine  
Results presented so far have established that a strain defective in mlaD is sensitive to LSB.  
As the mlaD gene is part of a five-gene operon, it was of interest to determine whether the 
same phenotype would result from a mutation in other genes from this operon.  The 
mlaC::aph mutation was therefore transduced from the Keio library into the BW25113 
parent and the ΔpqiAB and ΔpqiAB ΔyebST mutants. The primers used at all stages to 
check mlaC mutants were mlaC_check_F and mlaC_check_R.  
Growth of these 3 new strains on 1% (w/v) LSB was compared with the equivalent 
mlaD mutants (Figure 4.14). The growth of mlaC::aph single and double mutants was 
similar to that of the corresponding mlaD deletion strains, while no growth was observed 
for either of the triple mutants. As the phenotypes of the mlaC and mlaD deletion strains 






Figure 4.13. The growth of the parent and individual pqiA::aph, pqiB::aph and 
ymbA::aph mutants on lauryl sulfobetaine. The strains were plated onto A. LA, B. LA 












































Figure 4.14. The growth of the mlaC mutants vs the mlaD mutants on lauryl sulfobetaine. 
The strains were plated onto A. LA, B. LA supplemented with 1% (w/v) LSB and C. LA 















































































4.2.14. Determination of whether truncated PqiB and YebT proteins can 
complement the lauryl sulfobetaine sensitivity phenotype of the pqiAB 
deletion strain  
Aside from 4 additional MCE domains in YebT and the large C-terminal alpha helix in PqiB, 
the secondary structures of these two proteins were predicted to be very similar (see 3.11). 
The first aim of these experiments was to identify segments of PqiB necessary for its 
function. The second aim was to determine whether a “pqiAB-like” yebST operon could 
complement the phenotype of the ΔpqiAB mutant.  
Three truncated operons were synthesised and cloned by Genscript into the 
restriction sites NdeI and XhoI of the plasmid pET17b. The constructs were as follows: 1) 
pET17b-pqiAB_3, which encodes PqiB without the C-terminal alpha helix; 2) pET17b-
pqiAB_2α, which encodes PqiB that lacks the most C-terminal MCE domain but has the C-
terminal alpha helix still intact; and 3) pET17b- yebST_3α, which encodes a truncated YebT 
protein with the first three MCE domains from YebT and the alpha helix from PqiB added to 
the C terminus. The constructs were transformed into the ΔpqiAB mutant and screened on 
LA supplemented with 1 and 4% (w/v) LSB (Figure 4.15). In contrast to the vector pET17b-
pqiAB, which fully complemented the ΔpqiAB mutant, none of the other constructs restored 
any resistance to LSB. This suggests that the C-terminal alpha helix and the C-terminal 
MCE domain are essential for PqiB function, and that a “pqiAB-like” yebST operon cannot 
function as pqiAB.   
 
4.2.15. Predictions of PqiA, PqiB, YebS and YebT subcellular locations 
Online bioinformatics resources were used to predict the cellular locations of PqiA, PqiB, 
YebS and YebT. The transmembrane hidden Markov model (TMHMM) server was used to 
predict transmembrane regions in the proteins and PslPred was used to predict the 
subcellular locations (Bhasin et al., 2005; Krogh et al., 2001). TMHMM predicted that both 
PqiA and YebS span the membrane 8 times, with the N- and C-termini located inside the 





Figure 4.15. The growth of the ΔpqiAB mutant with various complementation vectors on 
lauryl sulfobetaine. A. The architectures of PqiB and YebT, B. growth of the strains on LA 
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Figure 4.16. Predictions of the locations of PqiA, PqiB, YebS and YebT using online 
bioinformatic resources. A. The prediction of transmembrane helices using TMHMM. B. 
Subcellular localisation predictions using Pslpred. 
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span the membrane once with the C-termini located outside of the membrane. PqiA and 
YebS were predicted by Psipred to locate to the cytoplasmic membrane (Figure 4.16B). The 
location predictions of PqiB and YebT were inconclusive. These results suggest that all four 
proteins are membrane localised and that PqiA and YebS are integral inner membrane 
proteins. 
 
4.2.16. Expression of PqiA, PqiB, YebS and YebT  
In order to determine the cellular location of PqiA, PqiB, YebS and YebT experimentally, 
antibodies specific to each protein were required. Each gene was cloned into pET22b (+), an 
expression vector with an IPTG-inducible T7 promoter and a polyhistine C-terminal 
histidine tag. To improve protein solubility, the first 120 bps were removed from pqiB and 
yebT, which encode the predicted TM regions. The following primer pairs were used to 
amplify the genes by PCR: pqiA_NdeI_F and pqiA_XhoI_R; pqiB_TM_NdeI_F and 
pqiB_XhoI_R; yebS_NdeI_F and yebS_XhoI_R and yebT_TM_NdeI_F and 
yebT_XhoI_R. The amplified genes were cloned into pET22b using NdeI and XhoI 
restriction sites and transformed and checked as described previously.  
For expression, the pET22b-pqiA, pET22b-pqiBΔTM, pET22b-yebS and pET22b-
yebTΔTM constructs were transformed into the expression strain BL21 DE3. To check for 
expression, cells were grown to an OD600 of 0.6 in 10 ml of LB and induced with 1 mM IPTG 
for 3 hours at 37°C. PqiA and YebS could not be produced, even when a range of IPTG 
concentrations were used for induction for various times and at different temperatures. The 
production of PqiB and YebT was successful and the subsequent purifications are described 
in the next section. 
 
4.2.17. Purification of PqiB and YebT for antibodies 
Without the N-terminal TM regions, the molecular weights of PqiB and YebT are 56 kDa 
and 85 kDa, respectively. For purification, the cultures expressing PqiB and YebT were 
scaled up to 1 l and induced under the same conditions. After 3 hours of induction, the cells 
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were pelleted and lysed and the lysate was centrifuged to remove unbroken cells. The cell 
lysate was bound to a 1 ml nickel column overnight. The column was washed twice 200 mM 
imidazole and the proteins were eluted in 1 ml fractions using 500 mM imidazole. The flow-
through, washes and eluted fractions from each purification were analysed by SDS-PAGE, 
revealing purified PqiB and YebT with some minor contaminants (Figure 4.17A and B). A 
large amount of PqiB and YebT were still present in each flow-through, indicating that both 
proteins were well expressed. The eluted samples of the purified proteins were pooled and 
adjusted to a concentration of 0.5 mg/ml. The proteins were sent to Eurogentec to raise 
polyclonal antibodies in rabbits.  
 
4.2.18. Experimental confirmation that PqiB and YebT localise to the 
membrane 
To confirm the bioinformatic predictions that PqiB and YebT are membrane localised, the 
soluble (periplasm/cytoplasm) and insoluble (membranes) cellular fractions were isolated. 
Two litre cultures of the parent strain and ΔpqiAB ΔyebST mutant were grown to an OD600 
of 0.6-0.8 and the cells were pelleted and lysed. The cell lysates were centrifuged to pellet 
the cell membranes, leaving the components of the cytoplasm and periplasm in the 
supernatant. The pellets were re-suspended and analysed by western blotting alongside the 
supernatant with anti-PqiB and anti-YebT antibodies. Proteins of the correct molecular 
weight were observed in the membrane fraction (Figure 4.18). The absence of these bands 
in the ΔpqiAB ΔyebST mutant confirmed that the detected proteins were PqiB and YebT. 
These results confirm that PqiB and YebT are located in the cell membrane, as predicted by 
TMHMM.   
 
4.2.19. Sarkosyl extraction for the separation of inner and outer membranes 
Separate outer and inner membranes were required to identify the specific locations of PqiB 







Figure 4.17. SDS-PAGE analysis of the purification of PqiB and YebT for use in the 
generation of polyclonal antibodies. The proteins were his-tagged and purified using a 
nickel column. A. The purification of PqiB without the N-terminal TM domain. B. The 
purification of YebT without the TM domain. L=molecular weight ladder, F/T=flow 
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Figure 4.18. Western blot analysis of the soluble (S) and insoluble (I) cell components to 
confirm the membrane localisation of PqiB and YebT. The fractions of BW25113 and the 
ΔpqiAB ΔyebST mutant were analysed using anti-PqiB and anti-YebT antibodies. 

















the inner membrane (Hobb et al., 2009). To test the effectiveness of this method, the 
membranes of E. coli K-12 BW25113 were isolated as described previously and the inner 
membrane was solubilised overnight in 1% (w/v) sarkosyl. The insoluble outer membrane 
was pelleted by ultracentrifugation, leaving the soluble inner membrane in the supernatant. 
The success of the separation was determined by western blot analysis using antibodies 
against the known inner and outer membrane proteins AcrB and OmpF. The western blots 
revealed that the outer membrane fraction did not contain detectable inner membrane 
proteins but that inner membrane fraction was contaminated with outer membrane 
proteins (Figure 4.19A). This method is therefore only suitable for the isolation of pure 
outer membranes, and was not used for the determination of the locations of PqiB and 
YebT. 
 
4.2.20. Separation of inner and outer membranes by sucrose gradient 
centrifugation 
In an attempt to achieve better separation, the inner and outer membranes were separated 
by sucrose gradient centrifugation. The cell envelopes of E. coli K-12 BW25113 were isolated 
as described previously (see 4.2.18) and re-suspended in 20% (w/v) sucrose. The 
membranes made up the top layer of the sucrose gradient and the middle and bottom layers 
consisted of 60% (w/v) and 70% (w/v) sucrose, respectively. The gradient was ultra-
centrifuged for 16 hours to allow membrane separation. Following centrifugation, the 
cytoplasmic membrane fraction formed a discrete band at the 20-60% (w/v) sucrose 
boundary. The outer membrane fraction formed a second band at the 60-70% (w/v) 
boundary. The gradient was collected in ~0.5 ml fractions and analysed by SDS-PAGE and 
western blotting. SDS-PAGE revealed that the majority of the proteins were found in 
fractions 7 and 8, which contained the outer membranes, and in fractions 13 and 14, which 
included the inner membranes (Figure 4.19B). For western blot analysis, the outer 
membrane marker was changed from OmpF to BamA because BamA had similar expression 




Figure 4.19. Western blot and SDS-PAGE analysis to determine the success of various 
methods for inner and outer membrane separation in BW25113. OM= outer membrane 
fraction(s) and IM=inner membrane fraction(s).  A. Western blot analysis using anti-OmpF 
and anti-AcrB to assess membrane separation using sarkosyl extraction B. Coomassie 
stained SDS-PAGE gel and western blot (using anti-BamA and anti-AcrB antibodies) of a 
fractionated sucrose gradient following 16 hours of centrifugation.  C. Western blot analysis 
(using anti-TolC and anti-AcrB) of a sucrose gradient following spheroplasting and 40 
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fractions were less contaminated with outer membrane proteins than those isolated in the 
sarkosyl extraction method, but were still contaminated with outer membrane proteins. 
Furthermore, the outer membrane fractions were contaminated with inner membrane 
proteins. Therefore, this method was better for the isolation of inner membranes than the 
sarkosyl extraction method, but worse for the isolation of outer membranes. 
 
4.2.21. Separation of inner and outer membranes by spheroplast formation 
followed by sucrose gradient centrifugation 
An alternative method for preparing samples for sucrose gradient centrifugation was tested 
in an attempt to decrease cross-membrane contamination. This method incorporated three 
major changes into the protocol that are published to improve separation (Dalebroux et al., 
2015; Osborn and Munson, 1974). First, prior to the isolation of the total cell membranes, 
the whole cells were converted into spheroplasts by incubating them with lysozyme and 
EDTA. Secondly, the volume of the middle sucrose layer was increased to increase the 
separation of the inner and outer membranes in the gradient. Thirdly, the 
ultracentrifugation step was increased to 40 hours, allowing more time for the membranes 
to reach equilibrium within the gradient. Following centrifugation, the inner and outer 
membranes formed very distinct bands that were taken as individual fractions. For western 
blot analysis the outer membrane marker was changed to TolC to partner its inner 
membrane counterpart, AcrB. The western blots revealed that the separation of the inner 
and outer membranes was absolute, with no visual cross-contamination in either 
membrane fraction (Figure 4.19C). In conclusion, these alterations to the sucrose gradient 
method resulted in the efficient separation of the inner and outer membranes of E. coli.  
 
4.2.22. Sucrose gradient and western blot analysis to determine membrane 
locations of PqiB and YebT 
To determine whether PqiB and YebT are found in the inner or outer membrane, the 
membranes of BW25113 were separated using the optimised sucrose gradient protocol. As 
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controls, the membranes of the ΔpqiAB, ΔyebST and ΔpqiAB ΔyebST mutants were 
separated alongside. The fractions were analysed by western blotting using antibodies 
against TolC, AcrB, PqiB and YebT. The anti-TolC and anti-AcrB western blots confirmed 
the clean separation of the inner and outer membranes (Figure 4.20). The anti-PqiB and 
anti-YebT western blots detected proteins of the correct sizes in the BW25113 inner 
membrane fraction. The proteins were absent in the corresponding deletion strains, 
confirming that the detected proteins were PqiB and YebT. These results revealed that both 
PqiB and YebT are inner membrane proteins of E. coli.  
 
4.2.23. Thin-layer chromatography to identify phospholipids bound to 
purified MlaD, PqiB and YebT  
Despite the reported role of the Mla pathway in phospholipid trafficking, no study has 
looked at whether the components of this pathway directly bind phospholipids. To test 
whether MlaD, PqiB and YebT in E. coli bind phospholipids, all 3 proteins were purified 
without the N-terminal TM domain. PqiB and YebT were purified as described for antibody 
production and purified MlaD protein was provided by Dr Tim Knowles (School of 
Biosciences, University of Birmingham). Lipids were extracted by the addition of 3 ml of 2:1 
chloroform:methanol to 2 ml of 1 mg/ml protein (or buffer only as a control). After 
centrifugation, the mixture separated into an upper aqueous phase and a lower organic 
phase. The organic phases were analysed by one-directional thin layer chromatography 
(TLC) in a 65:25:4 chloroform:methanol:water solvent system alongside PE, PG and CL 
standards. Staining with phosphomolybdic acid revealed the presence of two major lipid 
species bound to MlaD, PqiB and YebT. No lipids were visible in the buffer only (Figure 
4.21). When compared to the standards the upper major lipid species migrated to a similar 
position as the PE standard, and the lower major lipid species to a similar position as the 
PG and CL standards.  
To identify the phospholipid species, the TLC plates were prepared again with and 




Figure 4.20. Western blot analysis of the outer membrane (OM) and inner membrane 
(IM) fractions to identify the presence of PqiB and YebT in the inner membrane. The 
membranes of the BW25113 parent strain and the ΔpqiAB, ΔyebST and ΔpqiAB ΔyebST 
mutants were separated using the optimised spheroplasting and sucrose gradient method. 
The western blots using anti-TolC and anti-AcrB antibodies confirm the successful 
separation of the inner and outer membranes. The western blots using anti-PqiB and anti-
YebT confirm the presence of PqiB and YebT in the inner membrane fraction, and their 































Figure 4.21. Thin layer chromatography of the lipid extracts from purified MlaD, PqiB and 
YebT (without the transmembrane domains). The lipids were separated in 65:25:4 
chloroform:methanol:water alongside PE, PG and CL standards. The lipid species were 

























were calculated from the stained TLC plates to predict the locations of the lipid species on 
the unstained plates. A mass spectrometry was used to determine the masses of all of the 
major lipid species by electrospray ionisation, directly from the TLC plates. The mass to 
charge ratios of the major species in the upper spots were 688, 702, 716 and 742, and in the 
lower spots were 691, 719, 733 and 747. By comparison to the standards, the upper major 
lipid species in the MlaD, PqiB and YebT lipid extracts were identified as PE and the lower 
lipid species were identified as PG. This experiment revealed that the soluble domains of 
MlaD, PqiB and YebT all co-purify with PE and PG. 
 
4.2.24. Two-direction thin layer chromatography to identify changes in 
membrane phospholipid composition in various MCE mutants 
As MlaD is part of a phospholipid trafficking pathway in E. coli, the membranes of various 
MCE mutants were analysed to determine differences in membranes composition relative to 
the parent strain. The inner and outer membranes of the parent strain and the ΔmlaD, 
ΔpqiAB, ΔyebST, ΔpqiAB ΔyebST and the triple deletion strain were prepared using the 
optimised sucrose gradient protocol. Lipids were extracted from the separated inner and 
outer membranes using a Bligh-Dyer extraction method (Bligh and Dyer, 1959). The loading 
of the samples onto TLC plates was normalised by the amount of phospholipid, as 
determined by an ammonium ferrothiocyanate colourimetric assay (see 2.9.4). The samples 
were separated by 2 directional TLC. The solvent system for the first direction was 65:25:4 
chloroform:methanol:water, which separates out most phospholipids, but not PG and CL. 
The solvent system for the second direction was 80:12:15:4 chloroform:methanol:acetic 
acid:water that separates out phospholipid species further, including PG and CL.  
 The 2D TLC plates were stained with phosphomolybdic acid, revealing the inner and 
outer membrane profiles of all 6 strains. The relative locations of PE, PG, CL and acyl-PG 
were known from a previous study, allowing their identification on the TLC plates (Figure 




Figure 4.22. Thin layer chromatography of the inner membrane lipid extract of BW25113 
with known phospholipid species identified. The lipids were separated in 65:25:4 
chloroform:methanol:water (direction 1) and 80:12:15:4 chloroform:methanol: acetic 














similar for all 6 strains (Figure 4.23 and 4.24). Some minor changes were observed in the 
inner membranes of the ΔyebST, ΔpqiAB ΔyebST and triple deletion strains, but in 
unknown lipid species (Figure 4.231i-iii). However, there were no major changes in the 
membrane phospholipid compositions of the various mutants in E. coli. 
 
4.3. Discussion 
In this chapter, a phenotype associated with defects in all three MCE operons was 
discovered: sensitivity to the zwitterionic detergent LSB. The similar sensitivities of ΔpqiAB 
and ΔmlaD mutants on LSB and additional attenuation of a double mutant suggest that 
these genes fulfill partially overlapping but nevertheless distinct roles in protection against 
this detergent. The additive phenotype of the ΔpqiAB ΔyebST mutant was greater than the 
additive phenotype of the ΔmlaD ΔyebST mutant, suggesting the functions of yebST and 
pqiAB are more related than the functions of yebST and mlaD. The triple mutant was 
unable to grow on 1% (w/v) LSB, demonstrating an increase in sensitivity with increasing 
loss of MCE domain containing proteins. LSB has been shown to inhibit the carnitine/acyl-
carnitine transporter in mitochondria, as a substrate analog (Indiveri et al., 1998). A 
potential explanation for the observed phenotype is that LSB is also inhibiting a lipid 
transport pathway in E. coli, perhaps one that has some overlap in function with the MCE 
pathways. Alternatively, MCE domain containing proteins might be involved in trafficking 
LSB away from its target. Given the related phenotypes for ΔmlaD, ΔpqiAB and ΔyebST 
mutants it is entirely possible that the roles of the three proteins are similar, albeit with 
mechanistic differences. 
Sensitivity to detergents often signifies an outer membrane defect (Zhou 2012). 
Therefore, sensitivity to LSB could indicate a loss of outer membrane integrity. Detergents 
besides LSB were tested to determine the specificity of the phenotype. While no mutants 
showed sensitivity to SDS alone, the mlaD mutants were sensitive to SDS and EDTA, which 
coincides with previous findings for the Mla pathway (Malinverni and Silhavy, 2009). 





Figure 4.23. Thin layer chromatography of the inner membrane lipid extracts of BW25113 
(1), the ΔmlaD mutant (2), the ΔpqiAB mutant (3), the ΔyebST mutant (4), the ΔpqiAB 
ΔyebST mutant (5) and the ΔmlaD ΔpqiAB ΔyebST mutant (6). The red circles marked i, ii 
and iii mark potential changes between membrane profiles. The lipids were separated in 
65:25:4 chloroform:methanol:water (direction 1) and 80:12:15:4 chloroform:methanol: 










Figure 4.24. Thin layer chromatography of the outer membrane lipid extracts of BW25113 
(1), the ΔmlaD mutant (2), the ΔpqiAB mutant (3), the ΔyebST mutant (4), the ΔpqiAB 
ΔyebST mutant (5) and the ΔmlaD ΔpqiAB ΔyebST mutant (6). The lipids were separated 
in 65:25:4 chloroform:methanol:water (direction 1) and 80:12:15:4 chloroform:methanol: 





carbon chain. Screens on other sulfobetaines revealed that a ΔpqiAB mutant was equally as 
sensitive on SB3-10 as on LSB, but with less of an additive phenotype for the ΔpqiAB 
ΔyebST mutant. The pqiAB gene pair might specifically be required for protection against 
sulfobetaines (or zwitterionic detergents in general) while yebST is only required in the 
absence of pqiAB. The specificity of the phenotypes for each deletion strain could be related 
to the charge and chain length of the molecules but more detergent screens are required to 
investigate this hypothesis. Nevertheless, the variation of results on different detergents 
shows that the functions of mlaD, pqiAB and yebST are not redundant.  
 Vancomycin is a hydrophobic antibiotic used to treat infections of Gram-positive 
bacteria. It works by inhibiting the synthesis of peptidoglycan (Hammes and Neuhaus, 
1974). Gram-negative bacteria are inherently more resistant to vancomycin due to an 
additional barrier, the outer membrane, shielding the peptidoglycan. Defects in LPS 
biogenesis often cause a large increase in sensitivity to hydrophobic antibiotics (Vaara, 
1993; Vuorio and Vaara, 1992). Therefore, like detergents, vancomycin sensitivity can be 
used as a marker for loss of outer membrane integrity. Unexpectedly, some of the deletions 
strains in this study were much more resistant to vancomycin than the parent strain. This 
phenotype was observed for all of the mlaD mutants, and the ΔpqiAB ΔyebST mutant. 
Increased resistance to vancomycin has been linked to accumulation of phosphatidic acid 
(PA) on the outer leaflet of the outer membrane (Sutterlin et al., 2014). As PA has a large 
net negative charge, Sutterlin et al. (2014) proposed that vancomycin forms associations 
with PA in the outer leaflet and is therefore kept away from its target. Mutants defective in 
the Mla pathway in E. coli accumulate phospholipids on the cell surface, which could 
explain the vancomycin resistance phenotype observed here (Malinverni and Silhavy, 
2009). Although it is usually sensitivity to vancomycin that is seen as a marker for loss of 
membrane integrity, this discussion suggests vancomycin resistance could also be used as a 
marker for loss of membrane homeostasis.   
 To test whether the phenotype observed for the mlaD mutants were applicable to 
the whole mla operon, mlaC mutants were also screened for increased sensitivity to LSB. 
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The phenotypes of the mlaC mutants were exactly those of the mlaD mutants on LSB, 
suggesting that all the individual components of the mlaFEDCB operon might be required 
for resistance to LSB. MlaC is the periplasmic chaperone of the Mla pathway, and there is 
no homolog in the pqiAB and yebST operons. If MlaC is the sole chaperone for all MCE 
domain containing proteins in E. coli, an mlaC gene deletion would disrupt all 3 MCE 
pathways and the phenotypes of the mlaC::aph and ΔmlaD ΔpqiAB ΔyebST mutants on 
LSB would be similar. As the phenotype of the ΔmlaC mutant was similar to phenotype of 
the ΔmlaD mutant and not the ΔmlaD ΔpqiAB ΔyebST triple mutant, it is unlikely that 
MlaC is chaperoning lipids for all 3 MCE pathways (or at least it is not the only chaperone).  
Similar to the ΔpqiAB mutant, the individual gene deletion strains (in pqiA::aph, 
pqiB::aph and ymbA::aph) were all sensitive to LSB, suggesting that the three genes are 
functionally connected. The LSB phenotype of the ΔpqiAB mutant was also manipulated to 
identify important components of PqiB. If either the C-terminal alpha helix or MCE domain 
was removed from PqiB, the protein could not protect against LSB, suggesting these 
components of PqiB are important for function. Furthermore, a “PqiAB-like” YebST (with 
the first 3 YebT MCE domains and an added PqiB C terminal alpha helix), could not 
complement the ΔpqiAB mutant, despite their structural similarity. This result indicates 
that that are more intricate differences between PqiB and YebT than the number of MCE 
domains and alpha helices, and that these differences are important for function. In the 
future, the presence of each truncated PqiB and YebT protein will be confirmed by western 
blot to confirm that these proteins are expressed and stable. This investigation could be 
taken further to identify other important components of PqiB for function, and to 
determine whether it is differences between PqiA and YebS, PqiB and YebT, or both that are 
responsible for these results.  
The location of a protein is an important factor in understanding its function. 
Therefore, one aim of this chapter was to determine the subcellular locations of PqiB and 
YebT in E. coli. Bioinformatic predictions revealed that both proteins localise to the 
membrane, which was then confirmed experimentally. After the optimisation of the 
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separation of inner and outer membranes in E. coli, PqiB and YebT were identified as inner 
membrane proteins. This is the first study to identify the location of natively expressed 
multi-MCE domain proteins in Proteobacteria. This result differs from the previous work on 
the Vibrio parahaemolyticus YebT homolog, MAM-7, which was reported to be surface 
localised when over-expressed (Krachler et al., 2011). However it is in agreement with all 
other published literature on the location of MCE domain containing proteins in Gram-
negative bacteria, including MlaD, and the chloroplast protein, Tgd2 (Awai et al., 2006; 
Hong et al., 1998; Monaco et al., 2006). This result is consistent with the fact that MCE 
domain containing proteins generally have no predicted signal peptide cleavage sites 
(Petersen et al., 2011). Bioinformatic predictions have led to the conclusion that PqiB and 
YebT, like MlaD, face the periplasm in E. coli. In the future this prediction will be confirmed 
by immunofluorescence using the anti-PqiB and anti-YebT antibodies generated in this 
study.  
 Another aim of this chapter was determine whether MlaD, PqiB and YebT bind 
lipids, specifically phospholipids. To explore this, lipid extracts of purified MlaD, PqiB and 
YebT were analysed by TLC and mass spectrometry to reveal the presence of PE and PG. 
These results are supported by the recently published study on the Mla pathway, which 
identified PE and PG bound to purified MlaD (Thong et al., 2016). Furthermore, MAM-7 
and the protein from Arabidopsis thaliana, Tgd2, have both been found to bind 
phosphatidic acid (Awai et al., 2006; Krachler et al., 2011). It is plausible that these proteins 
have a general affinity towards phospholipids (or lipids in general) and that the results 
observed for MlaD, PqiB and YebT are a consequence of the E. coli lipid composition. PE 
and PG are the most abundant phospholipids, making up 80% and 15% of the E. coli cell 
membrane, respectively (Ingram, 1977). In the future, fluorescence-based experiments can 
be used to determine the lipid binding affinities of MCE domain containing proteins and the 
kinetics of a particular protein-lipid interaction. This technique could also be used for 
competition assays to determine whether the proteins have preferences towards particular 
phospholipids.  
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 With the prior knowledge of the Mla pathway and discovery that all three MCE 
domain containing proteins bind phospholipids, it was appropriate to determine whether 
various MCE mutants have altered membrane phospholipid compositions and thus 
determine whether these proteins have a role in trafficking membrane phospholipids. Two-
dimensional TLC of lipid extracts revealed minor changes for the inner membrane samples. 
Although these might be genuine, they might also be artefacts introduced through sample 
preparation, loading or staining. Either way, no major changes were observed in the 
phospholipid compositions of the inner and outer membranes, suggesting that the MCE 
domain containing proteins do not have a major role in the maintenance of the membrane 
phospholipid composition. Although the Mla pathway is involved in the removal of 
unwanted phospholipids from the cell surface, only minor phospholipid accumulation was 
observed in its absence (Malinverni and Silhavy, 2009). The techniques used here were 
probably not sensitive enough to detect such minor changes, so a minor role in the 
phospholipid composition of the cell membranes cannot be ruled out. In the future, mass 
spectrometry will be used as a more quantitative and sensitive measure for the 
determination of membrane composition and will also allow chain length determination. 
Furthermore, no work has been done to check for an overall increase or decrease in 
phospholipid content of the cell membranes, by comparing the ratios of phospholipid to 
membrane proteins and/or LPS in the outer membrane. Future work will also focus on 
repeating the phenotype of phospholipid accumulation on the surface of mlaD mutants and 
determining whether this phenomenon occurs in other MCE deletion strains.  
Overall the results in this chapter represent a step towards understanding the 
function of the three MCE domain containing proteins in E. coli, and their relationship to 
one another. The phenotypes identified in this chapter suggest that there is some overlap in 
function between the three pathways (particularly between PqiAB and YebST), but that they 
do not overlap completely. All three MCE domain containing proteins in E. coli are located 
in the inner membrane and have a general affinity towards phospholipids. Although the 
results did not ultimately determine one way or another whether the proteins are involved 
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in phospholipid trafficking, they rule out a major role in the trafficking phospholipids to or 
from membranes. Nevertheless, based on the existing knowledge of the Mla pathway, 
specific detergent sensitivities and vancomycin resistance it seems feasible that there is a 
minor function in the maintenance of outer membrane phospholipid content. It is also 
possible that MCE domain containing proteins have a role in trafficking phospholipids 
across membranes, perhaps for uptake from the external environment. A role in uptake has 
been demonstrated for MCE pathways in other bacteria, as shown by the inability of 
mutants to grow on lipids as a carbon source (Endo et al., 2007; Mohn et al., 2008; Pandey 
and Sassetti, 2008). Unfortunately the E. coli strain used in this study could not grow on 
phospholipids and therefore this theory could not easily be tested. In the next chapter, the 
focus is moved towards determining the first crystal structure of an MCE domain 
containing protein to provide more information on the lipid binding properties and general 




























PURIFICATION AND CRYSTALLOGRAPHY OF PQIB 
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5.1. Introduction 
To date no structure has been determined for any MCE domain containing protein. X-ray 
crystallography has been a key technique in the field of structural biology since the 
determination of the structure of myoglobin in the 1950s (Kendrew 1958). This technique 
involves screening the protein of interest in a variety of conditions with the aim of growing 
well-ordered crystals. A well-formed crystal can diffract X-ray waves that are detected and 
visualised as a pattern of spots, from which information about the structure of the protein 
can be mathematically determined. The diffraction pattern provides information about the 
direction from which a wave came (the spot position) and the amplification of a wave (the 
spot intensity). Information is lost about the phase of the waves, resulting in what is termed 
the “phase problem”. Without this information, the crystal structure cannot be fully solved. 
For some proteins, solving the “phase problem” is made easier by utilising information from 
existing structures of similar proteins. Where similar structures are unavailable, multiple 
isomorphous replacement can be used.  This method requires datasets from two crystals: 
one native (picked directly from the conditions the crystal formed in) and one soaked in 
heavy atoms. The heavy atoms attach to two or more positions in the protein and datasets 
from both crystals are compared to reveal the heavy atom positions (Smyth and Martin, 
2000). From the data, the phase of the heavy atoms can be determined and the phases of 
the native crystal can then be solved mathematically (Smyth and Martin, 2000). If the 
crystal(s) diffract to a high enough resolution, then the data can provide information on 
protein structure.  
As discussed previously, the basic secondary structure for an MCE domain 
containing protein is predicted to be an N-terminal alpha helix in the TM domain and 6 
conserved beta sheets in the MCE domain. In more complex MCE domain containing 
proteins there are large C-terminal alpha helices and/or multiple MCE domains. Both of 
these characteristics are found in PqiB, in which there are 3 MCE domains and a C-terminal 
alpha helix of approximately 120 amino acids in length (Buchan et al., 2013). A crystal 
structure of PqiB would therefore provide information on all of the common features of 
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MCE domain containing proteins. The aim of this chapter was to determine the structure of 
PqiB using crystallography.  
 
5.2. Results 
5.2.1. Purification of full-length PqiB for crystallography 
To obtain the first crystal structure of an MCE domain containing protein, full-length PqiB 
was expressed and purified for crystallography. The pqiB gene sequence was amplified by 
PCR using pqiB_NdeI_F and pqiB_XhoI_R and ligated into pET22b(+) using NdeI and 
XhoI restriction sites, and transformed into E. coli BL21 DE3. To test for protein 
production, 10 ml cultures were induced at an OD600 of 0.6 with 1 mM IPTG and left 
overnight at 18°C. The low induction temperature was used to slow down production and 
improve folding and incorporation of PqiB into the membrane. As this trial experiment 
resulted in the accumulation of sufficient PqiB the cultures were scaled up to six 1 l cultures. 
After overnight induction, the membranes were isolated from lysed cells and re-suspended 
in 0.5% of the detergent n-dodecyl-β-D-maltoside (DDM) for overnight solubilisation. The 
protein was purified as described previously (see 4.2.18) and 0.1% DDM was used 
throughout to maintain protein solubility. The flow-through, washes and protein elution 
fractions were analysed by SDS-PAGE (Figure 5.1). Substantial amounts of PqiB were eluted 
using imidazole, which also contained visible contamination of other proteins or PqiB 
breakdown products. Therefore, further purification was required to prevent crystallisation 
of contaminants.  
 
5.2.2. Gel filtration chromatography of purified full-length PqiB  
The partially purified PqiB sample was further purified by size exclusion chromatography to 
remove the unwanted contaminants. This involved passing the sample through a 120 ml 
Superdex 200 10/300 GL column gel filtration column using the ÄKTA Pure 
chromatography system, where the rate of travel was proportional to the size of the protein. 





Figure 5.1. SDS-PAGE analysis of the purification of full length PqiB for crystallography. 
The full-length his-tagged protein was solubilised in DDM and purified using a nickel 
column. L=molecular weight ladder, F/T=flow through, W1=wash 1 and W2=wash 2.  
	 	
Elutions 
 L     F/T   W1  W2  
60kDa 
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protein in each fraction was detected by measuring its absorbance at 280 nm, which  
revealed that PqiB had eluted between  42 and 58 ml (Figure 5.2A). Analysis of alternate 
fractions by SDS-PAGE revealed much purer PqiB protein than prior to gel filtration (Figure 
5.2B). The fractions were pooled and concentrated to ~20 mg/ml for crystallography. 
 
5.2.3. Crystallography of full-length PqiB 
As PqiB has an TM region and a large soluble domain, the purified protein was screened in 
conditions designed for both membrane proteins and soluble proteins. These included the 
JCSG+, ProPlex, Morpheus HT-96, Midas HT-96, PACT premier and PEGRx screens, each 
consisting of 96 conditions. The crystallography trials were set up as 600 nl sitting drops in 
96-well crystallisation plates with a 1:1 protein to condition ratio. Protein precipitation was 
observed immediately in most conditions, suggesting either that the protein concentration 
was too high, or that the protein solubility was too low. Therefore, the same screens were set 
up with a decreased initial protein concentration of 10 mg/ml, which resulted in slightly less 
precipitation. After 1 month, no crystals were observed. The focus of the crystallography was 
moved to the soluble region of PqiB with the aim of improving protein solubility and crystal 
formation.  
 
5.2.4. Purification and gel filtration of the soluble component of PqiB for 
crystallography 
Expression PqiB without the TM domain was achieved using E. coli BL21 DE3 transformed 
with pET22b-PqiBΔTM. One litre of cells were grown as described previously (see 4.2.17), 
but with overnight induction at 18°C. The expressed protein was purified using a nickel 
column and the flow-through, washes and elution fractions were analysed by SDS-PAGE. 
The yield of PqiB had improved substantially compared to the procedure used previously 
for the production of antibodies (Figure 5.3). The elution fractions were pooled and further 
purified by gel filtration chromatography. The 280 nm absorbance trace revealed a double 





Figure 5.2. Gel filtration of full length PqiB for crystallography using the Superdex 200 
10/300 GL column A. The 280 nm absorbance peak revealing the elution volume of PqiB. 
B. SDS-PAGE analysis of the alternate PqiB elution fractions. L=molecular weight ladder.   
A 
B 














 L        42        44         46        48         50        52       54         56        58 






Figure 5.3. SDS-PAGE analysis of the optimised purification of PqiB without the TM 
region for crystallography. The proteins were his-tagged and purified using a nickel column. 
L=molecular weight ladder, F/T=flow through, W1=wash 1 and W2=wash 2.  
Elutions 
 L    F/T  W1  W2  
55kDa 
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Fractions spanning the entire peak were analysed by SDS-PAGE, which revealed very pure 
PqiB protein in all fractions (Figure 5.4B). The early eluting PqiB was potentially aggregated 
and was therefore excluded from further experimentation. The later eluting PqiB was 
pooled and concentrated to ~20 mg/ml for crystallography.  
 
5.2.5. Initial crystallography of PqiB without the transmembrane region 
Purified PqiB without the transmembrane region was placed in the same crystal screens as 
used previously for the full-length protein. There was less initial protein precipitation than 
in the previous screens, suggesting that removal of the TM domain had substantially 
improved protein solubility. After 2.5 weeks the first PqiB crystals were observed in the 
PEGRx screen in 0.1 M MES, pH 6 and 28% (w/v) polyethylene glycol (PEG) 4000 (Figure 
5.5i). The crystals were picked and stored in the condition it formed, or soaked in bromine 
for phase determination. The crystals were stored in liquid nitrogen and transported to 
Diamond Light Source for X-ray analysis. The best crystal diffracted to a resolution of 12 Å, 
which confirmed the crystals were protein but could not provide any structural information.  
In an attempt to improve crystal growth the drop size was scaled up to 4 µl with a 
range of pH (5.5 to 6.5) and PEG 4000 concentrations (20 to 32% (w/v)). After 2.5 weeks 
new crystals had formed within the range of pH 5.5 to 6.0 and 24 to 28% (w/v) PEG 4000 
(Figure 5.5ii). These crystals only diffracted to a resolution of 10 Å and therefore could not 
be used to obtain structural information. 
 
5.2.6. Microseed matrix screening to improve crystal growth 
Different conditions are often required for crystal nucleation and crystal growth, which 
decreases the chances of crystal formation in a given condition. Microseed matrix screening 
overcomes this problem by breaking up crystals and using them as a nucleation point in 
new screens (Ireton and Stoddard, 2004). In an attempt to improve crystal growth, the 
poorly diffracting PqiB crystals from the previous section were used for microseed matrix 





Figure 5.4. Gel filtration of PqiB without the TM region for crystallography using the 
Superdex 200 10/300 GL column. A. The 280 nm absorbance peak revealing the elution 
volume of PqiB. B. SDS-PAGE analysis of the PqiB elutions. L=molecular weight ladder.  
 L     43   45   47    49    51   53    55    57    59    61   63   65    67   69  
Elution volume (ml) 





















Figure 5.5. The workflow of the crystallography of PqiB without the TM domain. Initially, 
protein at a concentration of 20 mg/ml was placed in a variety of crystallography trials in 
200 nl drops. The first crystals were observed in the PEGRx screen in PEG 4000 based 
condition. Crystal growth was optimised by scale-up of the condition to a 2: 2 µl drop 
(Scale-up) or microseed matrix screening into a new condition (Seed). 











vortexing. The crystal stock was used for seeding new 600 nl screens with a 1:2:3 ratio of 
stock : condition : protein.  The crystals that diffracted to 10 Å were used for seeding into 
the ProPlex, PACT premier and Midas HT-96 screens. After 1 week new crystals had formed 
in the ProPlex screen in 0.1 M Na HEPES, pH 7 and 15% (w/v) PEG 20000 (Figure 5.5iii). 
However, these crystals did not diffract.  
The crystals that diffracted to 12 Å were used for seeding into the PACT screen. After 
1 week crystals had formed in 0.1 M MIB buffer (sodium malonate dibasic monohydrate, 
imidazole, boric acid) pH 8 and 25% (w/v) PEG 1500 (Figure 5.5iv). These crystals 
diffracted to a resolution of 12 Å. After another 5 days, crystals had formed in 0.02 M 
sodium/potassium phosphate and 20% (w/v) PEG 3350 (Figure 5.5v). These crystals 
diffracted to a much-improved resolution of 4 Å, but this resolution was achieved only for 
the bromine-soaked crystal and not for those obtained from the native condition, and 
therefore the structure could not be solved.   
Overall, the crystallography process identified that PqiB forms crystals in conditions 
with low Mr PEG, and that the best crystals formed in PEG 3350 following microseed 
matrix seeding. This information can be used to further optimise PqiB crystallography.  
 
5.2.7. Determining the oligomeric state of PqiB using gel filtration 
Gel filtration size exclusion was used to determine the oligomeric state of purified PqiB. The 
partition coefficients (Kav) of proteins with known molecular weights (Table 5.1) were 
obtained by gel filtration on a Superdex 200 PG 16/60 column.  The partition coefficient 
was calculated as follows: Kav = (Ve – Vo)/(Vt – Vo), where Ve is the elution volume of the 
protein, Vo is the void volume of the column and Vt is the total column volume. The total 
column volume for the Superdex 200 PG 16/60 column is 120 ml. The void volume of the 
column was determined using blue dextran, a dye with a molecular weight of 2000 kDa that 
is too large to enter the gel matrix. Blue dextran eluted at 45.19 ml. The partition 




Table 5.1. The standards used for generation of a standard curve for gel filtration.  The 
partition coefficients wer calculated for each protein based on the following equation: Kav = 
(Ve – Vo)/(Vt – Vo), where Ve is the elution volume of the protein, Vo is the void volume of the 
column and Vt  is the total column volume. 	
Standard Mr Log Mr Kav 
Ferritin 474000 5.68 0.169 
Aldolase 156800 5.2 0.311 
ConAlbumin 76000 4.88 0.426 
Albumin 66500 4.82 0.303 
Ovalbumin 45000 4.65 0.49 
Carbonic 
anhydrase 29000 4.46 0.581 
Cytochrome C 12000 4.08 0.677 
Aprotinin 6511 3.81 0.787 
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form a standard curve from which unknown molecular weights could be calculated (Figure 
5.6).  
The peak elution volume for full length PqiB was 44 ml. This was in the void volume 
of the column and therefore the molecular weight could not be determined. This also 
suggested that the purified full length PqiB was aggregated. The peak elution volume for 
PqiB without the TM domains was 58 ml. This equated to a molecular weight of 375400 Da, 
as calculated from the standard curve (Figure 5.6). This molecular weight was 6.72 times 
the molecular weight of PqiB without the TM domain monomer (55863 Da), suggesting that 
the purified PqiB was either a hexamer or heptamer. 
 
5.3. Discussion 
The aim of this chapter was to determine the structure of PqiB. While this was not achieved, 
crystals that diffracted to 4 Å were obtained. PqiB production and crystallisation were 
optimised and it was revealed that PqiB forms reasonable crystals in low molecular weight 
PEG - based conditions. This goes a significant way towards identifying appropriate 
conditions for crystallisation of MCE domain containing proteins, laying the foundations for 
the future determination of crystal structures. Other techniques could also be adopted such 
as NMR (on a single MCE domain or shorter protein), small-angle X-ray scattering and 
cryo-electron microscopy.  
 During the crystallography process, data obtained from gel filtration was used to 
determine the oligomeric state of PqiB. Full-length PqiB eluted in the void volume, 
suggesting aggregation had occurred. In hindsight, this could be responsible for the lack of 
crystals obtained for full length PqiB. The molecular weight of the truncated PqiB, without 
the TM domain, was 6.72 times that of a equivalent PqiB monomer, suggesting that the 
protein forms either a hexamer or heptamer. Although this could be an artefact of protein 
overproduction, other MCE domain containing proteins have been reported to form 
homoligomers. In A. thaliana the complex involved in trafficking phosphatidic acid is 





Figure 5.6. A standard curve obtained from gel filtration using a Superdex 200 PG 16/60 
column. The log molecular weight (log Mr) of each protein was plotted against the partition 
coefficient (Kav). Kav = (Ve – Vo)/(Vt – Vo), where Ve is the elution volume of the protein, Vo is 




















al., 2012). Furthermore, MlaD from E. coli has recently been published as forming a 
hexamer (Thong et al., 2016). With this in mind, it is likely that the results observed for 
PqiB are genuine and that it probably forms a hexamer. How or why MCE domain 
containing proteins form homooligomers will become clear with future functional and 
structural studies. In the next chapter, the focus is moved to determining the importance of 
























THE ROLE OF MAMMALIAN CELL ENTRY DOMAINS 
IN SALMONELLA TYPHIMURIUM PATHOGENESIS 
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6.1. Introduction 
The Salmonella Typhimurium murine infection model is commonly used to investigate the 
role of proteins in pathogenesis. Whilst it is primarily a pathogen of the gastrointestinal 
tract, systemic infection results in the spread of bacteria to reticuloendothelial system 
organs such as the liver and spleen. The importance of MCE domains during murine 
infection has already been demonstrated in Mycobacterium tuberculosis, where mce 
mutants are usually found to be attenuated (Marjanovic et al., 2010; Senaratne et al., 
2008). The infection phenotypes of mutants lacking MCE domain containing proteins in 
Gram-negative bacteria are less well characterised. Infection studies in Gram-negative 
bacteria have only focussed on homologues of yebT. For example, Mahmoud et al. (2016) 
showed that a Shigella sonnei strain lacking multivalent adhesion molecule SS01327 was 
attenuated in Galleria mellonella. Furthermore, mutants of yebT homologues in a range of 
Enterobacteriaceae have been shown to exhibit decreased cell attachment and invasion of 
mammalian cells (Krachler et al., 2011; Mahmoud et al., 2016). 
 Studies on this topic generally focus on insects or nematodes (Krachler et al., 2011; 
Mahmoud et al., 2016): the role of MCE domains during infection of mammals has never 
been studied for a Gram-negative pathogen. Furthermore, nothing is currently known about 
the importance of MlaD and PqiB during infection. In this chapter, experiments are 
described in which Salmonella Typhimurium was used to determine whether MCE domain 
containing proteins in Proteobacteria have a role in mammalian pathogenesis. The first aim 
was to determine, through in vitro experiments, whether MlaD, PqiAB and YebST play a 
role in initial infection. The second aim was to investigate a potential role for MCE domain 
containing proteins in other stages of infection, through in vivo experiments. Given that S. 
Typhimurium is able to grow using phospholipids as a sole carbon source (Antunes et al., 
2011), the third and final aim was to determine whether MCE domain containing proteins 





6.2.1. Construction of pqiAB deletions in Salmonella Typhimurium SL1344 
The pqiAB genes span positions 1110249 to 1113147 on the S. Typhimurium SL1344 
genome. Deletions were constructed using gene doctoring, a method that involves λ Red 
recombination from a plasmid (Lee et al., 2009). First, the kanamycin resistance cassette 
was generated by PCR using the plasmid pDoc-K as a template. For generation of the pqiAB 
fragment for cloning, pqiA_GD_F and pqiB_GD_R primers were designed from the SL1344 
genome with HindIII (forward primer) and BamHI (reverse primer) restriction sites. The 
PCR produced a kanamycin resistance cassette flanked by regions of homology upstream 
and downstream of pqiAB. The fragment was ligated into pDoc-C using HindIII and BamHI 
restriction sites, and the constructs were transformed and checked as described previously. 
The resulting construct consisted of the kanamycin cassette flanked by two I-SceI digestion 
sites in pDoc-C, which also contains the gene for sucrose sensitivity, sacB.  
 S. Typhimurium SL1344 was electroporated with both the pDoc-C construct and 
pACBSCE, a vector harbouring the λ Red recombination machinery, I-SceI digestion sites 
and the I-sceI gene. One transformant was grown in 1 ml of LB with arabinose to induce 
expression of the recombination machinery and I-SceI endonuclease. Cleavage of the I-sceI 
sites on pDoc-C allows linearisation of the kanamycin resistance cassette fragment for 
recombination onto the chromosome. After 5 hours of growth in arabinose, the culture was 
plated onto LA with kanamycin and 5% sucrose. The sucrose was used to differentiate 
between true recombinant colonies, which were kanamycin and sucrose resistant, and those 
that simply carry the pDoc-C construct, which were kanamycin resistant but sucrose 
sensitive due to the sacB gene. Kanamycin and sucrose resistant colonies were checked by 
colony PCR for the deletion of pqiAB using pqiA_STm_check_F and pqiB_STm_check_R 
primers (Figure 6.1A), which annealed to the flanking regions of pqiAB. The PCR included 
the S. Typhimurium SL1344 parent as a control, and a successful deletion was shown by a 
decrease in PCR product from ~3500 bp to ~2500 bp (Figure 6.1B, lanes 2 and 3). The 




Figure 6.1. Confirmation of the disruption of pqiAB and yebST in S. Typhimurium 
SL1344. A. The positions of the pqiAB and yebST check primers and B. Gel electrophoresis 
of PCR products confirming the disruption of pqiAB and yebST by a kanamycin cassette 
using pqiAB and yebST check primers: lane 1: molecular weight marker, lane 2: SL1344, 
lane 3: SL1344 pqiAB::aph, lane 4: molecular weight marker, lane 5: SL1344, lane 6: 
SL1344 yebST::aph.	
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using P22 bacteriophage. Successful transduction was confirmed by colony PCR using the 
same check primers.  
 
6.2.2. Construction of yebST deletions in Salmonella Typhimurium SL1344 
The yebST genes span positions 1902180 to 1906065 on the SL1344 chromosome. Deletions 
were made in SL1344 using the same protocol described above for construction of the 
pqiAB::aph mutant. A yebST fragment was generated by PCR using the primer pair 
yebS_GD_F and yebT_GD_R and was ligated into pDoc-C using HindIII and BamHI 
restriction sites. Deletions in yebST were constructed as described for construction of the 
pqiAB::aph mutant, and potential mutants were screened using the primer pair 
yebS_STm_check_F and yebT_STm_check_R. A decrease from ~5000 bp to ~2500 bp 
showed successful deletion of yebST (Figure 6.1B, lanes 5 and 6). The deletion was 
transferred into a clean SL1344 background using P22 transduction to construct the 
kanamycin resistant mutant yebST::aph.  
 
6.2.3. Preparation of lipopolysaccharide to check for the presence of O-
antigen following P22 transduction 
The P22 bacteriophage enters S. Typhimurium by the attachment and cleavage of O-antigen 
(Andres et al., 2010). To check that the transduced strains still had intact O-antigen, the 
lipopolysaccharide (LPS) was extracted from the SL1344 parent and from the pqiAB::aph 
and yebST::aph mutants from before and after P22 transduction. The LPS was analysed by 
SDS-PAGE and silver staining. A characteristic O-antigen ladder was observed for the 
parent strain and the strains from prior to P22 transduction, representing the different O-
antigen chain lengths (Figure 6.2A). However, no O antigen was present in the LPS 
extracted from the mutants from after P22 transduction, suggesting that it had been 
removed during the transduction (Figure 6.2B). As O-antigen is essential for pathogenesis, 





Figure 6.2. SDS-PAGE of the LPS profiles of SLI1344, pqiAB::aph and yebST::aph 
mutants before and after P22 transduction. A. Silver stained profiles of the mutants from 
before P22 transduction in comparison to the parent strain, lane 1: molecular weight ladder, 
lane 2: SL1344, lane 3: SL1344 pqiAB::aph and lane 4: SL1344 yebST::aph. B. Silver 
stained profiles of the mutants from after P22 transduction in comparison to the parent 
strain, lane 1: molecular weight ladder, lane 2: SL1344, lane 3: the pqiAB::aph mutant  and 
lane 4: the yebST::aph mutant.  
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6.2.4. Genome sequencing of the pqiAB and yebST deletion strains from prior 
to P22 transduction  
The genomes of pqiAB::aph and yebST::aph strains from before P22 transduction (with 
intact O-antigen) were sequenced alongside the genome of the SL1344 parent. When 
compared to the parent, the strains contained no additional mutations other than the 
desired gene deletions. The pqiAB::aph and yebST::aph mutants could therefore be used 
for further experimentation. To remove the kanamycin resistance, the pqiAB::aph and 
yebST::aph mutants were electroporated with plasmid pCP20, as described previously (see 
4.2.1). The kanamycin sensitive ΔpqiAB and ΔyebST mutants were further checked by 
colony PCR to confirm removal of the kanamycin cassette.  
 
6.2.5. Generation of a pqiAB yebST double mutant 
To generate a ΔpqiAB ΔyebST mutant, the vectors used for the generation of the 
yebST::aph mutant were transformed into the ΔpqiAB deletion strain. The yebST::aph 
disruption was constructed as described previously (see 6.2.1 and 6.2.2) and colonies were 
checked using the same primers. Potential double mutants were first screened by colony 
PCR and then genome sequenced to check for second site mutations on the chromosome. 
No additional mutations were found.  The ΔpqiAB yebST::aph mutant was transformed 
with pCP20 to remove the kanamycin cassette and generate the kanamycin sensitive  
ΔpqiAB ΔyebST mutant. 
 
6.2.6. Generation of mlaD deletion strains in S. Typhimurium SL1344 using 
an alternative method 
The mlaD genes span positions 3498363 to 3498998 on the S. Typhimurium SLI1344 
chromosome. An mlaD::aph mutant was already available in a S. Typhimurium 14028s 
library (Porwollik et al., 2014). As the P22 transduction protocol resulted in loss of O-
antigen, an alternative method was used to transfer this mutation to the S. Typhimurium 
SLI1344 strain. The primers mlaD_STm_DW_F and mlaD_STm_DW_R were designed 
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approximately 250 bp upstream and downstream from the mlaD gene deletion, flanking a 
region that is identical in the SL1344 and 14028s parent strains. The primers were used to 
amplify the mlaD::aph mutation from the library with large regions of homology upstream 
and downstream. Mutations in mlaD were generated in the parent strain and the ΔpqiAB 
ΔyebST mutant by the Datsenko and Wanner method (see 2.4.1). The mlaD mutants were 
checked by colony PCR using mlaD_STm_check_F and mlaD_STm check_R primers 
(Figure 6.3A). An increase in PCR product from ~1250 bp to ~2500 bp indicated that the 
mlaD gene had been replaced with a kanamycin resistance cassette (Figure 6.3B, lanes 2, 3 
and 4). The mlaD::aph and the triple deletion strains were further checked by genome 
sequencing, revealing no unwanted mutations. 
 
6.2.7. Serum bactericidal assay to test for the ability of the six strains to 
survive in healthy human serum 
A serum bactericidal assay (SBA) assesses the ability of a strain to resist complement-
mediated killing. To check for changes in resistance to serum, the SL1344 parent strain and 
all 5 deletion strains were exposed to serum obtained from healthy humans. S. 
Typhimurium SL1344 without O-antigen was used alongside as a known sensitive strain 
(positive control). Overnight cultures of all 7 strains were adjusted to an OD600 of 
approximately 0.1 and were mixed 1:10 with serum. Samples were taken before serum 
exposure (time 0) and at 45, 90 and 180 minutes and plated onto LA plates for counting of 
viable cells. After 45 minutes of exposure, there was substantial decrease in the number of 
CFUs for the positive control strain (Figure 6.4). After 180 minutes, a slight reduction in 
viability was observed for the parent strain and all 5 mutants, but overall they were equally 
resistant to the serum. These results indicate that MlaD, PqiAB and YebST are not required 





Figure 6.3. Confirmation of the disruptions in mlaD to construct an mlaD::aph mutant 
and triple ΔpqiAB ΔyebST mlaD::aph mutant in S. Typhimurium. A. The positions of the 
mlaD check primers and B. Gel electrophoresis of PCR products confirming the 
disruptions: lane 1: molecular weight marker, lane 2: SL1344 parent strain, lane 3: 
mlaD::aph mutant and lane 4: triple mutant.	
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Figure 6.4. Bacterial survival of the S. Typhmurium strains in the presence of healthy 
serum. A serum bactericidal assay was used to check the ability to survive serum obtained 











































6.2.8. Adhesion and invasion of HeLa cells by SL1344 and the mutant strains 
The ability of the Salmonella mutants to adhere to and invade HeLa cells was tested to 
determine whether the MCE domain containing proteins are required for mammalian cell 
entry. For each of the 6 strains, 106 bacterial cells were added to 105 HeLa cells. The strains 
were left for either 30 minutes, to measure adherence, or for an additional 2 hours with 
gentamycin treatment, to measure invasion. At each time point the HeLa cells were lysed 
and plated onto LA for counting bacterial CFUs. The experiment repeated 3 times with 
biological replicates and mean number of CFUs was calculated for each strain.  
For adherence, there were no obvious differences in the number of CFUs (Figure 
6.5). A Kruskal-Wallis test was used to test the entire adherence dataset and confirmed that 
there were no significant differences (p=0.08). For invasion, the mean numbers of CFUs for 
the ΔpqiAB, ΔpqiAB ΔyebST and mlaD::aph mutants were noticeably lower than the 
parent strain (Figure 6.5). However, the decreased mean was only observed when there was 
a greater amount of variance. A Kruskal-Wallis test revealed that there were no significant 
differences in the invasion dataset (p=0.06). These results indicate that MlaD, PqiAB and 
YebST are not required for the adherence and early invasion of HeLa cells.  
 
6.2.9. Survival of the strains in bone marrow derived macrophages  
The survival of S. Typhimurium inside macrophages is important for the establishment of 
murine infection. To test whether MlaD, PqiAB and YebST are important for survival in 
macrophages, bone marrow derived macrophages were infected with the 6 strains, as 
described for the infection of HeLa cells. After 2, 5 and 24 hours, the cells were lysed and 
plated on LA. There were no large differences in the number of CFUs at any time point 
(Figure 6.6). This was confirmed by the Kruskal-Wallis test that produced p values of 0.5, 
0.44 and 0.21 for the 2, 5 and 24 hour datasets, respectively. Therefore, it was concluded 
that MlaD, PqiAB and YebST are not required for the entry or survival of S. Typhimurium in 




Figure 6.5. Adhesion and invasion of HeLa cells with the parent strain and five deletion 
strains. For adhesion, the bacteria were left to adhere to HeLa cells for 30 minutes and the 
HeLa cells were lysed and plated onto LB agar plates. For the 2 hour time point, the bacteria 
were given an additional 2 hours in the presence of gentamycin to test for invasion only. 
The bars are a mean of 3 biological replicates and the error bars represent the standard 
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Figure 6.6. Survival of the parent strain and five deletion strains in bone marrow derived 
macrophages after 2, 5 and 24 hours of invasion. The bars are a mean of 3 biological 
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6.2.10. Intraperitoneal infection of mice with the six Salmonella strains to 
determine the importance of MCE domains during murine infection 
S. Typhimurium is known to cause systemic infection of mice, particularly in organs of the 
reticuloendothelial system such as the liver and spleen. A pilot study was conducted in mice 
to check for differences in systemic infection between the strains. Two C57/BL6 mice were 
infected via intraperitoneal injection with 1000 bacterial cells for each strain. After 3 days 
the mice were culled and the livers and spleens were mashed and plated onto LB plates. The 
pilot study revealed decreased numbers of CFUs/organ for some of the mutants, and 
therefore the same experiment was repeated with 4 mice per strain. The data from both the 
pilot and scale-up experiments were combined and the mean numbers of CFUs/organ were 
calculated for each strain. No viable bacteria were observed in a mouse infected with the 
ΔyebST mutant or in another infected with the triple mutant. This was possibly due to 
unsuccessful injections and these data were therefore excluded from further analysis.  
In both the liver and spleen there appeared to be attenuation of the ΔpqiAB ΔyebST, 
mlaD::aph and the triple mutants, but no differences were observed for the ΔpqiAB and 
ΔyebST single mutants (Figure 6.7A and B). The p values from a Kruskal-Wallis test were 
2.4e-05 and 1.0e-04 for the liver and spleen datasets, respectively, confirming that there 
were significant differences present. Pairwise comparisons between datasets for each strain 
were done using a Mann-Whitney U test, and the Bonferroni correction was applied to all p 
values to correct for multiple testing (Figure 6.8). There were no significant differences 
between the datasets for the parent, ΔpqiAB and ΔyebST deletion strains in either the liver 
or the spleen. The numbers of CFUs for the ΔpqiAB ΔyebST, mlaD::aph and triple deletion 
strains were significantly different from the parent strain, with p values of less than 0.01 in 
both organs. In the liver, the numbers of CFUs for these 3 attenuated strains were also 
significantly different from one another, revealing that the mutants become increasingly 
attenuated in the following order: ΔpqiAB ΔyebST, mlaD::aph and ΔpqiAB ΔyebST 




Figure 6.7. Survival of the parent strain and five deletion strains in C57/BL6 mice. The 
mice were infected with the strains for 3 days via IP injection. The CFUs/organ were 
counted in the liver (A) and spleen (B). Each point represents the number of CFUs/organ 
from a single mouse, and the line indicates the mean number of CFUs.  
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SL1344               ΔpqiAB               ΔyebST              ΔpqiAB              mlaD::aph           ΔpqiAB  
                                                                                 ΔyebST                                         ΔyebST 
                          mlaD::aph 
  
SL1344               ΔpqiAB               ΔyebST              ΔpqiAB              mlaD::aph           ΔpqiAB  
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Figure 6.8. Pairwise comparisons of all datasets obtained from the mouse infection 
experiments using a Mann-Whitney U test. The Bonferroni correction was applied to 
correct for multiple comparisons. The numbers in bold represent significant p values 
(p<0.05).  




SL1344 - 0.9127 0.7642 0.005 0.005 0.0065 
 ΔpqiAB  0.588 - 0.9372 0.0065 0.0065 0.0065 
 ΔyebST  0.71 0.71 - 0.0065 0.0065 0.0108 
ΔpqiAB 
ΔyebST  0.013 0.033 0.013 - 0.0065 0.0065 









not significant. Overall these results reveal an additive phenotype for the ΔpqiAB ΔyebST 
and triple deletion strains. Furthermore, they suggest that all MCE domain containing 
proteins, particularly MlaD, have some role in the systemic infection of S. Typhimurium. 
 
6.2.11. Growth of the parent strain and triple mutant on lyso-
phosphatidylglycerol as a sole carbon source 
A previous study has demonstrated that S. Typhimurium metabolises phospholipids in bile, 
and that it can use some lyso-phospholipids as a sole source of carbon (Antunes et al., 
2011). With the clear link of MlaD, PqiB and YebT to phospholipids, it was appropriate to 
test the growth of the S. Typhimurium parent strain and triple mutant with lyso-
phospholipids as the only carbon source in M9 minimal medium. To first check the growth 
profiles, the strains were inoculated into M9 medium supplemented with 200 mM histidine 
(as S. Typhimurium SL1344 is a histidine auxotroph) with or without 10 mg/ml glucose as a 
carbon source. Neither of the strains grew in M9 and histidine only, confirming that the 
strain could not grow without a specific carbon source (Figure 6.9A). The growth profiles 
with glucose were the same for both strains, revealing that the mutant has no altered ability 
to grow in minimal media.  
To test for changes in the ability to grow on lyso-phospholipids, the strains were 
grown in M9 supplemented with 200 mM histidine and 1 mg/ml lyso-PG. The growth 
profiles revealed a growth defect for the triple deletion strain, which was present in all 3 
biological replicates (Figure 6.9B). The loss of the ability to grow on lyso-PG indicates that 
MlaD, PqiAB and/or YebST function in the utilisation of lyso-PG as a carbon source.  
 
6.3. Discussion 
The first aim of this chapter was to determine whether MlaD, PqiAB and YebST were 
important for infection in vitro. Following the construction of the mlaD::aph, ΔpqiAB, 
ΔyebST, ΔpqiAB ΔyebST and ΔpqiAB ΔyebST mlaD::aph deletion strains, the ability of 
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Figure 6.9. Growth of the parent and triple mutant on lyso-PG as a carbon source. The 
strains were grown in M9 minimal media supplemented with 200 mM histidine. The strains 
were grown with either no carbon source (A-circles), 10 mg/ml glucose (A-squares) or 1 
mg/ml lyso-PG (B). For B, each point represents the mean OD600 from 3 biological 
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the strains to survive challenge by serum from healthy humans was tested. The results show 
that, as with the parent strain, all 5 mutants were resistant to serum, and are therefore able 
to withstand complement-mediated killing.  
 In vitro tissue culture experiments also indicated that MlaD, PqiAB and YebST are 
not required for the attachment or early invasion of HeLa cells. These results are in contrast 
to similar experiments with Shigella sonnei (SS01327) and Vibrio parahaemolyticus 
(MAM-7), which demonstrated a role for MAM-7 in the attachment and invasion of HeLa 
cells (Krachler et al., 2011; Mahmoud et al., 2016). It is possible that these results 
demonstrate differences between the role of MCE domains between bacterial species. 
Krachler et al. (2011) also reported that the MAM-7 deletion strain was less cytotoxic for 
mammalian cells. Further experiments will be necessary to determine whether the same is 
true for S. Typhimurium mutants.  
  Whilst HeLa cells are ideal for cell entry experiments, they do not fairly represent 
the harsh intracellular environment in which S. Typhimurium has to persist to establish 
infection. An important stage of S. Typhimurium infection is the ability to survive in 
macrophages by withstanding factors designed to kill invading microorganisms. The results 
from this chapter indicate that MCE domain containing proteins are not required for the 
survival of S. Typhimurium in macrophages derived from bone marrow. Together with the 
results from the HeLa experiments, these results indicate that MCE domain containing 
proteins are not necessary for S. Typhimurium mammalian cell entry or survival.  
 The second aim of this chapter was to determine whether MCE domain containing 
proteins are important for S. Typhimurium infection of mice. The results revealed that the 
ΔpqiAB ΔyebST, mlaD::aph and ΔpqiAB ΔyebST mlaD::aph mutants were all attenuated 
in mice, but the ΔpqiAB and ΔyebST mutants were not. The trend in the data suggests that 
the mlaD deletion strain is more attenuated than the ΔpqiAB ΔyebST deletion strain, and 
that the triple mutant is the most attenuated. This trend was proven to be significant in the 
liver, but not in the spleen. However the spread of the data for the spleen was large and it is 
therefore likely that this trend would be significant with more replicates. The data indicate 
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that MlaD is the most important MCE domain containing protein for establishing systemic 
infection (at least in the liver), and is more important than both PqiAB and YebST 
combined. Furthermore, additive phenotypes for the ΔpqiAB ΔyebST and triple deletion 
strains were identified, similar to those observed in E. coli. Overall, these results reveal that 
MlaD, PqiAB and YebST all contribute to some extent to S. Typhimurium systemic 
infection.  
 In the previous chapter, a role for MCE domain containing proteins in phospholipid 
uptake was considered, but experiments with E. coli K-12 BW25113 were unsuccessful due 
to a lack of growth on phospholipids. With the knowledge that S. Typhimurium is able to 
grow on lyso-PLs (Antunes et al., 2011), the third aim of this chapter was to determine 
whether the proteins are required for this process. Decreased growth was observed for the 
triple mutant on lyso-PG, suggesting that the proteins are necessary for either uptake or 
metabolism of phospholipids. Future experiments will test growth of the individual mutants 
to determine whether all three MCE domain-containing proteins are involved in this 
process. Furthermore, other phospholipids will be tested to determine whether the 
phenotype is general or specific to lyso-PG.   
Overall, the experiments described in this chapter revealed for the first time that 
MCE domain containing proteins in Gram-negative bacteria are important for mammalian 
infection.  With the knowledge that MCE domain containing proteins are unlikely to be 
required for S. Typhimurium mammalian cell entry and/or survival, other possible 
scenarios for this attenuation phenotype have to be considered. Whilst there are many 
harsh environments for S. Typhimurium to withstand, the ability to survive in bile is 
particularly important for systemic infection. It is known that phospholipids in bile can act 
as a carbon source for S. Typhimurium, and therefore the ability to utilise phospholipids 
might be an important part in establishing systemic infection (Antunes et al., 2011). It is 
therefore possible that the attenuation phenotype observed in mice is linked to the role of 
MCE domain containing proteins in phospholipid metabolism in bile, a hypothesis 











7.1. The evolution of the MCE domain-containing proteins as components of 
transporters 
Prior to this study, the link between MCE domains and transport had already been 
established. MCE domain containing proteins have previously been identified as 
homologous to the substrate binding components of ABC transporters (Kumar et al., 2005) 
and an in depth bioinformatic study in 2007 identified a strong link between MCE domains 
and ABC transporters in Actinobacteria (Casali and Riley, 2007).  
 In this study, a similar bioinformatic study was conducted but with more focus on 
the different types of MCE domain containing proteins, particularly in Proteobacteria. 
These analyses revealed that MCE domains have remained conserved throughout bacterial 
evolution and that proteins with greater than two MCE domains, such as PqiB and YebT, 
are specific to and have evolved within Proteobacteria. Furthermore, it was shown that 
single MCE domain containing proteins are nearly always part of an ABC transporter, as 
already indicated (Casali and Riley, 2007), but that the multi-domain proteins are part of a 
novel type of transporter with PqiA domain containing proteins. This work complements 
the existing literature that reports a role of MCE domains in transport, and for the first time 
highlights the distinction between single and multi-MCE domain containing proteins. 
The co-evolution of multi-MCE domain containing proteins and PqiA domain 
containing proteins in Proteobacteria suggests that these proteins are functionally linked. 
Whilst the mechanisms of ABC transporter domains are fairly well understood, the function 
of a PqiA domain is completely unknown. Other than the predicted homology to an 
antiporter domain (Hunter et al., 2009), there is no evidence that PqiA domains are 
involved in transport. Therefore, it is important for future experiments to focus on the 
function of PqiA domains as transporters.  
 The presence of the multi-domain operons in only Proteobacteria suggests that they 
have evolved a role that is not required in other bacterial phyla. As Proteobacteria are a 
large and diverse group of organisms, and the multi-domain proteins are found in all of the 
major classes, it is difficult to identify why they would be specific to this phylum. Therefore, 
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a more extensive analysis is required to look more closely at the species in Proteobacteria 
that harbour the multi-domain protein types, and their lifestyles.  
  
7.2. The relationship between the three pathways in E. coli and their link to 
phospholipids 
The Mla pathway of E. coli was first identified in 2009 (Malinverni and Silhavy, 2009), as a 
retrograde phospholipid trafficking pathway and subsequent studies have looked at the 
more specific characteristics of the pathway (Chong et al., 2015; Thong et al., 2016). In this 
thesis the two other MCE operons in E. coli were highlighted: pqiAB-ymbA and yebST, both 
of which encode multi-MCE domain containing proteins and were previously unstudied. 
The major aim of this study was to gain a general understanding of the multi-domain 
proteins in E. coli, PqiB and YebT, by identifying phenotypes and determining sub-cellular 
locations. This aim was met and further explored to understand the relationships between 
PqiB, YebT and the single domain protein, MlaD. It was shown that PqiB and YebT localise 
to the same place in the cell as MlaD: the inner membrane. Sulfobetaine sensitivity and 
vancomycin resistance phenotypes revealed that the functions of the three proteins are 
distinct but overlapping, with the multi-domain pathways overlapping the most. 
Furthermore, the use of lipidomics revealed that, despite the reported role of the Mla 
pathway (Malinverni and Silhavy, 2009), none of the MCE pathways play a major role in 
the phospholipid composition of the cell membrane. However, MlaD, PqiB and YebT 
proteins were all found to bind phospholipids, suggesting that these proteins most likely 
impact the cell membrane in some capacity. These novel findings explore, for the first time, 
the functional relationships between the three MCE pathways in E. coli.  
 Whilst this is the first study to look at all three MCE domain containing pathways 
and identify that there are differences between them– it is still not known how these 
pathways differ. It is possible that they have different substrate specificities, are induced 
under different conditions or are simply functionally redundant – although the phenotypes 
observed here make the latter unlikely. The varying sensitivities of the mutants to 
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sulfobetaines with different chain lengths suggest that the different pathways might vary by 
their chain length specificities. The lack of sensitivity to SDS alone suggests that the 
phenotypes might be specific to zwitterionic detergents, or specifically sulfobetaines. Future 
experiments will focus on identifying the range of detergents that these phenotypes are 
observed for. 
 Arguably the easiest way to determine chain length specificities is to scrutinise the 
phospholipid species bound to MlaD, PqiB and YebT. Further investigation of the protein-
lipid extracts by mass spectrometry will identify if there are differences, and this could be a 
key experiment for determining the differences between the three pathways in E. coli. 
Similarly, determining by mass spectrometry the acyl chain lengths in membrane 
phospholipids derived from the various mutants will help determine whether the proteins 
are involved in more subtle alterations of membrane phospholipids. 
Future work should also focus on the mechanism of transport within the MCE 
pathways, and what are the precise roles of each component. This has recently been a focus 
of research on the Mla pathway, where MlaD has been shown to form a hexamer as part of a 
stable ABC transporter complex with MlaB, E and F, located in the inner membrane (Thong 
et al., 2016). It has been proposed that the periplasmic chaperone, MlaC, does not strongly 
interact with either the inner membrane complex or outer membrane complex (MlaA-
OmpC), and that the ability of MlaC to transfer phospholipids to/from these complexes is 
purely due to its affinity to phospholipids (Thong et al., 2016). Whilst such detailed studies 
do not exist for the PqiAB-YmbA pathway, the results presented here suggest that PqiB, like 
MlaD, might also form a hexamer in the inner membrane. Furthermore, a recent study has 
shown that PqiB in the inner membrane and YmbA in the outer membrane interact, 
suggesting that PqiB spans the periplasm (Nakayama and Zhang-Akiyama, 2016). It is likely 
that the same is true for YebT as it is a larger protein than PqiB, but this has not been 
confirmed. The ability of PqiB and YebT to span the periplasm would explain why the 
pqiAB-ymbA and yebST operons do not encode predicted periplasmic chaperones. 
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Currently, it is unknown whether the PqiAB-YmbA and YebST systems are also 
associated with OMPs, like the Mla pathway (Chong et al., 2015). Further experimentation 
is required to identify any other components of the multi-domain pathways. Simple protein 
pull-down experiments could identify other components through their interactions. 
Alternatively the phenotypes discovered in this thesis could be manipulated to identify 
additional components. The most thorough way of doing this is through the use of a high-
density transposon library, which contains transposon insertions throughout the genome. 
Such a library could be grown on lauryl sulfobetaine and sequenced to identify all the 
mutants in E. coli that are inhibited by the detergent. Any candidates can be further tested, 
for example by protein-protein interactions, to determine if they are linked to the pathway 
of interest.  
 
7.3. The future of MCE domain structural biology 
There is currently no published structure for an MCE domain containing protein. To 
address this, one aim of this study was to determine the first crystal structure of the 
domain, with particular focus on PqiB. Whilst this was not achieved in this study, 
significant steps were taken toward optimising conditions for crystal growth and improving 
the quality of crystals. However, during the writing of this thesis, it became apparent that 
another group had successfully obtained the structures of MlaD, PqiB and YebT by a 
combination of crystallography and cryo electron microscopy. Collaboration has been 
established with these researchers, and all future structural biology will take place in their 
institution.  
 Now that structures exist for MlaD, PqiB and YebT, the key residues in the MCE 
HMM (see Figure 1.12) can be highlighted in the structures to identify why they are so 
conserved. Furthermore, these key residues can be altered to determine how important they 
are for the structure and this can be linked with genetics and lipid binding assays to 
determine their function.  
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7.4. MCE domains are not required for Salmonella to enter mammalian cells  
Since the first MCE domain was identified in 1993, the role of MCE domain containing 
proteins in infection has been a main focus of the literature. As the name suggests, the 
original function was thought to directly involve mammalian cell entry (Arruda et al., 1993). 
However, in this study it was revealed that MCE domain containing proteins are not 
required for Salmonella entry of HeLa cells or survival in macrophages, suggesting that they 
are not directly involved in mammalian cell entry.  
Whilst these results might appear counter-intuitive, few studies have actually 
concluded that mutants display decreased cell entry. The Mce1A protein found in M. 
tuberculosis was the original protein shown to aid E. coli entry and survival into 
macrophages (Arruda et al., 1993). Beads coated with Mce1A also have the ability to enter 
HeLa cells (Arruda et al., 1993; Chitale et al., 2001; El-Shazly et al., 2007; Saini et al., 
2008). However mce1 mutants do not show decreased ability to enter and survive in 
mammalian cells (Marjanovic et al., 2010; Shimono et al., 2003). This indicates that whilst 
MCE domains might be important for cell entry and survival in particular laboratory 
conditions, this might not be their primary role in vivo. This hypothesis is supported by the 
fact that MCE domains are present in a wide range of non-pathogenic bacterial and 
eukaryotic species (Figures 3.2 and 3.3).  
 
7.5. MCE domain containing proteins are required for systemic infection of 
Salmonella Typhimurium and for phospholipid uptake 
Several studies in Actinobacteria have identified that MCE domain containing proteins are 
important for mammalian infection in vivo (Marjanovic et al., 2010; Senaratne et al., 
2008). However, prior to this work no parallel studies existed for Gram-negative bacteria. 
In agreement with the literature, the results presented here suggest that MCE domain 
containing proteins in S. Typhimurium are important for systemic infection in mice, 
although their precise role remains unclear.  
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 In Actinobacteria, the same proteins that are required for infection are also required 
for uptake of various lipids (Cantrell et al., 2013; Klepp et al., 2012; Mohn et al., 2008; 
Pandey and Sassetti, 2008), suggesting that the attenuation phenotype observed could be 
linked to lipid uptake. This work indicates that the same is true for Salmonella, as a strain 
lacking all three MCE-domain containing proteins is less able to grow on phospholipids. 
This suggests that at least one of the MCE domain containing proteins is important for 
phospholipid uptake. As phospholipids are an important nutrient source in bile (Antunes et 
al., 2011), this could explain why these strains are attenuated in mice. Interestingly, the 
same mutants in S. Typhimurium that were attenuated in mice (the double pqiAB yebST 
mutant, mlaD mutant and triple mutant) were also resistant to vancomycin in E. coli. As 
increased vancomycin resistance might be linked to phospholipid accumulation on the cell 
surface (Sutterlin et al., 2014), it is possible that the attenuation phenotype observed for 
Salmonella is a direct consequence of phospholipid accumulation on the cell surface.  
 Further experimentation is required to determine if the observed attenuation 
phenotype is due to the decreased ability of the mutants to utilise phospholipids in bile. 
Simple growth curves will identify whether the MCE domain containing proteins are 
required for growth in bile. Furthermore, longer-term infection studies can investigate the 
importance of MCE domain containing proteins in the faecal shedding of Salmonella, which 
is largely sourced from the release of infected bile into the intestinal lumen (Monack et al., 
2004). 
 
7.6. A hypothesised model for the Mla, Pqi and Yeb pathways 
The bioinformatics and lipid binding results presented here reveal that there is a clear link 
to phospholipid trafficking, which is supported by the literature on the Mla pathway 
(Malinverni and Silhavy, 2009). The Salmonella phospholipid growth curves and lipid 
uptake experiments in the literature indicate that the pathways are specifically involved in 
uptake, which is supported by the fact that substrate-binding proteins (to which MCE 
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domains containing proteins are homologous) have only been identified in importers 
(Higgins, 2001).  
If all three pathways are involved in uptake from the external environment, this 
would suggest that description of the role of the Mla pathway is incomplete, and that this 
import pathway functions in uptake of phospholipids from outside the cell, not just from 
the outer membrane (Malinverni and Silhavy, 2009). Therefore, it is possible that the three 
pathway can function in maintaining the outer membrane but also in providing 
phospholipids as a carbon source when other nutrients are scarce, such as in bile. Currently, 
the final destination of the phospholipids trafficked by the Mla system remains unknown. It 
has not been determined whether the phospholipids are inserted into the inner membrane 
or whether they enter the cytoplasm. The requirement of the MCE domain containing 
proteins for growth on phospholipids suggests that at least one of the MCE pathways result 
in phospholipids reaching the cytoplasm for degradation.  
With this in mind, a model was hypothesised for all three MCE pathways in 
Proteobacteria (Figure 7.1). This model proposes that all three pathways take phospholipids 
from the cell surface and external environment. It is possible that these two processes are 
not distinct, and that the phospholipids are first inserted into the outer leaflet and then 
removed for uptake. The model for all three MCE pathways starts with OMPs, which for the 
PqiB and YebT systems are currently unknown. In the Mla pathway, MlaA obtains 
phospholipids from OmpC, which are subsequently passed to MlaC and then onto the inner 
membrane MlaBDEF complex, which includes an MlaD hexamer (Thong et al., 2016) 
(Figure 7.1A). The proposed mechanism for the Pqi pathways is similar, where 
phospholipids are passed from the unknown OMP to PqiB, via YmbA (Figure 7.1B). In this 
model, PqiB forms a hexamer that spans the periplasm, through which the phospholipids 
pass to reach PqiA in the inner membrane. The proposed model for the YebST pathway is 
the same, except the outer membrane lipoprotein is not present and YebT can directly 
interact with the OMP (Figure 7.1C). In this model, phospholipids trafficked by the MCE 
pathways end up the cytoplasm for degradation. The model presented here seems 
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Figure 7.1. A model for the MCE domain containing phospholipid uptake pathways in E. 
coli. Phospholipids are taken from the cell surface or from outside the cell. A. The Mla 
pathway: phospholipids pass through OmpC, to the inner membrane lipoprotein, MlaA. The 
phospholipids are passed from MlaA to MlaC and through the MlaD channel onto MlaFEB 
inner membrane complex. The phospholipids are transported through the MlaE permease 
and into the cytoplasm for degradation. B. The Pqi pathway: phospholipids pass through an 
unknown OMP to the lipoprotein YmbA. From YmbA, phospholipids pass to the PqiB 
channel and through to PqiA in the inner membrane. Here, the phospholipids are 
transported through PqiA by and unknown mechanism. C. The Yeb pathway: the 
phospholipids pass from an unknown OMP straight through the YebT pore and on to YebS 
in the inner membrane. 
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the most likely given the existing literature and the results presented in this thesis. 
However, aside from the growth on phospholipids, there is no experimental data to suggest 
the direction of the phospholipid transport. To address this future experiments will involve 
tracking radiolabelled phospholipids in E. coli, as described by Jones and Osborn (1977).  
As fatty acids are the major component of phospholipids, links to the fatty acid 
degradation (Fad) system must also be considered. FadL is required for transport of longer 
chain fatty acids across the outer membrane (Black, 1991), and FadD for transport across 
the inner membrane (Black et al., 1992). However, the method by which fatty acids cross 
the periplasm is currently unknown (Parsons and Rock, 2013). The link of the MCE 
pathways to lipid uptake indicates that they could be a missing part of the fatty acid 
degradation system in Proteobacteria. However, experimentation with the various 
components of the Fad system and with fatty acids is required to test this hypothesis.  
Overall, this study has expanded our knowledge of MCE domain containing 
proteins in Proteobacteria. The results demonstrate that MCE domains are not directly 
involved in mammalian cell entry, as originally thought (Arruda et al., 1993). Instead the 
evidence suggests a role in phospholipid transport in Proteobacteria that is important for 













1 11012 MCE 
2 2718 MCE, DUF3407 
3 2026 MCE, MCE, MCE 
4 1042 MCE, MCE, MCE, MCE, MCE, MCE, MCE 
5 236 MCE, MCE, MCE, MCE, MCE, MCE 
6 125 MCE, MCE 
7 35 MCE, DUF330 
8 20 MCE, MCE, MCE, MCE 
9 15 MCE, MCE, MCE, MCE, MCE 
10 8 MCE, MCE, DUF3407 
11 7 MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE 
12 4 MCE, DUF3407, MCE 
13 4 MCE, MCE, MCE, DUF330 
14 2 MCE, AP2 
15 2 PqiA, PqiA, MCE, MCE, MCE, DUF330 
16 2 PqiA, MCE, MCE 
17 2 MCE, PLU-1 
18 2 MCE, OmpA 
19 1 MCE, MCE, MCE, MCE, Molybdopterin 
20 1 PqiA, PqiA, MCE, MCE, MCE, MCE, MCE, MCE, MCE, Nol1_Nop2_Fmu, Methyltransf_31, Methyltransf_18, Methyltransf_26, Nol1_Nop2_Fmu, Nol1_Nop2_Fmu_2 
21 1 MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE, MCE 
22 1 MCE, DUF4455 
23 1 OTCace_N, OTCace, MCE 






25 1 MCE, Inositol_P 
26 1 Permease, MCE, Tol_Tol_Ttg2, STAS_2, BolA 
27 1 MCE, Bacillus_HBL 
28 1 MCE, RTX 
29 1 MCE, Serine_rich 
30 1 MCE, MCE, MCE, MCE, PqiA, MCE, MCE, MCE 
31 1 MCE, DUF3407, MCE, DUF3407 
32 1 MCE, DUF3407, DUF3407 
33 1 PqiA, MCE, MCE, MCE, MCE, MCE, Nol1_Nop2_Fmu, Nol1_Nop2_Fmu_2 
34 1 MCE, LXG 
35 1 MCE, GCN5L1 
36 1 ABC_tran, MCE 
37 1 NDUFA12, MCE, DUF2155 
38 1 MreC, MCE, MCE 
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Appendix ii – Distribution of the top nine MCE domain containing architectures across 
bacteria 
 



















Appendix iii – Biolog data 
 






BW25113 (red) vs BW25113 ΔyebST (green) 
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BW25113 (red) vs BW25113 ΔpqiAB ΔyebST (green) 
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Appendix iv – Growth of the BW25113 parent and mutant strains on LA supplemented 
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